{"data":{"roots":[{"slug":"clearing","name":"Clearing","cluster":"biology","canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"slug":"cryonics","name":"Cryonics","cluster":"biology","canonical_statement":"Preserve the biological substrate (whole body, brain, or connectome) at the moment of biological failure so that future technology can revive or substitute the failed parts. The only intervention paradigm that does not operate on active biology — it pauses everything and bets on later tech for the actual revival. Includes whole-body cryopreservation (Alcor, Cryonics Institute, Tomorrow Biostasis), neuropreservation, aldehyde-stabilized cryopreservation for connectome preservation (Nectome), and plastination / vitrification variants."},{"slug":"editing","name":"Editing","cluster":"biology","canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"slug":"modulating","name":"Modulating","cluster":"biology","canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"slug":"repairing","name":"Repairing","cluster":"biology","canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"slug":"replacing","name":"Replacing","cluster":"biology","canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"slug":"reprogramming","name":"Reprogramming","cluster":"biology","canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"slug":"training","name":"Training","cluster":"biology","canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"slug":"delivering","name":"Delivering","cluster":"method","canonical_statement":"Vehicles that get therapeutic payloads to their targets — AAV vectors with engineered tropism, lipid nanoparticles (LNPs), exosomes and extracellular vesicles, engineered nanoparticle carriers, non-viral genetic delivery, Mitlet-style organelle-delivery vehicles."},{"slug":"discovering","name":"Discovering","cluster":"method","canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"slug":"measuring","name":"Measuring","cluster":"method","canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"slug":"operating-trials","name":"Operating Trials","cluster":"method","canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"slug":"translating","name":"Translating","cluster":"method","canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."}],"nodes":[{"node_id":"01bd4f4f-8ee2-4eef-a921-0616a554d4f1","node_slug":"clear-7-ketocholesterol-from-foam-cells","node_name":"Clear 7-ketocholesterol from foam cells","alternate_names":[],"scope_statement":"Clears 7-ketocholesterol and related cytotoxic oxysterols from plaque macrophages and foam cells, then routes the sterol cargo into hepatic or biliary excretion to restore macrophage function by removing the junk rather than pretending the cells can be talked out of it.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"5bb60a71-00ae-48b8-88bc-29d326c5d5f3","node_slug":"clear-adipocytes-by-apoptosis","node_name":"Clear adipocytes by apoptosis","alternate_names":[],"scope_statement":"Clears excess adipose tissue by triggering programmed death in targeted adipocytes, so the cells are removed outright instead of merely being bullied into shrinking.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"194a3876-58a0-45f4-bb31-8511bea74a2f","node_slug":"clear-amyloid-beta-with-antibodies","node_name":"Clear Amyloid-Beta With Antibodies","alternate_names":[],"scope_statement":"Clears aggregated amyloid-beta species from the brain by using monoclonal antibodies that bind plaques and soluble oligomers for microglial removal, lowering proteopathic burden rather than rebuilding damaged neurons.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"4dfc7f7e-ed64-4558-a026-c6d141e96a16","node_slug":"clear-cells-by-apoptosis","node_name":"Clear Cells by Apoptosis","alternate_names":["Clear damaged and transformed cells"],"scope_statement":"Clears designated cell populations by activating apoptotic programs such as caspase-8/caspase-9, BAX/BAK, or death-receptor signaling so they are dismantled and efferocytosed instead of bursting open and spraying inflammatory debris everywhere.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"fd07d4b2-6957-428c-9783-265093a45930","node_slug":"clear-cellular-junk-with-spermidine","node_name":"Clear Cellular Junk with Spermidine","alternate_names":["autophagy-based intracellular cleanup","Boost Autophagic Clearance","Clear Waste via TFEB","enhance lysosomal autophagy","induce autophagic clearance","promote mitophagy and proteostasis","stimulate cellular housekeeping"],"scope_statement":"Clears intracellular protein and organelle debris by using spermidine to induce autophagy, often through EP300 inhibition and LC3/ATG-dependent lysosomal flux rather than any vague 'vitality' nonsense.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"fab748a5-a29d-4070-9f74-5941d9c87578","node_slug":"clear-circulating-debris-extracorporeally","node_name":"Clear Circulating Debris Extracorporeally","alternate_names":[],"scope_statement":"Clears unwanted blood-borne material such as senescent cells, immune complexes, protein aggregates, microvesicles, or inflammatory factors by extracorporeal apheresis, hemoperfusion, or membrane filtration, then returns the cleaned blood to the patient.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"90e64cf9-326a-4c68-b115-1ffb14d12026","node_slug":"clear-damaged-endoplasmic-reticulum","node_name":"Clear damaged endoplasmic reticulum","alternate_names":[],"scope_statement":"Clears damaged or excess endoplasmic reticulum by ER-phagy, using selective autophagy receptors such as FAM134B, TEX264, CCPG1, SEC62, RTN3L, or ATL3 to send ER fragments to lysosomes instead of letting proteostasis fall apart.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"251819bb-bde8-44be-bd19-57c4cb59f265","node_slug":"clear-damaged-extracellular-matrix","node_name":"Clear Damaged Extracellular Matrix","alternate_names":["Soften Cross-Linked Stem-Cell Niches"],"scope_statement":"Clears or remodels age-damaged extracellular matrix proteins, especially cross-linked collagen and elastin, to remove stiff, protease-resistant, inflammation-provoking matrix debris rather than pretending the tissue will fix itself.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"0a026e6d-6752-4763-a24a-fcf5be2c5fbe","node_slug":"clear-damaged-mitochondria","node_name":"Clear damaged mitochondria","alternate_names":["Repair Mitochondrial Quality Control"],"scope_statement":"Clears depolarized or oxidatively damaged mitochondria through mitophagy programs such as PINK1-Parkin, BNIP3/NIX, or FUNDC1, cutting mitochondrial debris and the downstream stress from broken organelles doing what broken organelles do.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"e4372673-69eb-452a-ba78-57dc37a5025f","node_slug":"clear-damaged-mitochondria-by-mitophagy","node_name":"Clear damaged mitochondria by mitophagy","alternate_names":["activate PINK1-Parkin mitophagy","Activate PINK1/Parkin mitophagy","boost mitochondrial quality control","Boost Parkin-dependent mitophagy","Brain-penetrant mitochondrial clearance","Central nervous system mitophagy activation","CNS-targeted mitophagy induction","damaged mitochondria clearance","Enhance PINK1-mediated mitochondrial quality control","Enhancing mitophagy through USP30 blockade","induce mitophagy with urolithin analogs","induce selective mitochondrial autophagy","mitochondria-specific autophagic clearance","mitophagic removal of dysfunctional mitochondria","Neuronal mitophagy enhancement","Neurotargeted mitochondrial turnover","Parkin-dependent mitophagy activation via USP30","pharmacologic mitochondrial quality-control clearance","PINK1-Parkin mitophagy activation","PINK1-Parkin sensitization via USP30 inhibition","promote mitochondrial clearance by depolarization","promote mitophagy","Promote selective mitophagy of impaired mitochondria","selective mitophagy","stimulate mitochondrial turnover","Targeted enhancement of mitochondrial clearance","targeted mitochondrial quality control","Targeting USP30 to promote selective mitophagy","Trigger mitochondrial damage surveillance clearance","urolithin-derived mitophagy induction","USP30 blockade to enhance mitophagy","USP30 blockade to enhance PINK1/Parkin mitophagy","USP30 depletion-driven mitophagy enhancement","USP30 deubiquitinase inhibition","USP30 inhibition for mitophagy","USP30 suppression of mitochondrial quality control","USP30-targeted mitochondrial clearance","USP30-targeted mitochondrial quality control"],"scope_statement":"Clears depolarized or otherwise damaged mitochondria through PINK1-Parkin and receptor-mediated mitophagy pathways to reduce mitochondrial ROS, mtDNA leakage, and the downstream stress signals from keeping broken organelles around.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"6c863e09-b936-4223-8ed4-60452b1cf7e0","node_slug":"clear-intracellular-cholesterol-buildup","node_name":"Clear intracellular cholesterol buildup","alternate_names":["Clear Pathologic Cholesterol Deposits"],"scope_statement":"Clears cholesterol and cholesteryl ester accumulations from diseased cells, especially macrophage foam cells, by restoring lysosomal trafficking, ester hydrolysis, and ABCA1/ABCG1-mediated efflux to reduce plaque burden and inflammation rather than merely pushing down circulating LDL.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"92e3acbb-8fd9-45c3-a83a-4df66dcad952","node_slug":"clear-membrane-proteins-via-lysosomes","node_name":"Clear membrane proteins via lysosomes","alternate_names":["AbTAC-mediated degradation","cell-surface protein degradation","cell-surface targeted protein degradation","endolysosomal surface protein clearance","endolysosomal targeted protein clearance","lysosomal clearance of membrane proteins","lysosomal membrane protein degradation","receptor-mediated lysosomal degradation","targeted membrane protein degradation","ubiquitin-driven receptor downregulation"],"scope_statement":"Clear cell-surface and endosomal membrane proteins by forcing their endocytosis and delivery to lysosomes through pathways such as CI-M6PR-, ASGPR-, or ESCRT-mediated trafficking, which improves proteostasis without the gene-editing fan fiction.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"b2a44fa8-2ce6-46fc-9641-d9fc02d5f24c","node_slug":"clear-oxidized-cholesterol-species","node_name":"Clear oxidized cholesterol species","alternate_names":["7-KC detoxification","7-ketocholesterol clearance","7-ketocholesterol extraction therapy","Atherosclerotic oxysterol removal","cholesterol oxidation product clearance","Clear Targets With Cyclodextrins","Cyclodextrin dimer sterol scavenging","cyclodextrin-mediated 7KC removal","Cyclodextrin-mediated plaque sterol extraction","engineered cyclodextrin oxysterol clearance","foam-cell lysosomal sterol clearance","oxidized cholesterol removal from plaques","oxysterol clearance","Oxysterol clearance from plaques","oxysterol scavenging with cyclodextrin dimers","Plaque cholesterol debris clearance","plaque oxysterol clearance","removal of oxidized cholesterol","selective plaque cholesterol detoxification"],"scope_statement":"Clears toxic oxidized cholesterol species such as 7-ketocholesterol and related oxysterols by binding, extracting, or promoting their removal from tissues and circulation before they keep wrecking cells.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"9a3d2d59-e7cf-4aa5-b843-6d250b1fafe0","node_slug":"clear-pathogenic-proteins-by-vaccination","node_name":"Clear pathogenic proteins by vaccination","alternate_names":[],"scope_statement":"Primes the adaptive immune system with active vaccines against pathogenic protein species such as amyloid-beta, tau, alpha-synuclein, or transthyretin so the patient's own antibodies bind, neutralize, and help clear those aggregates over time.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"ded05975-2448-4700-86e2-5ab7f87cdec2","node_slug":"clear-proteins-by-targeted-degradation","node_name":"Clear proteins by targeted degradation","alternate_names":["event-driven pharmacology","heterobifunctional degrader strategy","induced proximity degrader approach","PROTAC-mediated target degradation","targeted protein degradation"],"scope_statement":"Clears a chosen protein by tethering it to cellular disposal machinery such as E3 ubiquitin ligases or lysosome-targeting receptors, using approaches like PROTACs, molecular glues, LYTACs, AUTACs, or ATTECs so the target gets destroyed instead of lingering around causing trouble.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"cc3e8d0f-1771-4f71-aaee-e51183f734be","node_slug":"clear-proteins-via-cma","node_name":"Clear Proteins via CMA","alternate_names":[],"scope_statement":"Clears damaged intracellular proteins through chaperone-mediated autophagy by routing KFERQ-motif cargo via HSPA8/Hsc70 to the lysosomal receptor LAMP2A, preserving proteostasis and the regenerative function of muscle satellite cells with age.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"5d6a755a-51b6-4509-8b9a-af070a275b2d","node_slug":"clear-senescent-cells-immunologically","node_name":"Clear Senescent Cells Immunologically","alternate_names":["body-wide senescent cell elimination","Boost immune-mediated cell clearance","CAR immune cell senolysis","enhance innate clearance of senescent cells","immune-mediated senescent cell clearance","immunomodulatory senolysis","immunosenolytic therapy","innate immune senescent-cell clearance","macrophage-mediated senescent-cell clearance","NK-cell senolysis","pan-tissue senescent cell targeting","reinvigorate immune senolysis","restart endogenous senescent-cell clearance","Restore Immune Senescent Cell Clearance","restore senescence immune surveillance","reverse immune exhaustion to clear senescent cells","senescence surveillance restoration","senescence-targeted immunotherapy","senescent cell immunosurveillance restoration","senolytic immunotherapy","small-molecule immune senolytic reactivation","systemic senolysis","systemic senolytic therapy","whole-body senescent cell clearance"],"scope_statement":"Clears senescent cells by driving immune surveillance against senescence-associated surface antigens and SASP-marked targets, using approaches such as senolytic CAR T cells, NK-cell activation, or senescence-directed vaccines instead of blunt cytotoxins.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"382f10a5-97e4-4926-8260-1bb5d97262d8","node_slug":"clear-senescent-cells-via-gpx4","node_name":"Clear senescent cells via GPX4","alternate_names":[],"scope_statement":"Clears senescent and other pathology-driving cells by disabling GPX4-dependent lipid peroxide defense, forcing selective ferroptotic death and reducing the local tissue damage those cells keep causing.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"4423ae5e-8f55-46fc-a62c-7bbc0d313620","node_slug":"clear-senescent-cells-via-inkt","node_name":"Clear Senescent Cells via iNKT","alternate_names":["Activate iNKT Senescent-Cell Clearance","CD1d agonist senolysis","CD1d-NKT senescence surveillance","endogenous NKT senescent-cell clearance","immune-enabled senolytic via NKT cells","iNKT-driven senescent cell killing","iNKT senolytic immunotherapy","NKT-based clearance of senescent cells","NKT-mediated senescent cell clearance","NKT-mediated senolysis","pharmacologic NKT senolysis","reactivate iNKT clearance of senescent cells","rejuvenate tissue NKT surveillance","restore resident NKT senolysis","senolytic NKT activation"],"scope_statement":"Clears senescent cells by transiently activating CD1d-restricted invariant natural killer T cells, restoring failed immune surveillance so the immune system kills the senescent cells instead of trying the usual brute-force poisoning routine.","depth":1,"parent_node_id":"d374a111-9991-4ec2-b598-a71068712bb2","probability_of_confirmation":null,"root_slug":"clearing","root_name":"Clearing","root_cluster":"biology","root_canonical_statement":"Remove harmful accumulations and harmful cells — senolytic destruction of senescent cells, autophagy-flux enhancement to clear intracellular junk, AGE-cross-link breakers, amyloid clearance, cholesterol / plaque clearance, retrotransposon suppression."},{"node_id":"f5e6697e-7077-47a6-a0f3-4091baee8a4e","node_slug":"deliver-genes-to-the-liver","node_name":"Deliver genes to the liver","alternate_names":["APOE4 liver gene editing","APOE genotype correction in hepatocytes","Deliver In Vivo Protein Expression","Deliver Secreted Protein Payloads","hepatic AAV depot delivery","Hepatic APOE allele conversion","hepatic factory approach","hepatic secretory depot","hepatocyte-based secreted protein expression","hepatocyte-based systemic secretion","In vivo APOE editing","in vivo hepatic bioreactor delivery","liver bioreactor gene therapy","liver-directed AAV protein delivery","Liver-directed APOE gene therapy","liver-directed protein delivery","liver-tropic AAV systemic secretion"],"scope_statement":"Delivers an in vivo gene-transfer payload, usually an AAV or hepatotropic LNP carrying a transgene, to hepatocytes so the liver serves as a durable factory for a secreted therapeutic factor instead of forcing repeated protein dosing.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"d33d1e3b-030f-4404-bfd8-de02c56022c2","node_slug":"deliver-plasmids-for-local-expression","node_name":"Deliver Plasmids for Local Expression","alternate_names":["Deliver Payloads by Intramuscular Targeting","Deliver plasmid gene therapy"],"scope_statement":"Delivers non-viral plasmid DNA into a defined tissue so nearby cells transiently express a therapeutic protein at the injection site, usually via intramuscular, intradermal, or electroporation-assisted transfer, without pretending this is durable systemic gene therapy.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"de4b3f47-b4de-4f1d-a0d5-5e9205c816fc","node_slug":"deliver-silencing-payloads-by-capsid-targeting","node_name":"Deliver silencing payloads by capsid targeting","alternate_names":[],"scope_statement":"Delivers RNAi or antisense genetic silencing payloads to skeletal muscle or Schwann cells by engineering AAV capsid tropism and administration route so the payload reaches the right cells without absurd dosing.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"665fd1f1-14ac-4b34-befd-e2afa7f77b39","node_slug":"design-sequence-guided-genome-edits","node_name":"Design sequence-guided genome edits","alternate_names":["Design guide RNAs for editing","Discover edit designs in silico","Discover optimal genome editing strategies","Discover self-improving genome edits","Edit Genomes with AI Design","Predict edit outcomes in silico","Predict Minimal Genomic Edit Sets"],"scope_statement":"Designs and tests de novo DNA, RNA, or guide sequences from genomic context to make targeted edits with CRISPR, base editors, or prime editors rather than waving the usual AI smoke around.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"6afd50d2-3611-43d1-b685-67d8580a51b1","node_slug":"edit-cells-with-multigene-payloads","node_name":"Edit Cells with Multigene Payloads","alternate_names":["combinatorial gene therapy","combinatorial gene therapy for rejuvenation","combinatorial genetic reprogramming","Drive systemic transgene overexpression","Edit cells with synthetic DNA","Edit Multiple Disease Drivers","Edit Multiple Pathways Simultaneously","Edit Multiple Pathways Together","Edit muscle-preserving genes","gene cocktail therapy","multigene rejuvenation editing","multi-gene therapy","multi-gene therapy editing","multi-payload gene therapy","multiplex gene editing","multiplex longevity gene editing","multiplex pathway editing","multiplex transgene delivery","multiplex transgene intervention","multi-vector genetic intervention","partial reprogramming gene therapy","polygenic gene delivery","polygenic therapeutic gene transfer","rejuvenation factor cocktail delivery"],"scope_statement":"Edits somatic cells with polycistronic AAV or lentiviral constructs to drive persistent co-expression of genes such as VEGFA, FST, BDNF, PPARGC1A, and TERT, hitting angiogenesis, muscle growth, neurotrophic signaling, mitochondrial biogenesis, and telomere maintenance in one shot instead of pretending one pathway will do the whole job.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"c05c9781-d41f-4acd-9b59-12b184c82a48","node_slug":"edit-endogenous-tert-expression","node_name":"Edit endogenous TERT expression","alternate_names":[],"scope_statement":"Edits the endogenous TERT locus in mesenchymal stem cells to raise telomerase activity in small, controlled increments under native promoter control, aiming to support telomere maintenance, delay replicative senescence, and preserve stem-cell function without the usual mess of constitutive overexpression.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"4d3eb730-3032-4868-9cfa-16a798d045c7","node_slug":"edit-gene-silencing-methylation","node_name":"Edit gene silencing methylation","alternate_names":["Edit immune inflammatory programs","Edit MyD88 Transcription","Modulate transcription by promoter chromatin editing"],"scope_statement":"Edits locus-specific DNA methylation at promoters or enhancers of pathogenic genes using programmable epigenome editors such as dCas9-DNMT3A or zinc-finger methyltransferases to durably repress transcription without making a double-strand break.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"5655f32b-a8e1-4302-8f7a-c2e6d5877e39","node_slug":"edit-klotho-pathway-activity","node_name":"Edit klotho pathway activity","alternate_names":["Deliver Klotho by Nasal AAV","Modulating klotho expression"],"scope_statement":"Edits KL/Klotho pathway activity by changing KL expression or its upstream regulators to suppress IGF-1, TGF-beta, Wnt/beta-catenin, and NF-kappaB signaling, with the aim of reducing senescence, inflammation, fibrosis, vascular calcification, and cognitive decline.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"42bf6729-3db8-42f3-9984-ec5a6f70853f","node_slug":"edit-pcsk9-to-lower-ldl","node_name":"Edit PCSK9 to lower LDL","alternate_names":[],"scope_statement":"Edits or silences PCSK9 in hepatocytes using in vivo gene editing or other one-time gene therapy approaches to durably reduce LDL cholesterol and cut atherosclerotic cardiovascular risk.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"4f4a40a0-9b57-4621-8115-0f199004a62b","node_slug":"edit-rna-with-crispr","node_name":"Edit RNA with CRISPR","alternate_names":[],"scope_statement":"Edits RNA transcripts with sequence-specific CRISPR-derived systems such as Cas13, dCas13 effectors, or guide-recruited ADAR to rewrite bases, splice isoforms, or modulate transcript abundance without cutting genomic DNA.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"8967c196-1f19-4122-8f76-97948d95d826","node_slug":"edit-tumor-suppressor-copy-number","node_name":"Edit tumor suppressor copy number","alternate_names":[],"scope_statement":"Adds extra copies of protective genes such as TP53 to increase dosage-sensitive DNA-damage sensing and apoptosis, copying the tumor-suppression architecture seen in long-lived large mammals like elephants.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"a22bdb41-c7dd-4737-8398-532c9de94ee2","node_slug":"install-longevity-associated-alleles","node_name":"Install longevity-associated alleles","alternate_names":["Edit phenotype-relevant alleles"],"scope_statement":"Edits the human genome to introduce protective variants enriched in centenarians, using tools such as CRISPR knock-in, base editing, or prime editing to copy phenotypes nature already tested.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"826a034b-8138-45e2-b4c4-089b7d46fc20","node_slug":"perform-multiplex-genome-editing","node_name":"Perform multiplex genome editing","alternate_names":["Deliver multiplex genome edits","Edit Many Loci at Once","Edit many loci in parallel","Edit Multiple Genomic Loci","Edit Multiple Loci at Once","Edit Polygenic Risk Loci"],"scope_statement":"Edits many genomic loci at once using multiplex CRISPR guide arrays, MAGE/eMAGE, or combinatorial base editing to install coordinated genotypes that one-edit-per-generation workflows handle far too slowly.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"ac2285f6-2487-4714-92a8-1b959b73fabf","node_slug":"replace-genomic-dna-segments","node_name":"Replace genomic DNA segments","alternate_names":["Edit Disease-Causing DNA","Edit genomes by de novo synthesis","Insert Large Synthetic DNA Programs","Write de novo genomic programs"],"scope_statement":"Replaces endogenous genomic blocks with designed DNA constructs using targeted genome writing or large-fragment knock-in methods to impose a chosen genotype without fussing over one base at a time.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"f359f635-d7b9-4861-8ecd-b877b8be4fc2","node_slug":"upregulate-follistatin-expression","node_name":"Upregulate follistatin expression","alternate_names":["Edit follistatin expression","Increase follistatin expression","Modulate myostatin brakes with follistatin","Modulate Myostatin Signaling","Suppress myostatin with follistatin"],"scope_statement":"Upregulates FST to raise follistatin levels, blunt myostatin-family ligands such as GDF8 and activin A, and drive muscle hypertrophy by genetic tuning of an anabolic pathway rather than by pretending protein powder did the job.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"1d07a429-6eaa-4186-90df-b4886b5c2c2d","node_slug":"upregulate-muscle-angiogenesis","node_name":"Upregulate Muscle Angiogenesis","alternate_names":["Edit Muscle Microvasculature with VEGF","Edit Muscle VEGF Expression","Edit perifollicular angiogenesis with VEGF","Edit Scalp Angiogenic Expression","Modulate Muscle VEGF Signaling","Modulate pro-angiogenic signaling","Modulate skeletal muscle angiogenesis","Modulate VEGF-Driven Angiogenesis","Upregulate VEGFA by Gene Transfer","Upregulate VEGF in Muscle"],"scope_statement":"Upregulates pro-angiogenic genes in skeletal muscle, typically with in vivo gene transfer of factors such as VEGFA or HIF1A, to increase capillary density and preserve oxygen delivery as age-related microvascular rarefaction does its usual damage.","depth":1,"parent_node_id":"b1b61f29-8499-4acc-83c2-9ab1535ee9a2","probability_of_confirmation":null,"root_slug":"editing","root_name":"Editing","root_cluster":"biology","root_canonical_statement":"Precisely modify the genome or epigenome — CRISPR-Cas9, base editing, prime editing, epigenome editing (GEMS-style), gene therapy delivering modified DNA, vectorized miRNA suppression, targeted DUX4-style transcription factor inhibition via genetic intervention."},{"node_id":"bc2bed57-8ec8-4c08-b4dd-2b33bea6b369","node_slug":"activate-apelin-receptor-signaling","node_name":"Activate apelin receptor signaling","alternate_names":["Modulate apelin/APJ signaling"],"scope_statement":"Activates the apelin receptor APJ (APLNR) with peptides or small-molecule agonists to restore exercise-linked metabolic signaling and improve obesity-related glucose, insulin, and weight phenotypes without literal exercise training.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"604715bc-b6a9-4fbd-bf3a-2f8cc8fad9fa","node_slug":"activate-eif2b-to-tune-isr","node_name":"Activate eIF2B to Tune ISR","alternate_names":["Activate eIF2B to blunt ISR","Activate eIF2B to damp ISR","Modulate eIF2B signaling","Modulate integrated stress response","Modulate ISR for myelin lipids"],"scope_statement":"Activates eIF2B to dampen maladaptive integrated stress response signaling in neurons and glia, with falling GDF15 used as a downstream readout rather than pretending GDF15 is the target.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"590e03f8-061f-4d73-9001-703c3e9df25b","node_slug":"activate-sirt1-signaling","node_name":"Activate SIRT1 signaling","alternate_names":["Activate sirtuin stress responses"],"scope_statement":"Activates SIRT1 with small-molecule agonists to drive NAD+-dependent deacetylation programs that shift cellular stress-response transcription and metabolic regulation.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"8825de23-065c-49ce-b99f-06dbc8ae7186","node_slug":"antagonize-nmda-receptor-signaling","node_name":"Antagonize NMDA receptor signaling","alternate_names":["Modulate NMDA Receptor Signaling"],"scope_statement":"Blunts glutamatergic NMDA receptor activity, usually at GRIN-encoded receptor complexes, to reduce excitotoxic neuronal dysfunction and improve behavioral or neuropsychiatric symptoms.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"bb1950a4-77e0-42f3-add0-263460fd4925","node_slug":"block-bone-regeneration-brakes","node_name":"Block Bone Regeneration Brakes","alternate_names":[],"scope_statement":"Blocks extracellular or circulating inhibitors such as sclerostin (SOST), DKK1, or activin-family ligands to lift suppression of Wnt/BMP-driven osteoblast activity and improve bone formation and fracture repair.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"117e9d85-7b65-4b42-9cad-7c71adfe05bf","node_slug":"boost-glutathione-precursor-supply","node_name":"Boost glutathione precursor supply","alternate_names":["glutathione precursor therapy","glycine and cysteine repletion","glycine plus N-acetylcysteine","GlyNAC supplementation","GSH restoration via amino acid precursors"],"scope_statement":"Boosts intracellular glutathione synthesis by supplying precursors such as cysteine and glycine, typically via N-acetylcysteine or GlyNAC, to shift cellular redox balance and blunt oxidative, mitochondrial, inflammatory, and metabolic dysfunction.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"d9b6ba16-2a06-4f94-95e6-866d943e30dc","node_slug":"correct-micronutrient-deficiencies","node_name":"Correct Micronutrient Deficiencies","alternate_names":["Modulate stress tolerance with minerals"],"scope_statement":"Corrects vitamin or mineral insufficiency by supplying defined micronutrients such as vitamin D, iron, vitamin B12, iodine, zinc, selenium, or magnesium to restore impaired physiological pathways rather than inventing a new aging mechanism out of basic nutrition.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"e195fcba-8009-46af-9f9d-645cc8dcaf8a","node_slug":"increase-testosterone-signaling","node_name":"Increase Testosterone Signaling","alternate_names":["Modulate Androgen Signaling","Train Endogenous Androgen Production"],"scope_statement":"Increases androgen signaling pharmacologically by raising testosterone production, supplying exogenous testosterone, or activating the androgen receptor, usually to push the endocrine state toward higher circulating androgens and the usual claims of vigor.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"8eb2431d-3c5f-497d-ab77-6953134f2832","node_slug":"induce-torpor-like-hypometabolism","node_name":"Induce Torpor-Like Hypometabolism","alternate_names":["Modulate reversible hypometabolic gene expression"],"scope_statement":"Modulates whole-body or organ-level metabolism into a reversible torpor-like state by suppressing thermogenesis, oxygen consumption, and ATP demand through pathways such as adenosine A1 receptor signaling, H2S exposure, or targeted hypothalamic circuit control.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"e94d86e8-c327-4d10-974d-ec121ee863c8","node_slug":"inhibit-beta-amyloid-oligomerization","node_name":"Inhibit beta-amyloid oligomerization","alternate_names":[],"scope_statement":"Inhibits beta-amyloid (Aβ), especially Aβ42, oligomer formation with orally bioavailable small molecules to reduce neurotoxic aggregate seeding in Alzheimer's disease rather than trying to rebuild the brain after the damage is done.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"dbd3767e-bc0b-4314-b2be-92f843d6b2c2","node_slug":"inhibit-cblb-immune-brake","node_name":"Inhibit CBLB Immune Brake","alternate_names":["Cbl-b blockade","CBLB inhibition","Cbl-b inhibitor therapy","Pharmacologic CBLB inhibition","Targeting CBLB in T cells"],"scope_statement":"Inhibits the E3 ubiquitin ligase CBLB with small molecules to release downstream T-cell and NK-cell signaling checkpoints, altering immune-response pathways instead of pretending cell replacement or damage repair is the same job.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"2f3324d4-bdae-47eb-b654-219bfbcc3394","node_slug":"inhibit-cd38-signaling","node_name":"Inhibit CD38 signaling","alternate_names":[],"scope_statement":"Inhibits CD38 NADase activity to preserve intracellular NAD+, shifting sirtuin-, PARP-, and inflammatory signaling away from age-linked metabolic and immune dysfunction.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"954570e7-44e0-4a86-8e0d-40db0c53b460","node_slug":"inhibit-cdk20-signaling","node_name":"Inhibit CDK20 signaling","alternate_names":[],"scope_statement":"Inhibits CDK20 with a small molecule to modulate downstream kinase signaling rather than replacing cells, repairing tissue, or reprogramming cell fate.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"024a5c90-968f-4f7d-ade3-9a28a8a67b23","node_slug":"inhibit-cdk246-signaling","node_name":"Inhibit CDK2/4/6 signaling","alternate_names":[],"scope_statement":"Blocks CDK2, CDK4, and CDK6 kinase activity to shut down cyclin-dependent cell-cycle progression, reduce RB phosphorylation, and suppress proliferative signaling.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"8a70455d-7918-4849-94b0-cc2147875d6d","node_slug":"inhibit-ddr1-signaling","node_name":"Inhibit DDR1 signaling","alternate_names":[],"scope_statement":"Inhibits discoidin domain receptor 1 (DDR1) with small molecules to suppress collagen-triggered kinase signaling rather than fiddling vaguely with an entire pathway family.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"259c842a-6ef3-4d3b-b288-2c2f688969f7","node_slug":"inhibit-dgk-alpha-signaling","node_name":"Inhibit DGK alpha signaling","alternate_names":["DGKa blockade in tumor-infiltrating lymphocytes","DGKA inhibition","DGKA inhibitor immunotherapy","DGKalpha inhibition","DGKalpha inhibitor therapy","DGKA small-molecule modulation","diacylglycerol kinase alpha blockade","Diacylglycerol kinase alpha blockade","Targeting DGKa to restore T-cell function","targeting DGKA to reverse T-cell dysfunction"],"scope_statement":"Inhibits diacylglycerol kinase alpha (DGKalpha/DGKA) to raise diacylglycerol signaling and thereby rewire PKC-, RasGRP-, and mTOR-linked immune or growth-control pathways.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"e860c0e7-cd5a-4818-bed0-352b151c9902","node_slug":"inhibit-hpk1-kinase-signaling","node_name":"Inhibit HPK1 kinase signaling","alternate_names":["HPK1 kinase blockade","MAP4K1 small-molecule inhibition","pharmacologic HPK1 modulation","selective HPK1 inhibition","targeted HPK1 inhibitor design"],"scope_statement":"Inhibits HPK1 (MAP4K1) kinase to remove a well-known brake on T-cell, B-cell, and dendritic-cell receptor signaling, increasing downstream NFAT, AP-1, and NF-kappaB transcriptional activity.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"c93b3e2a-601b-47e5-8fc1-b4b9e1b7e83f","node_slug":"inhibit-hpk1-signaling","node_name":"Inhibit HPK1 signaling","alternate_names":["HPK1 inhibition","HPK1 inhibitor immunotherapy","MAP4K1 inhibition","small-molecule HPK1 blockade","targeting HPK1 in T cells"],"scope_statement":"Blocks hematopoietic progenitor kinase 1 (HPK1, MAP4K1) with small molecules to modulate downstream immune signaling, typically by relieving HPK1-mediated suppression of T-cell and dendritic-cell activation.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"917e0f58-aa7d-4a16-a8c8-8bf8bdc92d89","node_slug":"inhibit-mat2a-signaling","node_name":"Inhibit MAT2A Signaling","alternate_names":[],"scope_statement":"Inhibits MAT2A to cut S-adenosylmethionine synthesis, lowering methyl-donor availability and shifting methylation-linked metabolic and transcriptional programs without pretending this is a new law of aging.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"460fa681-1e05-4e56-9bf8-1851917c2fbb","node_slug":"inhibit-polymerase-theta-repair","node_name":"Inhibit polymerase theta repair","alternate_names":[],"scope_statement":"Inhibits DNA polymerase theta (POLQ) and theta-mediated end joining to suppress error-prone double-strand break repair and reshape the DNA-damage response rather than repairing damage directly.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"675b59fa-f16f-4c73-bfd4-2db8c0b60b34","node_slug":"inhibit-prmt5-signaling","node_name":"Inhibit PRMT5 signaling","alternate_names":[],"scope_statement":"Inhibits PRMT5 to reduce symmetric arginine dimethylation and thereby rewire dysregulated gene-expression, RNA-splicing, and signaling programs, often with selective pressure in MTAP-deleted, MTA-accumulating cells.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"d8b2c2c1-b42d-4ac5-bb6d-753122c5edc9","node_slug":"inhibit-sirtuin-activity","node_name":"Inhibit sirtuin activity","alternate_names":[],"scope_statement":"Inhibits NAD+-dependent sirtuin deacetylases, typically SIRT1 or Sir2-family enzymes, using nicotinamide or related tools to turn down stress-response and metabolic signaling on purpose.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"fda63840-5faf-4146-8f96-9f537dfcf4f6","node_slug":"inhibit-tnik-signaling","node_name":"Inhibit TNIK Signaling","alternate_names":[],"scope_statement":"Inhibits TNIK with a small molecule to damp a dysregulated Wnt or related signaling node and preserve tissue function instead of letting the pathway run amok.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"7be730de-365d-420e-ad18-64ce93061a7d","node_slug":"modulate-adipose-depot-partitioning","node_name":"Modulate adipose depot partitioning","alternate_names":[],"scope_statement":"Modulates lipid storage away from visceral, hepatic, and other ectopic depots and toward subcutaneous or gluteofemoral adipose tissue through tissue-specific control of adipocyte differentiation, expandability, and flux, so the same fat mass does less metabolic damage.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"06bb3f3c-28c3-4ca3-bc9b-d3d29eff7759","node_slug":"modulate-adipose-fat-partitioning","node_name":"Modulate adipose fat partitioning","alternate_names":[],"scope_statement":"Modulates adipocyte lipid partitioning so triglyceride storage shifts away from visceral, hepatic, myocardial, pancreatic, and other ectopic depots toward safer subcutaneous depots by acting on adipogenesis, expandability, insulin sensitivity, and depot-specific fat trafficking rather than merely making you lighter.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"d7f47179-afd4-4aba-b97e-5d8f9a1c854d","node_slug":"modulate-aged-tissue-with-secretome","node_name":"Modulate aged tissue with secretome","alternate_names":[],"scope_statement":"Modulates inflammatory, regenerative, and metabolic signaling in aged muscle and related metabolic tissue by delivering mesenchymal stem cell secretome, conditioned medium, or extracellular vesicles instead of trying the far harder trick of replacing the tissue outright.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"bd7b2076-5705-404b-87fb-9afa6fdf1382","node_slug":"modulate-aging-pathways-with-nutraceutical-combinations","node_name":"Modulate aging pathways with nutraceutical combinations","alternate_names":["combination nutraceutical strategy","Combine Parallel Geroprotective Regimens","Modulate aging pathways for resilience","Modulate aging pathways polypharmacologically","Modulate Multiple Aging Pathways","Modulate Multiple Disease Pathways","Modulate Pathways in Combination","multi-ingredient dietary supplementation","multi-nutrient intervention","nutrient stack modulation","systems nutrition intervention"],"scope_statement":"Modulates AMPK, mTOR, NF-kB, SIRT1, SASP, and autophagy using multi-compound nutraceutical stacks such as polyphenols, NAD precursors, spermidine, and related dietary actives; it is pathway tweaking, not repair dressed up in a supplement bottle.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"8f7f6f01-7c7d-4090-a606-0cc9f33ce047","node_slug":"modulate-androgen-signaling-with-exercise","node_name":"Modulate androgen signaling with exercise","alternate_names":[],"scope_statement":"Modulates androgen receptor signaling with exogenous testosterone or anabolic steroids plus resistance exercise to increase skeletal muscle protein synthesis and blunt sarcopenia.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"4d27a59e-3e15-486d-b9b5-1821814e2893","node_slug":"modulate-brain-circuits-electrically","node_name":"Modulate Brain Circuits Electrically","alternate_names":["Modulate Brain Circuits Noninvasively"],"scope_statement":"Modulates pathological neural firing and network dynamics by delivering patterned electrical stimulation to defined brain circuits using techniques such as deep brain stimulation, responsive neurostimulation, or cortical stimulation.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"594dbbfb-9264-4f1e-846c-fe997f10d1a0","node_slug":"modulate-brain-metabolism-nutritionally","node_name":"Modulate Brain Metabolism Nutritionally","alternate_names":["Modulate Brain Nutrient Signaling","Modulate function with nutrient blends"],"scope_statement":"Modulates neuronal metabolism with defined mixes of substrates and cofactors such as uridine, choline, DHA, B vitamins, antioxidants, or ketone precursors to support synaptic membrane synthesis, maintain neuronal function, and slow functional decline.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"6804d60c-62b9-4226-8e63-a732bfb3ef94","node_slug":"modulate-brown-fat-thermogenesis","node_name":"Modulate brown fat thermogenesis","alternate_names":[],"scope_statement":"Modulates brown adipose tissue thermogenic programs by driving UCP1-dependent mitochondrial uncoupling and adrenergic fuel oxidation in brown and beige adipocytes, which is just metabolic signaling with a space heater attached.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"27cac385-7e13-45e6-87da-27fb9ed2c8e6","node_slug":"modulate-camp-to-activate-tfeb","node_name":"Modulate cAMP to activate TFEB","alternate_names":[],"scope_statement":"Modulates cAMP-dependent signaling to transiently increase nuclear TFEB, drive lysosome biogenesis, and upregulate CLEAR-network lysosomal genes rather than pretending a whole new intervention class has appeared.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"ad6844f5-9473-4f8a-ab15-30b5d0295ebe","node_slug":"modulate-canine-frailty-signaling","node_name":"Modulate canine frailty signaling","alternate_names":[],"scope_statement":"Modulates metabolic and inflammatory signaling in older dogs with drugs targeting pathways such as mTOR, AMPK, NF-kB, IL-6, or TNF-alpha to slow frailty and functional decline; replacing tissues is a different job entirely.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"0f1b6504-d1cf-4449-a6b7-1ea3b672786a","node_slug":"modulate-canine-metabolic-pathways","node_name":"Modulate Canine Metabolic Pathways","alternate_names":[],"scope_statement":"Modulates age-disrupted metabolic signaling in older dogs with drugs that tune pathways such as AMPK, mTOR, insulin/IGF-1, PPAR, or NAD+ metabolism to blunt later-life metabolic dysfunction without pretending this is cell replacement, damage cleanup, or reprogramming.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"0fb2639c-1e3b-4376-b89d-75c9079b49e2","node_slug":"modulate-cdc42-in-neurons","node_name":"Modulate Cdc42 in Neurons","alternate_names":[],"scope_statement":"Modulates Cdc42 signaling in aged neurons to blunt alpha-synuclein toxicity, reduce synuclein-linked pathology burden, and preserve motor function instead of pretending the damage will sort itself out.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"3c1787b7-e3b4-45cf-b98a-3a1505c8a8b8","node_slug":"modulate-cellular-regulatory-noise","node_name":"Modulate Cellular Regulatory Noise","alternate_names":[],"scope_statement":"Dampens stochastic gene-expression and stress-response noise by buffering transcriptional bursting, chromatin-state switching, and proteostasis feedback so cells stop drifting into dysfunctional regulatory states.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"84319e0f-b240-4d5e-930f-c68fc3427aab","node_slug":"modulate-cerebrovascular-risk-burden","node_name":"Modulate cerebrovascular risk burden","alternate_names":[],"scope_statement":"Modulates hypertension, insulin resistance or diabetes, dyslipidemia, obesity, and tobacco exposure to preserve white-matter integrity and functional brain connectivity by reducing cumulative vascular-metabolic injury rather than repairing damaged neural tissue.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"2952ba4a-b2ef-4ae4-8b99-5017b55ba778","node_slug":"modulate-circadian-rhythm-signaling","node_name":"Modulate circadian rhythm signaling","alternate_names":["Train Circadian Phase Before Travel"],"scope_statement":"Modulates circadian timing by acting on the suprachiasmatic nucleus melatonin axis and core clock genes such as CLOCK, BMAL1 (ARNTL), PER, and CRY to shift sleep-wake physiology and downstream endocrine signaling.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"b660bf17-0a94-4385-9481-b504efd88a42","node_slug":"modulate-circadian-signaling","node_name":"Modulate Circadian Signaling","alternate_names":["Train OPN5 Circuits With Violet Light"],"scope_statement":"Modulates circadian clock inputs and core oscillator pathways such as MTNR1A/MTNR1B, CLOCK:BMAL1, PER/CRY, and REV-ERB/ROR to shift phase, amplitude, or entrainment of daily physiology, because biology keeps time whether your schedule deserves it or not.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"1036acd7-50d2-43c8-80d1-232876f22a61","node_slug":"modulate-cox-2-signaling","node_name":"Modulate COX-2 Signaling","alternate_names":[],"scope_statement":"Modulates PTGS2 (COX-2) activity to reduce prostaglandin-driven inflammatory signaling, usually by selectively lowering PGE2 synthesis without broad nonselective COX inhibition.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"a3d9a78d-1a22-4fde-94d1-a8c836a32db7","node_slug":"modulate-endocrine-metabolic-signals","node_name":"Modulate endocrine metabolic signals","alternate_names":["Modulate Endocrine-Fibrotic Signaling","Modulate host metabolism with microproteins"],"scope_statement":"Modulates secreted metabolic hormones or cytokines such as FGF21, GDF15, adiponectin, leptin, irisin, or NRG4 to shift thermogenesis, inflammatory tone, appetite, and whole-body energy homeostasis rather than pretending metabolism runs on willpower.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"22d584a1-1602-4bd2-95bc-bc327cc65dbc","node_slug":"modulate-epithelial-mesenchymal-transition","node_name":"Modulate epithelial-mesenchymal transition","alternate_names":[],"scope_statement":"Modulates epithelial-mesenchymal transition and allied invasion-state programs by altering TGF-beta/SMAD, WNT/beta-catenin, AXL, or YAP/TAZ signaling to keep cells in a less migratory, less metastatic state.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"91dcd74b-8e23-45ce-b664-31b61a04a0e8","node_slug":"modulate-etc-dependent-glucose-derepression","node_name":"Modulate ETC-dependent glucose derepression","alternate_names":[],"scope_statement":"Modulates mitochondrial electron transport chain state to control AMPK/Snf1-dependent derepression of glucose-repressed genes during shifts to low glucose or alternative carbon sources, thereby preserving metabolic fuel-switching competence.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"9be8fd57-92d5-447c-9cbc-199ed0255e99","node_slug":"modulate-exclusion-zone-water","node_name":"Modulate exclusion-zone water","alternate_names":["Absorb Earth Electrons Barefoot","Ingest plant-cell structured water","Irradiate exclusion-zone water"],"scope_statement":"Modulates ordered, negatively charged exclusion-zone water at hydrophilic biological interfaces using infrared irradiation or high-EZ materials to alter interfacial water structuring, charge separation, and cellular energetics.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"b017678f-2d41-4c16-b62b-4ad6243c7c09","node_slug":"modulate-fgf21-signaling","node_name":"Modulate FGF21 Signaling","alternate_names":["Modulate FGF21 and TGF-beta Signaling","Modulate metabolism with FGF21"],"scope_statement":"Raises, restores, or sensitizes fibroblast growth factor 21 signaling through FGF21 itself or the FGFR1c-beta-Klotho receptor complex to shift hepatic, adipose, and stress-response programs tied to metabolic dysfunction and age-leaning phenotypes.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"87cdfcfb-b079-4044-a8e6-9372605b5e86","node_slug":"modulate-gene-expression-with-rnai","node_name":"Modulate Gene Expression with RNAi","alternate_names":["microRNA-directed repair gene activation","microRNA-mediated regenerative reprogramming","miRNA-based suppression of inhibitory gene programs","post-transcriptional editing for regeneration","transient miRNA derepression of repair genes"],"scope_statement":"Suppresses selected transcripts with siRNA, shRNA, or microRNA-guided RNA interference to reset dysregulated gene-expression programs and push cells toward a younger measured state, without pretending that knockdown is full cellular reprogramming or genome editing.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"f284c0f1-7116-4110-84b7-f8f685193ee7","node_slug":"modulate-glp-1-receptor-signaling","node_name":"Modulate GLP-1 Receptor Signaling","alternate_names":[],"scope_statement":"Modulates GLP-1 receptor signaling with agonists such as semaglutide or liraglutide to shift insulin secretion, glucagon suppression, gastric emptying, appetite circuits, and downstream inflammatory and metabolic signaling across adipose tissue, kidney, heart, and skeletal muscle.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"6fb68369-c9ac-46cd-9fe4-0db2b5d48022","node_slug":"modulate-glutamatergic-cholinergic-signaling","node_name":"Modulate Glutamatergic-Cholinergic Signaling","alternate_names":[],"scope_statement":"Modulates neuronal signaling by pairing NMDA receptor antagonism from memantine with acetylcholinesterase inhibition from donepezil, hitting glutamatergic excitotoxicity and cholinergic tone at the same time because single-pathway fixes rarely deserve the hype.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"b4f7458b-5a20-4392-8e16-2196a8148a3c","node_slug":"modulate-growth-hormone-signaling","node_name":"Modulate Growth Hormone Signaling","alternate_names":[],"scope_statement":"Raises GH-IGF-1 axis activity through growth hormone, GHRH agonists, ghrelin receptor agonists, or IGF-1 pathway activation to force an anabolic, nutrient-abundant growth program.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"df5df9ff-4795-4d54-b969-40a248aeaa08","node_slug":"modulate-gut-microbiota-composition","node_name":"Modulate Gut Microbiota Composition","alternate_names":["Activate neurogut control neurons","alginate-derived oligosaccharide fermentation shaping","alginate oligosaccharide fermentation therapy","alginate oligosaccharide microbiome modulation","alginate oligosaccharide prebiotic intervention","alginate oligosaccharide prebiotic modulation","AOS-driven gut fermentation modulation","AOS-driven SCFA modulation","dietary fiber microbiome modulation","dietary microbiome modulation","dietary prebiotic modulation","engineering the gut microbiota","fermentable fiber intervention","fermented probiotic preparation intervention","fiber-driven microbiome remodeling","gut microbiome modulation","LAB fermentate gut modulation","lactic acid bacteria-derived microbiome modulation","microbiome-mediated metabolic modulation with AOS","microbiome modulation with lactic acid bacteria fermentates","microbiome remodeling","microbiome-targeted intervention","microbiota-directed prebiotic intervention","microbiota-directed therapy","Modulate Immune Signaling with Microbes","nutrition-based microbiome modulation","post-fermentation microbiota modulation","prebiotic fiber supplementation","prebiotic microbiome modulation","prebiotic microbiota modulation","prebiotic supplementation","resistant starch gut microbiome modulation","SCFA-boosting prebiotic feeding","selective microbiota feeding","substrate-directed gut microbiome modulation"],"scope_statement":"Modulates gut microbial composition and metabolite output with prebiotics, probiotics, or synbiotics to change short-chain fatty acids, bile acid signaling, immune tone, and host metabolism; yes, this is microbiome modulation, not wizardry.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"1049daaa-76fa-4cc9-9f74-239879629928","node_slug":"modulate-hedgehog-cell-fate","node_name":"Modulate Hedgehog Cell Fate","alternate_names":[],"scope_statement":"Modulates Sonic Hedgehog and primary-cilium signal output to steer lineage commitment, patterning decisions, and progenitor cell fate across development and regeneration.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"740d9415-19e2-4fe7-9280-ef093f5775bb","node_slug":"modulate-host-rna-silencing","node_name":"Modulate host RNA silencing","alternate_names":["Edit Microglial miRNA Programs"],"scope_statement":"Modulates endogenous RNA-silencing pathways by suppressing Dicer-, Argonaute-, or RISC-mediated small-RNA control, thereby altering gene expression and antiviral signaling without changing genomic sequence.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"107fd51d-d39a-46b9-8086-4f85ff94dc2f","node_slug":"modulate-hypoxia-signaling-for-erythropoiesis","node_name":"Modulate hypoxia signaling for erythropoiesis","alternate_names":[],"scope_statement":"Modulates the HIF-prolyl hydroxylase oxygen-sensing axis and downstream erythropoietin-driven erythropoiesis to preserve or improve red-blood-cell indices in older adults and support recovery from perioperative anemia without transfusion, because 'anemia is just aging' is lazy medicine.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"08f1d9cb-5e5b-438f-8bcc-b56669f1013b","node_slug":"modulate-igf-via-papp-a2","node_name":"Modulate IGF via PAPP-A2","alternate_names":[],"scope_statement":"Modulates IGF signaling by having PAPP-A2 proteolytically cleave IGFBP5, shifting the balance between IGF-bound and bioavailable ligand rather than repairing tissue or waving reprogramming magic at the problem.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"0c2ef11b-8178-4052-9cae-60c9b8dc4ed5","node_slug":"modulate-innate-immune-tone","node_name":"Modulate Innate Immune Tone","alternate_names":["cytokine-state modulation in macrophages","M1-to-M2 macrophage shifting","macrophage polarization control","Modulate inflammatory immune signaling","Modulate Inflammatory Stress Pathways","Modulate TH1 M1 immune bias","pro-resolution macrophage reprogramming","resolution-phase immune modulation"],"scope_statement":"Modulates macrophage polarization and allied innate inflammatory programs, including NF-kB, NLRP3 inflammasome signaling, and SASP-amplifying cytokine output, to reduce chronic tissue-damaging inflammation without simply blunting host defense.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"1bf945a8-8b52-41af-b7ee-b1537c221e88","node_slug":"modulate-ketosis-with-exogenous-ketones","node_name":"Modulate Ketosis With Exogenous Ketones","alternate_names":["Modulate metabolism with ketone esters"],"scope_statement":"Modulates ketosis by administering beta-hydroxybutyrate, acetoacetate, ketone esters, ketone salts, or precursors such as 1,3-butanediol to shift brain and muscle fuel use, redox signaling, and mitochondrial bioenergetics without pretending this repairs anything.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"0c03eed9-0dbe-4dab-88fe-5cd0fbe85c6f","node_slug":"modulate-metabolism-with-alpha-ketoglutarate","node_name":"Modulate metabolism with alpha-ketoglutarate","alternate_names":["Modulate aging with alpha-ketoglutarate"],"scope_statement":"Modulates mitochondrial and epigenetic control by raising alpha-ketoglutarate availability, shifting TCA-cycle flux and alpha-ketoglutarate-dependent dioxygenase activity such as TET DNA demethylases and JmjC histone demethylases.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"14eb7003-c951-42e8-bf58-1d9c465d383e","node_slug":"modulate-mtorc1-signaling","node_name":"Modulate mTORC1 signaling","alternate_names":["AMPK-mTOR axis modulation","Modulate Cell Size Control","mTORC1 signaling modulation","mTOR pathway modulation","nutrient-sensing pathway modulation","pharmacologic mTOR regulation","Selectively suppress mTORC1 signaling"],"scope_statement":"Selectively dampens mTORC1 signaling through nutrient-sensing regulators such as mTOR, RPTOR, S6K, and 4E-BP1 to reduce growth-promoting programs linked to aging while staying within ordinary pharmacologic pathway modulation rather than any grand repair fantasy.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"749db0cf-ac6a-4949-a255-48fb0bca635d","node_slug":"modulate-mtor-pol-iii-signaling","node_name":"Modulate mTOR-Pol III Signaling","alternate_names":["MAF1-dependent translational downshifting","MAF1-mediated Pol III repression","mTORC1 control of Pol III transcription","mTORC1-MAF1 RNA polymerase III regulation","stress-induced tRNA transcription suppression"],"scope_statement":"Modulates mTOR-dependent stress-response signaling to change RNA polymerase III output, typically by altering Pol III transcription of tRNAs and other small noncoding RNAs via regulators such as mTORC1 and MAF1 rather than editing the genome or reprogramming cell identity.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"38ca02f3-1aed-4c62-9bcd-3e77a4a7ac05","node_slug":"modulate-muscle-regeneration-signaling","node_name":"Modulate Muscle Regeneration Signaling","alternate_names":[],"scope_statement":"Modulates Notch, Wnt7a, p38 MAPK, prostaglandin E2, or related satellite-cell signaling pathways with drugs to restart endogenous skeletal muscle repair and restore myofiber mass and function after damage control, without cell transplantation.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"6a649f49-dc5c-41e2-ab2e-abb0f5fd847a","node_slug":"modulate-nad-precursor-metabolism","node_name":"Modulate NAD+ precursor metabolism","alternate_names":["Augmenting NAD+ salvage","augment NAD metabolism","Augment NAD Precursor Metabolism","boost NAD+ levels","CD38-mediated NAD conservation","enhance cellular NAD metabolism","enhance NAD salvage","increase NAD bioavailability","Modulate NAD+ precursor availability","Modulate NAD with Precursors","NAD booster administration","NAD+ boosting","NAD boosting in aged oocytes","NAD+ boosting with NMN","NAD precursor supplementation","NAD+ precursor supplementation","NAD+ replenishment","NAD repletion","NAD salvage pathway modulation","nicotinamide mononucleotide therapy","Nicotinamide riboside supplementation","NMN-based NAD repletion","NMN for ovarian aging","NMN supplementation","oocyte NAD+ salvage augmentation","ovarian NAD+ restoration","pharmacologic NAD metabolism modulation","raise intracellular NAD+","reproductive aging modulation via NMN"],"scope_statement":"Modulates intracellular NAD+ pools by supplying precursors such as nicotinamide riboside, nicotinamide mononucleotide, or niacin to drive NAD+ salvage-pathway flux and downstream signaling through sirtuins, PARPs, CD38, and mitochondrial stress-response programs rather than repairing tissue directly.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"2b9b7543-7469-4fd4-8925-6ac4f19c118f","node_slug":"modulate-neural-circuits-electrically","node_name":"Modulate Neural Circuits Electrically","alternate_names":["Modulate Sensorimotor Circuits Electrically"],"scope_statement":"Modulates dysregulated neural circuits by delivering patterned stimulation to peripheral nerves, brain nuclei, or spinal pathways instead of trying to bludgeon signaling with drugs or gene edits.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"16cebc16-2c05-4b24-a4aa-66dcf01268d9","node_slug":"modulate-neutrophil-chemokine-trafficking","node_name":"Modulate neutrophil chemokine trafficking","alternate_names":["Modulate CXCL12 Signaling"],"scope_statement":"Modulates CXCR2-axis chemokine signaling such as CXCL8/IL-8, CXCL1, or CXCL2 to limit neutrophil recruitment or retention at infected tissue and reduce collateral inflammatory damage without trying to replace the immune system outright.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"4b947758-dc82-437f-9cc9-b5e5731ccf77","node_slug":"modulate-notch-signaling-activity","node_name":"Modulate Notch Signaling Activity","alternate_names":[],"scope_statement":"Modulates Notch pathway signaling through receptors such as NOTCH1 or NOTCH3, ligands such as DLL4 or JAG1, or downstream effectors such as RBPJ and HES1 to alter tissue resilience, immune behavior, and vulnerability patterns tied to lifespan biology and severe COVID-19.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"8b23abf7-5eb6-4cb7-b566-009b1659c874","node_slug":"modulate-oxidative-stress-signaling","node_name":"Modulate oxidative stress signaling","alternate_names":["Activate Cytoprotective Pathways With Diet","heat-shock factor modulation","heat-shock response induction","heat-shock transcriptional tuning","HSF1 activation","Modulate endogenous peroxide detoxification","Modulate stress pathways with phytochemicals","Modulate the heat shock response","Overexpress stress-response transcription factors","proteostasis network induction"],"scope_statement":"Modulates NRF2-KEAP1, HSF1, sirtuin, or related stress-response pathways with bioactive compounds to lower reactive oxygen species, reset maladaptive transcriptional states, and blunt amyloid-beta, tau, or alpha-synuclein aggregation without pretending that pharmacology is the same thing as clearance.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"eb9477a7-2762-424a-b073-be1274955bc2","node_slug":"modulate-pathways-with-biologic-cocktails","node_name":"Modulate pathways with biologic cocktails","alternate_names":["Modulate Multiple Pathways by Injection","Modulate systemic regenerative signals","Modulate tissues with youthful plasma","Modulate Youthful Serum Factors"],"scope_statement":"Modulates inflammatory and regenerative networks at once using complex biologic mixtures such as plasma fractions, conditioned media, secretomes, or extracellular vesicle preparations to push pathways like TGF-beta, NF-kappaB, IL-6, TNF-alpha, and muscle repair signaling away from the usual age-related slide.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"6d8625be-e6c3-4650-9a88-16261ca3887a","node_slug":"modulate-polycomb-chromatin-repression","node_name":"Modulate Polycomb Chromatin Repression","alternate_names":[],"scope_statement":"Modulates Polycomb repressive complex activity, especially PRC1 and PRC2, to reset H3K27me3-driven gene silencing and stabilize youthful transcriptional programs in aged cells.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"204a17c2-8908-40b8-b796-b86b1bbfe484","node_slug":"modulate-protein-bioavailability","node_name":"Modulate Protein Bioavailability","alternate_names":[],"scope_statement":"Modulates protein digestibility and amino acid uptake in older adults by reformulating food matrix, gastric release, and protein structure, using tactics such as whey hydrolysates, leucine enrichment, acidification, emulsification, and altered particle size to work around low gastric acid, slower gastric emptying, and weaker proteolysis.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"f750b9fa-42b5-4afa-a2b2-fad8518d3038","node_slug":"modulate-proteins-by-induced-proximity","node_name":"Modulate proteins by induced proximity","alternate_names":["Demonstrate induced-proximity causality"],"scope_statement":"Modulates a protein's abundance or activity by forcing it into proximity with an endogenous effector such as CRBN, VHL, MDM2, DCAF15, PP2A, or a deubiquitinase, using PROTACs, molecular glues, or other bifunctional recruiters.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"02854258-97fa-4804-8fb3-75215d72226d","node_slug":"modulate-rac1-exercise-signaling","node_name":"Modulate Rac1 Exercise Signaling","alternate_names":[],"scope_statement":"Modulates Rac1 signaling in skeletal muscle to mimic or amplify exercise-induced remodeling by controlling downstream actin remodeling, GLUT4 translocation, and contraction-responsive adaptation pathways.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"2acf1434-19d6-4d96-ac99-1a96de3180e4","node_slug":"modulate-rankl-bone-muscle-signaling","node_name":"Modulate RANKL Bone-Muscle Signaling","alternate_names":[],"scope_statement":"Modulates RANKL signaling, usually via RANKL blockade or osteoprotegerin-like decoy strategies, to dampen osteoclast-driven bone resorption and the downstream bone-immune-muscle crosstalk that worsens muscle dysfunction.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"981c6775-32c5-4846-b181-5fa4bac39c6d","node_slug":"modulate-retrotransposon-activity","node_name":"Modulate Retrotransposon Activity","alternate_names":[],"scope_statement":"Modulates LINE-1 and related endogenous retroelement expression or cDNA formation to curb age-linked transcriptional noise, DNA damage signaling, and cGAS-STING or interferon-driven inflammation.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"e2dbaec4-86a6-4dd4-ab24-2f6827a5f1d4","node_slug":"modulate-ripk3-mlkl-necroptosis","node_name":"Modulate RIPK3-MLKL Necroptosis","alternate_names":[],"scope_statement":"Modulates necroptotic cell death by inhibiting RIPK3 activation, blocking MLKL phosphorylation or oligomerization, or otherwise interrupting TNFR1-ZBP1-RIPK1-RIPK3-MLKL signaling before membrane rupture and inflammatory DAMP release.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"1a5875be-c4c4-44b1-b8ae-1c6b9a620143","node_slug":"modulate-scd1-lipid-desaturation","node_name":"Modulate SCD1 Lipid Desaturation","alternate_names":[],"scope_statement":"Modulates stearoyl-CoA desaturase 1 (SCD1) and allied lipogenic regulators in adipose tissue to shift triglyceride and membrane lipid pools from saturated and monounsaturated fatty-acid handling toward a deliberately remodeled unsaturation profile rather than pretending metabolism fixes itself.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"5d421afe-ae96-4781-a233-3e5cb922217a","node_slug":"modulate-senescence-control-pathways","node_name":"Modulate senescence control pathways","alternate_names":["Anti-senescent TNIK signaling inhibition","Modulate pro-fibrotic senescence signaling","Modulate PRPF19 or MAPK9 signaling","Modulate Senescent Cell State","Modulate shared aging-cancer pathways","TNIK blockade of senescence programs","TNIK inhibition for senescence control","TNIK pathway modulation in senescence","TNIK-targeted SASP suppression"],"scope_statement":"Modulates defined regulators such as CDKN2A/p16INK4a, CDKN1A/p21, NF-kB, NLRP3, cGAS-STING, mTORC1, or AMPK to blunt senescence-associated secretory signaling, chronic inflammation, immune misfiring, or metabolic dysfunction without pretending this is a new law of nature.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"7714ca5d-9b01-4431-9c52-91a8ec57522a","node_slug":"modulate-sex-hormones-by-gonadectomy","node_name":"Modulate Sex Hormones by Gonadectomy","alternate_names":["Modulate Sex-Hormone Exposure"],"scope_statement":"Modulates systemic androgen and estrogen signaling by permanently removing the testes or ovaries through orchiectomy, oophorectomy, or castration, thereby altering hypothalamic-pituitary-gonadal axis output.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"9d1801e7-2900-4f00-b2eb-8dafd59d8541","node_slug":"modulate-signaling-with-low-dose-lithium","node_name":"Modulate signaling with low-dose lithium","alternate_names":["chronic microdose lithium exposure","Deliver Reformulated Lithium","lithium-mediated GSK-3 inhibition","lithium pathway modulation","low-dose lithium neuromodulation","trace lithium neuropsychiatric modulation"],"scope_statement":"Modulates GSK3B-dependent signaling, neuroinflammation, microglial activation, tau phosphorylation, and possibly hippocampal ATP2A2/SERCA2 activity using subtherapeutic or microdose lithium exposure to chase neuroprotective effects without standard-dose lithium toxicity.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"b9e345d6-0414-4134-a5b7-bdaebb68dd0e","node_slug":"modulate-signaling-with-repurposed-agents","node_name":"Modulate signaling with repurposed agents","alternate_names":["Activate longevity pathways with oleate","drug repurposing for pathway modulation","geroscience repurposing","indication expansion using approved drugs","metabolic drug repurposing","metabolism-targeted drug repurposing","Modulate Cholinergic and NMDA Signaling","Modulate Conserved Aging Pathways","Modulate Nutrient-Sensing Pathways","Modulate nutrient sensing pharmacologically","Modulate pathways with combination stacks","Modulate pathways with repurposed drugs","Modulate pathways with small molecules","nutrient-sensing drug repurposing","pathway-targeted drug repositioning","pharmacologic metabolic modulation","reposition approved molecules","Repurpose approved drugs","Repurpose Approved Pathway Modulators","repurposed gerotherapeutic drugs","Repurpose Known Target Drugs"],"scope_statement":"Modulates pathways such as mTOR, AMPK, NF-kB, Nrf2, or cholinergic signaling with existing small molecules or supplements to improve muscle, cognitive, or immune function without the usual startup fantasy of inventing a new modality.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"a8b87252-68cb-4f59-bf52-ec9b6c87828e","node_slug":"modulate-skin-klotho-signaling","node_name":"Modulate Skin Klotho Signaling","alternate_names":["Deliver Klotho via microneedling"],"scope_statement":"Modulates alpha-Klotho signaling in aged or photoaged skin through local delivery to blunt UV- and stress-response damage while preserving dermal collagen, elastin, and fibroblast or keratinocyte resilience.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"28418de2-0cb8-4e1f-a5ea-f75e3c6ef24e","node_slug":"modulate-skin-stem-cell-signaling","node_name":"Modulate skin stem-cell signaling","alternate_names":[],"scope_statement":"Modulates Wnt, BMP, TGF-beta, Notch, and related niche signals in hair-follicle bulge and epidermal stem cells so endogenous LGR5+, KRT15+, and SOX9+ cells keep migrating, cycling, and repairing tissue instead of lapsing into senescence or miniaturization.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"b9a0860c-58fc-4403-aa34-3321cf6107f5","node_slug":"modulate-soluble-guanylate-cyclase","node_name":"Modulate soluble guanylate cyclase","alternate_names":["Stimulate soluble guanylate cyclase"],"scope_statement":"Modulates nitric oxide to cGMP signaling by stimulating or activating soluble guanylate cyclase (sGC, GUCY1A1/GUCY1B1) to restore downstream PKG-mediated vascular and cellular signaling, not by replacing tissue or pretending damage never happened.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"4f38a7df-695b-4218-8cc1-ade6c2443ba0","node_slug":"modulate-stem-cell-aging-pathways","node_name":"Modulate Stem Cell Aging Pathways","alternate_names":["Inhibit Cdc42 in Bone Cells","Modulate aged skeletal niche signaling","Modulate CDC42 in bone progenitors","Modulate Cdc42 Polarity Signaling","Modulating Cdc42 in HSCs","Repair Bone via Endogenous Skeletal Stem Cells"],"scope_statement":"Modulates p38 MAPK, mTOR, TGF-beta, Wnt/Notch, or Cdc42 signaling in endogenous stem cells to restore quiescence, self-renewal, and regenerative output without the usual sci-fi detour into cell replacement or genome rewriting.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"35af0318-542d-4935-b08a-1d6e8a8b1524","node_slug":"modulate-stem-cell-secretome-signaling","node_name":"Modulate Stem-Cell Secretome Signaling","alternate_names":["cell-free stem cell secretome","conditioned medium immunomodulation","Deliver cargo via extracellular vesicles","Deliver MSC exosome cargo","Deliver Payloads with Engineered Exosomes","Deliver regenerative exosome cargo","Deliver Secretome Instead of Cells","Deliver Targeted Extracellular Vesicles","Modulate Repair with Secretome","Modulate signaling with secretome cocktails","Modulate Tissue Signaling With Secretome","Modulate tissues with secretomes","Modulating Stem Cell Secretome Signaling","MSC secretome therapy","paracrine stem cell biologic","stem cell secretome immunomodulation"],"scope_statement":"Modulates inflammatory, metabolic, and tissue-repair pathways by administering stem-cell-derived secretomes, conditioned media, or extracellular vesicles to deliver paracrine signals such as TSG-6, VEGF, HGF, IGF-1, and IL-10 without transplanting the cells themselves.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"901e1045-e832-427a-8a2f-98b761a03cc0","node_slug":"modulate-systemic-signaling-via-liver-gene-transfer","node_name":"Modulate systemic signaling via liver gene transfer","alternate_names":["Drive Protective Genes by Transfer","endocrine gene therapy","in vivo protein delivery by gene therapy","liver-directed secretion platform","Modulate cardiac remodeling systemically","Modulate physiology via gene transfer","Modulate systemic signaling by gene transfer","Repurpose approved growth-factor gene therapy","secreted-factor gene transfer","systemic paracrine gene therapy"],"scope_statement":"Modulates systemic metabolic and stress-response pathways by using liver-tropic AAV vectors to drive durable hepatic expression of secreted factors such as FGF21, Klotho, or GDF11, because editing every tissue separately is the expensive kind of stupid.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"fb3c5346-3c55-4ec4-9662-f18cc47ef3a5","node_slug":"modulate-targets-by-induced-proximity","node_name":"Modulate targets by induced proximity","alternate_names":[],"scope_statement":"Modulates protein activity, signaling, or degradation by using heterobifunctional or molecular glue drugs to force selective proximity between proteins, E3 ligases, phosphatases, kinases, or other effectors and otherwise hard-to-drug targets.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"80853408-2426-4159-9d57-65b7de7c94f5","node_slug":"modulate-tissue-immune-setpoints","node_name":"Modulate tissue immune setpoints","alternate_names":["Modulate joint inflammatory signaling","Redirect smoke-driven immune conditioning"],"scope_statement":"Modulates dysregulated cytokine and innate-immune signaling in specific tissues to pull immune activity back toward a functional baseline, typically through targets such as TNF, IL-6, IL-1beta, JAK-STAT, NF-kappaB, NLRP3, or Treg-expanding interventions.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"90ba2477-fdea-4f40-bf3a-aad73d293e44","node_slug":"modulate-tissue-repair-signaling","node_name":"Modulate Tissue Repair Signaling","alternate_names":["alginate-encapsulated cell therapy","Edit VEGF for Revascularization","encapsulated stem cell delivery","engineered stem cell neurotrophic delivery","living depot cell therapy","local trophic factor cell depot","Modulate local wound signaling","Modulate macrophage repair signaling","Modulate Muscle Inflammation with Allogeneic Progenitors","Modulate Repair with Collagen Dipeptides","Modulate repair with collagen peptides","neuroprotective factor-releasing cell transplant","paracrine stem cell depot delivery","paracrine stem cell implant","Replace Damaged Tissue with Autologous MSCs","secretome-releasing cell scaffold","trophic factor-secreting stem cell grafts"],"scope_statement":"Delivers paracrine proteins, cytokines, extracellular vesicles, or gene-encoded trophic factors into damaged tissue to shift pathways such as VEGF, HGF, IGF-1, Wnt, Notch, and TGF-beta in resident cells toward survival, angiogenesis, and regeneration instead of replacing the cells outright.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"f98c5473-2683-414e-b3c9-da0a93e1b836","node_slug":"modulate-upstream-myostatin-activation","node_name":"Modulate upstream myostatin activation","alternate_names":[],"scope_statement":"Blocks promyostatin and latent myostatin with monoclonal antibodies to reduce activation of mature GDF8 signaling and increase muscle mass without the usual broad anti-TGF-beta blunderbuss.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"4c2f84c2-f737-4061-97e6-ecd854a06275","node_slug":"modulate-upstream-transcription-factors","node_name":"Modulate upstream transcription factors","alternate_names":["Anti-fibrotic STAT3 blockade","Block STAT3-driven fibrosis signaling","Discover cryptic transcription-factor inhibitors","dynamic transcriptional control of metabolism","JAK-STAT3 inhibition","Modulate DUX4 Transcriptional Activity","regulatory rewiring of biosynthetic pathways","STAT3 pathway inhibition","Suppress pathological STAT3 activation","TF-mediated flux redistribution","transcriptional rerouting of metabolic pathways","transcription factor engineering for metabolic flux control"],"scope_statement":"Modulates ligandable upstream transcription factors such as NRF2, HIF-2alpha, REV-ERB, RORgamma, STAT3, or beta-catenin/TCF with orally available small molecules, often allosterically, to reprogram whole downstream gene-expression states rather than playing whack-a-mole with one effector.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"46d5aec5-be04-473b-a5af-943543e6789b","node_slug":"modulate-vitamin-d-signaling","node_name":"Modulate vitamin D signaling","alternate_names":["Bone health supplementation","Calcium-vitamin D co-supplementation","Fracture prevention supplementation","Vitamin D and calcium supplementation","Vitamin D calcium replacement"],"scope_statement":"Modulates vitamin D receptor signaling with cholecalciferol supplementation in older adults to support calcium-phosphate homeostasis, muscle function, and bone turnover, aiming to slow frailty-related decline rather than pretend it discovered a new aging mechanism.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"467286a0-30ce-4e38-a335-7b1e7a9f374c","node_slug":"modulate-wrn-with-small-molecules","node_name":"Modulate WRN with small molecules","alternate_names":[],"scope_statement":"Modulates WRN helicase/exonuclease activity with small molecules to perturb DNA replication-stress and genome-maintenance pathways through direct target inhibition.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"2a50c485-3c0f-4127-84db-904a930203d6","node_slug":"modulating-ldl-signaling-pharmacologically","node_name":"Modulating LDL signaling pharmacologically","alternate_names":[],"scope_statement":"Modulates LDL receptor, PCSK9, HMG-CoA reductase, or related apoB-lipoprotein pathways with drugs to lower circulating LDL burden and slow, stabilize, or sometimes regress atherosclerotic plaque rather than pretending to invent a new mechanism.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"c8aa0ead-885d-42e9-8745-f1d3df261a00","node_slug":"modulating-nad-metabolism","node_name":"Modulating NAD+ metabolism","alternate_names":["Modulate lipid-coupled NAD+ regeneration","Modulate lipid-driven NAD+ regeneration","Modulate NAD Salvage Pathway","Modulate NAD+ Stress Signaling"],"scope_statement":"Modulates NAD+ biosynthesis, consumption, or sensing through targets such as NAMPT, CD38, PARP1, and sirtuins to improve mitochondrial energy handling, stress-response signaling, and age-linked functional decline; no, dumping random precursors into the system is not the whole story.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"1b2865b6-6a72-426c-816a-68d4a1508269","node_slug":"modulating-progerin-toxicity","node_name":"Modulating progerin toxicity","alternate_names":[],"scope_statement":"Modulates the toxic state of progerin in Hutchinson-Gilford progeria syndrome with small molecules that blunt LMNA-driven nuclear and cellular pathology rather than swapping out the cells or trying to reprogram the problem away.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"c172c61c-1eb9-4ffb-8ff1-62a47a2735b8","node_slug":"modulating-splicing-with-microbial-metabolites","node_name":"Modulating splicing with microbial metabolites","alternate_names":["Modulate Temperature-Responsive RNA Isoforms"],"scope_statement":"Modulates host alternative RNA splicing and downstream transcript isoform output through microbiome-derived metabolites such as short-chain fatty acids, bile acid derivatives, indoles, or trimethylamine-pathway products that act on splicing regulators, chromatin state, or RNA-binding proteins.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"892375f1-79e5-4f38-9d58-0df4ee14ef70","node_slug":"rejuvenate-the-circulating-metabolome","node_name":"Rejuvenate the Circulating Metabolome","alternate_names":[],"scope_statement":"Rejuvenates the circulating metabolome by pushing age-shifted plasma metabolites such as NAD precursors, ketone bodies, amino acids, and acylcarnitines back toward youthful ranges to reset nutrient sensing, inflammation, and tissue metabolism rather than just admiring the lab report.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"384eeb67-1bdb-471a-971e-5042e4b38c7e","node_slug":"relocalize-proteins-across-compartments","node_name":"Relocalize Proteins Across Compartments","alternate_names":["Modulate TFEB nuclear cycling"],"scope_statement":"Relocalizes a target protein such as FOXO3, mTORC1, YAP, or NRF2 to the nucleus, lysosome, mitochondria, plasma membrane, or biomolecular condensates so its signaling output changes without the usual hand-waving about inventing a new mechanism.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"733d51de-82c9-4a10-9a80-076c03c36a4c","node_slug":"silence-harmful-transcripts","node_name":"Silence Harmful Transcripts","alternate_names":["antisense-enabled regenerative reprogramming","microRNA-based reprogramming","RNA interference reprogramming","RNA-mediated cellular reprogramming","silencing-driven dedifferentiation"],"scope_statement":"Silences selected mRNA transcripts with RNA interference tools such as siRNA, shRNA, or Dicer-processed duplexes to reduce expression of pathogenic genes or signaling pathways without altering genomic DNA.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"37c716eb-9ea0-48ce-9284-3048207715cc","node_slug":"structuring-cellular-interfacial-water","node_name":"Structuring Cellular Interfacial Water","alternate_names":["Discover ordered biological water","Drink to rebuild easy water","Expose tissue to conditioning energy","Modulate body water structuring","Rehydrate Structured Intracellular Water"],"scope_statement":"Promotes a persistent interfacial gel phase of intracellular water, often framed as exclusion-zone water, to alter macromolecular organization, charge separation, proton flow, and cellular energy handling rather than treating cytoplasm as ordinary bulk liquid.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"ed743d9c-85cf-4faf-86db-ff4af057e956","node_slug":"supplement-omega-3-fatty-acids","node_name":"Supplement Omega-3 Fatty Acids","alternate_names":[],"scope_statement":"Supplement eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to shift eicosanoid and specialized pro-resolving mediator signaling, dampen NF-kB-driven inflammation, and tune lipid and insulin-related metabolic pathways that drift the wrong way with age.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"ae9065d6-c813-487a-91ff-9f148f9dc5f1","node_slug":"suppress-late-life-pro-aging-programs","node_name":"Suppress late-life pro-aging programs","alternate_names":["Silence pro-aging genes"],"scope_statement":"Suppressing a still-active longevity-limiting pathway such as daf-2/insulin-IGF-1 signaling with late-life RNAi, inducible knockdown, or pharmacologic inhibition shifts old animals into a slower-aging, longer-lived state without repairing or replacing damaged tissue.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"46b24ad1-c4f5-4f01-acc2-a06aa28f3093","node_slug":"suppress-lsd1-demethylase-activity","node_name":"Suppress LSD1 Demethylase Activity","alternate_names":[],"scope_statement":"Suppresses KDM1A/LSD1 histone demethylase activity to rewire chromatin-dependent transcriptional programs that govern proliferation, differentiation, and age-linked cellular decline.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"d52cde79-ef78-4c5c-bd6f-d9aa5ca6098a","node_slug":"target-ectopic-and-depot-fat","node_name":"Target Ectopic and Depot Fat","alternate_names":["Train Low-Inflammation Energy Balance","Train Weight Loss to Defat Liver"],"scope_statement":"Targets visceral, hepatic, intramyocellular, pericardial, marrow, or perivascular fat by modulating adipocyte differentiation, lipid flux, insulin signaling, PPAR, GLP-1, or adipose tissue browning to cut organ-specific metabolic and mechanical risk rather than pretending all fat depots behave the same.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"5e6c19dc-8901-4b3c-8380-29ceb5977e65","node_slug":"withdraw-inappropriate-medications","node_name":"Withdraw Inappropriate Medications","alternate_names":[],"scope_statement":"Withdraws potentially inappropriate, non-beneficial, or interacting medications in older adults through structured deprescribing to reduce anticholinergic load, sedative burden, falls, delirium, and drug-drug harm.","depth":1,"parent_node_id":"561edde7-92f6-4db8-82c3-1190e46b486d","probability_of_confirmation":null,"root_slug":"modulating","root_name":"Modulating","root_cluster":"biology","root_canonical_statement":"Adjust dysregulated signaling and expression — small-molecule inhibitors and activators across mTOR, IIS, AMPK, NLRP3, CD38, Cdc42, GPX4, FGF21, GDF11, IL-6, transcription factors. The catch-all for pharmacology that targets aging pathways without reprogramming, replacing, or editing the underlying cell."},{"node_id":"cee6700d-b82f-4eaa-98a0-10be6369b39d","node_slug":"deliver-factors-via-wound-hydrogel","node_name":"Deliver factors via wound hydrogel","alternate_names":["Deliver Payloads Into Resection Beds","Deliver stabilized wound microenvironments"],"scope_statement":"Delivers growth factors, cytokines, cells, or nucleic acids directly into a wound bed using a local hydrogel, scaffold, film, or depot so the payload acts where the tissue is damaged instead of sloshing uselessly through systemic circulation.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"63a9548f-a084-47e4-9080-54460439c8f7","node_slug":"preserve-endogenous-tissue-repair","node_name":"Preserve Endogenous Tissue Repair","alternate_names":["endogenous stem cell activation","in situ regenerative repair","intrinsic tissue regeneration","progenitor-driven tissue regeneration","Repair epithelial barrier integrity","resident stem cell-mediated repair"],"scope_statement":"Preserves organ function by sustaining endogenous regeneration-linked repair programs in adult tissues through pathways such as YAP/TAZ, Wnt/beta-catenin, Notch, ERK, and pro-regenerative immune signaling, rather than accepting the usual fibrotic decline.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"d9345076-9e8a-4dd1-bc15-e2d435b72644","node_slug":"repair-alveoli-with-p63-progenitors","node_name":"Repair alveoli with p63 progenitors","alternate_names":[],"scope_statement":"Repairs damaged lung tissue by expanding injury-induced, airway secretory-cell-derived p63+ progenitors and driving their differentiation into alveolar epithelial cells to rebuild alveolar structure locally rather than importing cells from elsewhere.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"576cd1bf-8522-49b5-b686-f55bd13e3778","node_slug":"repair-col17a1-stem-cell-support","node_name":"Repair COL17A1 stem-cell support","alternate_names":[],"scope_statement":"Repairs COL17A1-dependent hemidesmosome and niche signaling defects in epidermal and hair-follicle stem cells to preserve self-renewal, tissue adhesion, and regenerative capacity without replacing the cells outright.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"3cc86c18-b055-4ff8-bdd9-6171c526e856","node_slug":"repair-elastin-in-aged-tissues","node_name":"Repair Elastin in Aged Tissues","alternate_names":["Repair Extracellular Matrix Architecture"],"scope_statement":"Repairs structural tissue damage in place by restoring extracellular-matrix elasticity through increased elastin and tropoelastin deposition, elastin-fiber assembly, and crosslinking in aged tissues rather than fiddling with a biomarker and calling it medicine.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"7c3a9cd3-0b3d-4d71-a71e-7f35a8c64d9f","node_slug":"repair-germline-proteostasis","node_name":"Repair Germline Proteostasis","alternate_names":[],"scope_statement":"Repairs proteostasis in germline cells by strengthening chaperone networks, proteasomal degradation, and autophagic clearance in oocytes or spermatogonial cells so misfolded and damaged proteins are removed instead of piling up like neglected rubbish.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"3d71fe7b-de0f-422e-a190-6b74dd5dc818","node_slug":"repair-mitochondrial-energy-capacity","node_name":"Repair mitochondrial energy capacity","alternate_names":["Increase PGC-1alpha activity","Modulate mitochondrial bioenergetics","Modulate mitochondrial bioenergetics pharmacologically","Repair cardiolipin-driven inner fusion","Repair Mitochondrial Cristae Dynamics","Supplement coenzyme Q10"],"scope_statement":"Repairs age-impaired cellular energy production by driving mitochondrial biogenesis and restoring function of existing mitochondria in situ through regulators such as PGC-1alpha, NRF1, TFAM, AMPK, and SIRT1 rather than swapping the organelles out.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"58fb6c7b-d3e4-4420-bab5-3cdfdb0527b1","node_slug":"repair-motor-unit-connectivity","node_name":"Repair motor unit connectivity","alternate_names":["Modulate neuromuscular neurotrophic support"],"scope_statement":"Repairs age-damaged motor neurons and neuromuscular junctions to restore motor-unit recruitment, preserve innervation, and slow sarcopenic muscle loss instead of pretending the muscle failed on its own.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"eac21d12-1d0e-472e-871d-8f4266dc3988","node_slug":"repair-myelin-in-situ","node_name":"Repair Myelin In Situ","alternate_names":["Modulate remyelination brake pathways","Repair Myelin In Place"],"scope_statement":"Repairs damaged myelin around surviving axons by driving endogenous remyelination through oligodendrocyte precursor cell recruitment, differentiation, and sheath rebuilding rather than cell replacement.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"fe4f6392-c092-4515-a33b-796da15a9b47","node_slug":"repair-neuronal-lysosome-function","node_name":"Repair neuronal lysosome function","alternate_names":["Clear Aggregates by Lysosome Acidification","Modulate lysosomal acidification","Modulate lysosomal V-ATPase assembly","Repair lysosomal proteostasis switching"],"scope_statement":"Repairs damaged neuronal lysosomes by restoring membrane integrity, acidification, and hydrolase trafficking so autophagic cargo and aggregation-prone proteins can be degraded again instead of accumulating like uncollected rubbish.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"39403ef9-b325-4670-87ca-c60dc91ccb59","node_slug":"repair-nuclear-pore-integrity","node_name":"Repair Nuclear Pore Integrity","alternate_names":[],"scope_statement":"Repairs aged nuclear pore complexes by restoring long-lived nucleoporins such as NUP93, NUP98, POM121, or TPR to preserve nucleocytoplasmic barrier function and prevent chromosome mis-segregation and aneuploidy.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"85bc78a5-e221-40a9-a258-3c30e5939383","node_slug":"repair-organs-ex-vivo","node_name":"Repair organs ex vivo","alternate_names":["Recondition Donor Organs Ex Vivo","Repair organs ex vivo","Reprogram donor organs ex vivo"],"scope_statement":"Repairs age-related damage in explanted organs before transplantation or other use by ex vivo perfusion and targeted interventions such as normothermic machine perfusion, hypothermic oxygenated perfusion, mitochondrial rescue, and suppression of ischemia-reperfusion stress in the tissue itself.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"05169219-0834-4db3-a85e-640d46b2a372","node_slug":"repair-peripheral-nerve-tissue","node_name":"Repair Peripheral Nerve Tissue","alternate_names":[],"scope_statement":"Repairs damaged peripheral nerves in situ by restoring axons, Schwann cells, myelin, and target reinnervation rather than merely suppressing pain or compensating for lost function.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"156ac73a-c4b3-4232-a4b2-feb5c41368aa","node_slug":"repair-proteostasis-in-damaged-cells","node_name":"Repair Proteostasis in Damaged Cells","alternate_names":["Repair stressed neurons in place"],"scope_statement":"Repairs damaged cells by restoring proteostasis and easing mitochondrial stress through chaperone induction, proteasome or autophagy support, mitophagy, and mitochondrial quality-control pathways such as HSF1-HSP70, PINK1-Parkin, and the UPRmt axis involving ATF5, LONP1, and CLPP.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"be386b49-5b68-492c-82ce-0746738cfaad","node_slug":"repair-proximal-tubule-vesicle-trafficking","node_name":"Repair proximal tubule vesicle trafficking","alternate_names":[],"scope_statement":"Repairs endocytic and recycling vesicle trafficking in proximal tubule epithelial cells to restore apical transporter localization, megalin-cubilin uptake, and renal solute reabsorption that falls apart when the intracellular handling machinery is damaged.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"06059f9c-c830-4897-ba89-155a2aa94353","node_slug":"repair-synovial-lubrication-matrix","node_name":"Repair synovial lubrication matrix","alternate_names":[],"scope_statement":"Repairs joint mechanics by replenishing synovial fluid lubricants and viscoelastic matrix components such as hyaluronic acid and lubricin (PRG4) within the native joint space, improving boundary lubrication, shock absorption, and osteoarthritis symptoms without replacing the joint.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"753cc68d-838b-42a9-a55e-2c52ecf51b15","node_slug":"repair-thymic-involution","node_name":"Repair thymic involution","alternate_names":["Repair thymic epithelial niches"],"scope_statement":"Repairs the involuted thymus to restore thymopoiesis, naive T-cell output, and immune competence using thymic epithelial regeneration, FOXN1 reactivation, sex-steroid ablation, growth-factor programs, or thymic tissue engineering.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"e2e8cffb-75aa-431e-b805-f14fc8c5394e","node_slug":"repair-tissue-barrier-integrity","node_name":"Repair Tissue Barrier Integrity","alternate_names":[],"scope_statement":"Repairs age-damaged epithelial and endothelial interfaces such as the intestinal barrier and blood-brain barrier by restoring tight junctions, mucus or glycocalyx structure, and selective transport instead of pretending leakiness is harmless.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"09cd2978-82b2-47e7-800f-2d37052011a0","node_slug":"repair-tissues-with-stem-secretome","node_name":"Repair tissues with stem secretome","alternate_names":["cell-free mesenchymal repair therapy","extracellular vesicle regenerative therapy","MSC exosome-mediated tissue repair","MSC secretome therapy","paracrine regenerative signaling"],"scope_statement":"Repairs damaged muscle, adipose tissue, and liver by delivering stem cell-derived paracrine factors such as extracellular vesicles, exosomes, and conditioned media to suppress fibrosis, improve remodeling, and restore function without engrafting replacement cells.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"b020f69d-6039-438a-b93f-8cf4939ac990","node_slug":"repair-tissue-with-platelet-factors","node_name":"Repair Tissue with Platelet Factors","alternate_names":["autologous PRP joint injection","Autologous PRP treatment","intra-articular PRP injection","joint PRP infiltration","Orthobiologic PRP therapy","orthobiologic PRP treatment","Platelet concentrate injections","platelet-rich plasma therapy","Platelet-rich plasma therapy","PRP injection therapy"],"scope_statement":"Delivers autologous platelet-derived growth factors, typically via platelet-rich plasma or platelet lysate, into damaged tissue to drive local wound-healing and regeneration signaling without replacing the tissue itself.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"9c114dd0-f1cb-4407-be11-a8bf066c59d5","node_slug":"repair-vascular-elastin-networks","node_name":"Repair vascular elastin networks","alternate_names":[],"scope_statement":"Repairs arterial elastin by combining elastogenesis and elastic-fiber assembly drivers such as tropoelastin, LOX/LOXL1, fibulin-5, or lysyl oxidase support with elastase and MMP inhibition to rebuild elastic lamellae and restore vascular compliance.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"f2444272-47d7-4187-8d1b-d57c71eb5aea","node_slug":"restore-telomere-maintenance","node_name":"Restore Telomere Maintenance","alternate_names":["Activate Telomerase During Regeneration","anti-senescence telomerase modulation in bone stem cells","Deliver telomerase genes to bone","lifelong telomerase modulation","Modulate Telomerase in MSCs","restoring telomere maintenance in aged SSCs","somatic telomerase activation","somatic telomerase gene therapy","systemic telomerase delivery","telomerase activation in skeletal stem cells","telomerase maintenance","telomerase-mediated telomere elongation","telomerase-mediated telomere repair","telomerase reactivation","telomerase rescue of osteogenic stem cell senescence","telomere length restoration","telomere maintenance via telomerase","telomere restoration","TERT expression control","TERT expression therapy","TERT gene therapy","TERT reactivation in skeletal stem cells","whole-body hTERT transduction"],"scope_statement":"Restores telomere maintenance in existing somatic cells by reactivating or replacing telomerase and allied telomere-protection machinery such as TERT, TERC, or shelterin components, instead of swapping the cells out and pretending that counts as repair.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"c53226d5-78ae-48c9-a673-0207eeba3c35","node_slug":"steer-regeneration-with-bioelectric-cues","node_name":"Steer Regeneration with Bioelectric Cues","alternate_names":[],"scope_statement":"Repairs or regrows damaged tissue by applying controlled bioelectric fields or ion-channel modulation alongside regenerative cells to direct pattern formation, differentiation, and morphogenesis rather than merely dumping in stem cells and hoping for a miracle.","depth":1,"parent_node_id":"cf850f98-9b8b-4122-9a4f-06acd7870354","probability_of_confirmation":null,"root_slug":"repairing","root_name":"Repairing","root_cluster":"biology","root_canonical_statement":"Fix damage in place rather than replacing the damaged unit — DNA-repair enhancement, mitochondrial-DNA repair, protein quality-control restoration, regenerative repair of damaged tissues, U1 snRNP restoration."},{"node_id":"49c1d81c-bb98-4673-b2fe-3be25b7be578","node_slug":"manufacture-donor-mitochondria-ex-vivo","node_name":"Manufacture donor mitochondria ex vivo","alternate_names":[],"scope_statement":"Produces standardized, quality-controlled donor mitochondria ex vivo for later mitochondrial transplantation into cells or tissues, usually with release criteria based on membrane potential, respiratory function, and mtDNA integrity rather than wishful thinking.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"d9545c26-0393-494e-845d-e083d9bedf12","node_slug":"replace-cartilage-with-msc-scaffolds","node_name":"Replace cartilage with MSC scaffolds","alternate_names":["Replace Joint Repair Cells","Replace Tissue With Mesenchymal Progenitors"],"scope_statement":"Replaces damaged articular cartilage by implanting donor-derived mesenchymal stromal cells in a local biomaterial scaffold that keeps the cells in the joint long enough to support in situ cartilage repair.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"0de2eeae-6d7f-414a-8054-2a0792850773","node_slug":"replace-cells-via-self-organization","node_name":"Replace Cells via Self-Organization","alternate_names":[],"scope_statement":"Replaces damaged tissue with iPSC-derived graft cells produced through embryo-like self-organization, such as gastruloid, organoid, or blastoid differentiation routes, to yield more developmentally authentic and less immunogenic transplant material.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"38e51f4c-4e6f-4bcb-a77a-2405f3c2c923","node_slug":"replace-damaged-cells-with-autologous-grafts","node_name":"Replace damaged cells with autologous grafts","alternate_names":["autologous cell therapy","cell harvest modify reinfusion","engineered cell replacement","ex vivo cell replacement","ex vivo manipulated cell transplant","Replace Damaged Lung With ADSCs","Replace Damaged Spinal Tissue","Replace damaged tissue with cells","Replace Degenerating Disc Cells","Replace Regenerative Stromal Cells","Replace tissue with adipose cells","Replace Tissue With Adult Stem Cells","Replace tissue with autologous cells","Replace Tissue with Autologous Grafts","Replace Tissue With Banked Autologous Cells","Replace Tissue with Expanded Autologous Cells","Replace Tissue With Rejuvenated Cells","Reprogram nuclei by egg transfer"],"scope_statement":"Replaces damaged or dysfunctional cellular function by administering autologous reprogrammed cell grafts, typically generated ex vivo from a patient's own cells, to modulate immune activity and promote tissue repair.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"4af0380a-7c72-4f9b-8e91-9eb611fad45a","node_slug":"replace-degenerated-joint-surfaces","node_name":"Replace Degenerated Joint Surfaces","alternate_names":[],"scope_statement":"Replaces worn articular cartilage and subchondral joint surfaces in load-bearing joints such as the hip or knee with metal, ceramic, or polyethylene prosthetic components, because the failed joint is not going to repair itself by positive thinking.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"03cdc78f-463a-43ec-aa45-3c5ecd4b63d5","node_slug":"replace-dysfunctional-microglia","node_name":"Replace Dysfunctional Microglia","alternate_names":[],"scope_statement":"Replaces depleted or pathological CNS microglia with donor-derived, transplanted, or in situ repopulated microglial cells to restore debris clearance, synaptic pruning, and neuroimmune homeostasis.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"efe913b8-f77b-41df-b3fb-e671294e5441","node_slug":"replace-hematopoiesis-with-autologous-hscs","node_name":"Replace Hematopoiesis with Autologous HSCs","alternate_names":["durable donor hematopoietic reconstitution","Edit Hematopoietic Stem Cells Ex Vivo","mixed-chimerism stem cell transplantation","nonmyeloablative hematopoietic stem cell transplantation","reduced-intensity stem cell engraftment","Replace blood stem cells ex vivo","targeted niche conditioning for HSC engraftment"],"scope_statement":"Replaces a failing hematopoietic system by transplanting patient-matched hematopoietic stem cells expanded or derived ex vivo to durably reconstitute blood and immune cell production.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"ca18bed4-856b-4b84-bfc9-58b9a15ff93b","node_slug":"replace-mitochondria-in-stem-cells","node_name":"Replace Mitochondria in Stem Cells","alternate_names":["Replace blood with mito-loaded progenitors"],"scope_statement":"Replaces dysfunctional mitochondria in a patient's stem or progenitor cells by loading autologous cells ex vivo with healthy donor mitochondria and reinfusing the mitochondria-augmented cells as an organelle-substitution therapy.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"bfeaac0d-2cc6-4a5a-99e5-ab77d2bcb2ca","node_slug":"replace-mitochondria-via-vesicle-delivery","node_name":"Replace Mitochondria via Vesicle Delivery","alternate_names":[],"scope_statement":"Replaces damaged or respiration-defective mitochondria by delivering intact donor mitochondria or mitochondria-loaded extracellular vesicles into target cells, usually to restore oxidative phosphorylation rather than peddle vague 'mitochondrial support' nonsense.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"80306666-4866-4c84-a255-b096eae3aa97","node_slug":"replace-mitochondria-with-targeted-delivery","node_name":"Replace mitochondria with targeted delivery","alternate_names":["Deliver Mitochondria with Targeted Carriers","Replace Damaged Mitochondria by Transplantation","Replace Mitochondria by Transplantation"],"scope_statement":"Replaces or rescues dysfunctional mitochondria by engineering intact ex vivo organelles with cell-targeting ligands, peptides, antibodies, or membrane modifications so mitochondrial transplantation reaches defined recipient cell types rather than whatever happens to swallow them.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"64ac0677-e63b-431b-90e5-f828512ab659","node_slug":"replace-neurons-by-glial-reprogramming","node_name":"Replace neurons by glial reprogramming","alternate_names":["Replace Neurons by Lineage Conversion","Replace substantia nigra neurons"],"scope_statement":"Replaces lost central nervous system neurons by converting resident astrocytes or NG2 glia into functional neurons in situ with lineage-reprogramming factors such as NeuroD1, Ascl1, or Neurog2, usually delivered by AAV rather than by cell transplant.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"51365330-b023-494f-93fa-f62b2ededdc1","node_slug":"replace-organs-by-xenogenesis","node_name":"Replace organs by xenogenesis","alternate_names":["anencephalic clone donors","clone-grown replacement organs","immunologically matched organ cloning","patient-matched replacement bodies","therapeutic body cloning"],"scope_statement":"Replaces failing organs by growing transplantable human-compatible kidneys, livers, pancreases, or hearts inside engineered host animals using blastocyst complementation, developmental niche deletion, or related interspecies organogenesis methods.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"70e1b7ce-ffda-4d0c-a92c-4fec0ce0c45a","node_slug":"replace-tissues-with-autologous-ipscs","node_name":"Replace tissues with autologous iPSCs","alternate_names":["ESC or iPSC differentiation therapy","iPSC-based cell replacement","pluripotent cell replacement","pluripotent regenerative substitution","Replace Cells With Kill Switches","Replace tissues with ESC-derived cells","Replace Tissue with HLA-Matched Cells","stem-cell-derived tissue replacement"],"scope_statement":"Replaces damaged blood, organ, or tissue compartments with transplantable autologous or HLA-matched grafts derived from induced pluripotent stem cells, rather than trying to cajole failing cells into behaving better.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"76485d3c-fc29-417d-a448-7881412e4b32","node_slug":"replace-tissue-with-organoids","node_name":"Replace tissue with organoids","alternate_names":["Deliver reproducible organoid therapies"],"scope_statement":"Replaces damaged skin or hair-bearing tissue by growing ex vivo organoids, skin equivalents, or follicle germs from keratinocytes, fibroblasts, and stem cells for grafting or regenerative implantation; yes, this is tissue replacement, not magic.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"1805fdcb-835d-4801-9a86-1ab8e57077a6","node_slug":"replace-vessels-with-living-grafts","node_name":"Replace vessels with living grafts","alternate_names":["arterial or venous conduit replacement","bioengineered blood vessel replacement","blood vessel substitution","engineered vasculature implantation","engineered vessel replacement","Replace Small-Diameter Vessel Segments","Replace Tissue with Autologous-Cell Grafts","Replace Vascular Tissue with Living Grafts","small-diameter vascular graft engineering","tissue-engineered vascular grafting","tissue-engineered vascular grafts","vascular graft replacement","vascular tissue engineering"],"scope_statement":"Replaces damaged or missing blood vessels by implanting a biodegradable tissue-engineered scaffold seeded with autologous vascular cells or progenitors that remodels into an integrated, endothelialized living conduit.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"d51012ff-3d1d-4e5d-9ea5-119a514e9cc4","node_slug":"replace-worn-cell-compartments","node_name":"Replace Worn Cell Compartments","alternate_names":["Differentiate Cells Before Transplant"],"scope_statement":"Replaces aged or malfunctioning hematopoietic, immune, or tissue stem-cell compartments with iPSC-derived replacement cell populations, usually via ex vivo differentiation and engraftment rather than trying to coax broken cells into behaving.","depth":1,"parent_node_id":"214af5d5-4df4-4e3e-97b3-45846cb3e387","probability_of_confirmation":null,"root_slug":"replacing","root_name":"Replacing","root_cluster":"biology","root_canonical_statement":"Substitute damaged cells, tissues, or organelles with fresh ones — stem-cell therapy, iPSC-derived cell therapy, mitochondrial transplantation, parabiosis-derived factor restoration, in situ neuron / microglial replacement."},{"node_id":"ba0b5edc-b851-4b92-871a-84d0d53e2b4b","node_slug":"partially-reprogram-aged-cells","node_name":"Partially reprogram aged cells","alternate_names":["cyclic partial reprogramming","cyclic somatic cell reprogramming","cyclic Yamanaka factor induction","Edit aging control genes","epigenetic rejuvenation reprogramming","epigenetic rejuvenation via OSK","in vivo partial reprogramming","iterative partial reprogramming","multi-cycle OSK reprogramming","partial cellular reprogramming","repeated in vivo reprogramming","serial epigenetic reprogramming","transcriptional age reversal reprogramming","transient OSK reprogramming","Yamanaka factor-mediated rejuvenation"],"scope_statement":"Partially reprograms somatic cells with transient or inducible Yamanaka-factor expression, usually OSK or OSKM, to reverse age-linked epigenetic and functional decline without tipping cells into full pluripotency.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"471f9725-1ea6-466b-9a5e-97b7648f8892","node_slug":"rejuvenate-cells-by-partial-reprogramming","node_name":"Rejuvenate cells by partial reprogramming","alternate_names":["CRISPRa partial reprogramming","dCas9-guided partial cellular reprogramming","endogenous OSK activation","epigenetic rejuvenation via CRISPRa","transient Yamanaka factor CRISPR activation"],"scope_statement":"Reprograms somatic cells with transient Yamanaka-factor expression, usually OSK or OSKM, to reverse epigenetic age and restore youthful cellular programs without tipping the cells all the way into pluripotency.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"d20d1a63-b086-4ae0-a64d-a66a6d786713","node_slug":"reprogram-autologous-fibroblasts-ex-vivo","node_name":"Reprogram autologous fibroblasts ex vivo","alternate_names":["cell-state reset to iPSCs","induced pluripotent stem cell generation","induce pluripotency in somatic cells","Reprogram cells to pluripotency","somatic cell reprogramming","Yamanaka factor reprogramming"],"scope_statement":"Reprograms a patient's skin fibroblasts ex vivo with epigenetic reset factors into induced pluripotent or progenitor-like regenerative cells for autologous transplantation back into the same patient.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"69aa1599-8a62-486e-b96f-ea037c776a17","node_slug":"reprogram-cells-to-a-younger-state","node_name":"Reprogram cells to a younger state","alternate_names":["age reversal reprogramming","age-reversal reprogramming","epigenetic age reprogramming","epigenetic rejuvenation","epigenetic rejuvenation of the liver","epigenetic reprogramming","hepatic age-state reprogramming","hepatocyte rejuvenation by reprogramming","in vivo partial reprogramming","liver-targeted partial reprogramming","partial cellular reprogramming","partial liver reprogramming","Reprogram age through regeneration","Reprogram PRC2 age marks","transcription factor-mediated rejuvenation","transient in vivo reprogramming","transient reprogramming","transient Yamanaka-factor reprogramming","Yamanaka factor rejuvenation","Yamanaka-factor rejuvenation","Yamanaka factor reprogramming"],"scope_statement":"Resets aged cells toward a younger epigenetic and transcriptional state by transient partial cellular reprogramming, typically with controlled OSKM-factor expression to restore function without full dedifferentiation or teratoma-prone pluripotency.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"0788afba-8cb2-4986-9361-485e53ea44b1","node_slug":"reprogram-cells-with-one-factor","node_name":"Reprogram cells with one factor","alternate_names":["CRISPRa partial reprogramming","dCas9-mediated OCT4 rejuvenation","endogenous OCT4 activation reprogramming","epigenetic rejuvenation via endogenous Oct4","targeted OCT4 activation for cellular rejuvenation"],"scope_statement":"Reprogram somatic cells toward a younger epigenetic and functional state by transiently perturbing one reprogramming factor such as OCT4, SOX2, KLF4, or c-MYC while stopping short of pluripotency and teratoma-prone dedifferentiation.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"a08cc05e-2f45-497a-8ded-166f80e3e075","node_slug":"reprogram-hematopoietic-stem-cells","node_name":"Reprogram Hematopoietic Stem Cells","alternate_names":[],"scope_statement":"Reprograms hematopoietic stem cells with transient Yamanaka-factor or partial-reprogramming cocktails to push HSCs toward a younger epigenetic and functional state, not merely to tweak one miserable signaling pathway.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"18b95900-0f06-4a92-8848-3591cdfe387a","node_slug":"reprogram-myogenic-progenitor-state","node_name":"Reprogram myogenic progenitor state","alternate_names":["correct delayed fate commitment in aged muscle stem cells","promote myogenic commitment in aged satellite cells","reprogram aged MuSC cell-state transitions","rescue aged satellite cell differentiation","restore aged MuSC lineage commitment"],"scope_statement":"Reprograms aged muscle progenitor cells by driving myogenic differentiation or closely related cell-state transitions that reset epigenetic and transcriptional hallmarks of aging without requiring full pluripotency.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"f70d4e63-3060-4748-87af-ae9ad26f38c2","node_slug":"reprogram-tissues-in-vivo","node_name":"Reprogram Tissues In Vivo","alternate_names":["age reversal reprogramming","age-reversal reprogramming","Deliver OSK via AAV","Deliver OSK with AAV vectors","epigenetic reprogramming","in vivo cellular reprogramming","in vivo partial reprogramming","OSK gene therapy","partial cellular reprogramming","partial epigenetic reprogramming","Reprogram Cells Into Progenitors","transient OSKM reprogramming","Yamanaka factor rejuvenation"],"scope_statement":"Applies transient in vivo expression of Yamanaka or related reprogramming factors in adult tissues to reverse cellular age marks and restore function without fully dedifferentiating cells into a mess.","depth":1,"parent_node_id":"afdf5c90-c4c2-4c0b-9bc1-6216d3a615f6","probability_of_confirmation":null,"root_slug":"reprogramming","root_name":"Reprogramming","root_cluster":"biology","root_canonical_statement":"Restore cellular identity and youthful epigenetic state via reprogramming factors (Yamanaka factors, OSK partial reprogramming, transient reprogramming). The Information-Theory-of-Aging mechanism of action — reset the cell, don't just patch the damage."},{"node_id":"54a587e0-8390-4f42-b701-6d6aee1f4580","node_slug":"train-endogenous-antibody-production","node_name":"Train Endogenous Antibody Production","alternate_names":["antibacterial vaccination","antigen-specific immune priming","bacterial antigen immunization","pathogen-specific adaptive immune training","protective immune memory induction","Train antibody immunity actively"],"scope_statement":"Trains adaptive immunity with active immunization, usually peptide, protein, DNA, mRNA, or virus-like-particle vaccines plus an adjuvant, so your own B cells make antibodies against defined targets such as PCSK9, amyloid-beta, alpha-synuclein, or IL-17.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"12cf5f09-9701-4a58-b62a-b6513a369ee4","node_slug":"train-healthier-daily-environments","node_name":"Train Healthier Daily Environments","alternate_names":[],"scope_statement":"Trains metabolic, cardiovascular, and immune resilience by bundling exercise programming, dietary change, social prescribing, preventive screening, and exposure reduction into sustained changes in the places people live and how they behave, rather than repairing tissue or editing genes.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"ee863523-5066-412c-8fff-12d6f70a2f14","node_slug":"train-hormetic-exercise-adaptations","node_name":"Train Hormetic Exercise Adaptations","alternate_names":["aerobic interval training","exercise hormesis","high-intensity interval training","sprint interval training","Train Mitochondria via Complex I","VO2 max training"],"scope_statement":"Trains repeated high-intensity exercise bouts such as HIIT or sprint-interval work to provoke AMPK-PGC-1alpha signaling, mitochondrial biogenesis, lactate handling, and cardiovascular remodeling in existing tissues rather than repairing or replacing anything.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"44b9a1c3-d154-4b9e-966d-de527fd92a61","node_slug":"train-joint-range-of-motion","node_name":"Train joint range of motion","alternate_names":[],"scope_statement":"Repeatedly moves joints, muscles, tendons, and surrounding soft tissue through usable end ranges with mobility drills, loaded stretching, and controlled articular rotations to preserve or improve range of motion and movement capacity.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"172b7acc-59df-49f9-a863-d7c5d97399dc","node_slug":"train-lung-trm-immunity","node_name":"Train Lung TRM Immunity","alternate_names":[],"scope_statement":"Trains lung-specific, Th1-skewed tissue-resident memory T cells by mucosal vaccination to reprogram the local immune niche toward fibrosis resolution rather than more scar tissue, which is a lot more useful than spraying in another transient payload.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"56cf71eb-5036-417f-9c67-2571fd70e086","node_slug":"train-metabolic-stress-resilience","node_name":"Train Metabolic Stress Resilience","alternate_names":["alternate-day fasting","circadian time-restricted eating","daily feeding window restriction","early time-restricted feeding","fasting-induced immune hormesis","fasting-mediated inflammatory reprogramming","fasting-mimicking diet","fasting-mimicking immune resilience","intermittent fasting","intermittent fasting immune conditioning","metabolic stress training with fasting","periodic fasting","time-restricted eating","time-restricted feeding","Train Metabolic Flexibility","Train metabolism with timed fasting","Train nutrient-stress responses by fasting"],"scope_statement":"Trains endogenous stress-response programs by imposing repeated fasting periods that drive metabolic switching from glucose to fatty acids and ketones, activate AMPK and autophagy, inhibit mTOR signaling, and build tolerance to nutrient stress rather than repairing tissue directly.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"9c593c3f-6201-4222-9511-cc659c0e6ebe","node_slug":"train-metabolism-with-calorie-restriction","node_name":"Train metabolism with calorie restriction","alternate_names":["caloric restriction","dietary restriction","energy restriction","fasting-based hormesis","nutrient restriction training"],"scope_statement":"Cuts energy intake through calorie restriction, dietary restriction, fasting, or fasting-mimicking regimens to activate AMPK and sirtuin stress responses, suppress mTOR and IGF-1 signaling, and induce autophagy and metabolic adaptation rather than repairing anything.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"fcf7b727-04e5-470c-b956-e29f9f2053f0","node_slug":"train-nutrient-stress-adaptation","node_name":"Train nutrient stress adaptation","alternate_names":["adaptive root architecture conditioning","caloric restriction","dietary methionine restriction","dietary restriction","fasting-based metabolic conditioning","fasting-mimicking diet","hormetic nutrient deprivation training","low-phosphate root training","methionine-restricted diet","methionine restriction","nitrogen limitation acclimation","nutrient stress conditioning","one-carbon amino acid restriction","sulfur amino acid restriction","time-restricted feeding","Train fasting-like stress signaling"],"scope_statement":"Reduces caloric or amino-acid intake to activate hormetic stress programs such as AMPK, sirtuins, autophagy, and FOXO while suppressing insulin/IGF-1 signaling and mTORC1 activity.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"a51b22b9-1722-44d8-b3d0-4e5e19638160","node_slug":"train-postural-stability-and-balance","node_name":"Train Postural Stability and Balance","alternate_names":[],"scope_statement":"Trains vestibular, proprioceptive, and neuromuscular control through balance tasks, perturbation drills, and sustained postural loading so you can hold position under load without joints wobbling about like amateurs.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"5a3a054c-ee99-4f51-bd1a-b0fa9310f611","node_slug":"train-residual-cognitive-function","node_name":"Train Residual Cognitive Function","alternate_names":[],"scope_statement":"Trains remaining neural circuits and everyday cognitive behaviors with cognitive rehabilitation, compensatory strategy instruction, and repeated task practice to preserve or recover function without repairing or replacing brain tissue.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"e91bc94f-f884-4908-a874-c61e039fb6fe","node_slug":"train-senescent-cells-mechanically","node_name":"Train Senescent Cells Mechanically","alternate_names":[],"scope_statement":"Applies low-frequency mechanical stimulation to senescent cells to perturb cytoskeletal, mechanotransduction, and chromatin-state programs such as actomyosin tension, YAP/TAZ signaling, and nuclear lamina coupling, with the aim of restoring a less senescent functional state without senolytic ablation.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"f4337cc8-3c39-43e7-9422-14aeb20b1210","node_slug":"train-stress-response-resilience","node_name":"Train Stress-Response Resilience","alternate_names":["adaptive stress training","build mitohormetic resilience","build organismal resilience","exercise and caloric restriction hormesis","exercise-fasting adaptive conditioning","hormetic conditioning","induce hormesis with training","induce hormetic resilience","lifestyle hormesis","metabolic resilience training","mild stress conditioning","precondition whole-organism stress responses","resilience conditioning","stress inoculation","stress-train metabolic maintenance","Train Adaptive Resilience","Train Autonomic Balance with HRV","Train Immunometabolic Resilience"],"scope_statement":"Trains endogenous resilience by combining fasting or time-restricted feeding, aerobic and resistance exercise, and breathwork or yoga to repeatedly engage AMPK-mTOR-FOXO nutrient sensing, vagal regulation, and hormetic heat-shock and antioxidant defenses without changing the genome or adding a new biologic.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"1bc69010-91d6-4e7d-abd6-dea1d95de787","node_slug":"train-through-hormetic-exercise","node_name":"Train Through Hormetic Exercise","alternate_names":["adaptive exercise for brain resilience","aerobic conditioning","brain-directed hormetic training","cardiorespiratory fitness training","chronic exercise adaptation","endurance training","exercise across the lifespan","exercise hormesis conditioning","exercise hormesis for brain maintenance","exercise-induced neurotrophic support","lifelong exercise training","long-term exercise maintenance","neurotrophic exercise conditioning","progressive overload training","progressive resistance training","resistance exercise","stamina training","strength training","sustained training across adulthood","Train bone and muscle","Train Natural Movement Patterns","Train reserve before decline","Train With Hormetic Load","weight training"],"scope_statement":"Uses repeated aerobic, resistance, or interval exercise to condition skeletal muscle, mitochondria, neuromuscular function, and stress-response pathways so older adults keep strength, gait, and reserve capacity instead of chasing anti-aging fairy dust.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"202eeb9a-4160-4c1c-9292-13bca6f69eb4","node_slug":"train-tissue-resident-innate-immunity","node_name":"Train Tissue-Resident Innate Immunity","alternate_names":["innate clearance retraining","innate immune reprogramming","innate immune training","local immune reset","local trained immunity","macrophage conditioning","macrophage reboot therapy","microglial re-education","site-specific innate immune training","trained immunity","Train Immunity for Neuroprotection","Train Innate Pathogen Clearance","Train Organ-Specific Innate Immunity","Train organ-targeted innate immunity"],"scope_statement":"Trains tissue-resident innate immune cells through local immunomodulatory cues so macrophages, microglia, neutrophils, or NK cells clear chronic dysfunction more effectively without replacing cells or editing DNA.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"635aec73-eef8-4745-aec0-d5da9083fd86","node_slug":"train-with-hyperbaric-oxygen","node_name":"Train with Hyperbaric Oxygen","alternate_names":["Modulate Tissue Oxygenation with HBOT","Pressurize with Hyperbaric Oxygen"],"scope_statement":"Uses intermittent hyperbaric oxygen exposure, usually in a pressurized chamber at above 1 ATA, to provoke adaptive stress responses in hypoxia-response, angiogenesis, and tissue-repair pathways rather than pretending oxygen itself is some anti-aging fairy dust.","depth":1,"parent_node_id":"8641ace8-2242-4a32-9464-53e9e5e48cce","probability_of_confirmation":null,"root_slug":"training","root_name":"Training","root_cluster":"biology","root_canonical_statement":"Induce beneficial adaptive responses in existing biology — innate immune training, hormetic stress conditioning (exercise, cold, fasting), mitochondrial training, metabolic resilience training, immunomodulatory remodeling of aged tissue."},{"node_id":"a6d6d007-c2fd-4774-a6d3-d8f9e501189d","node_slug":"deliver-genes-body-wide","node_name":"Deliver genes body-wide","alternate_names":["Deliver Episomal Gene Payloads","Deliver genes systemically by AAV"],"scope_statement":"Delivers a therapeutic transgene systemically with vectors such as AAV9, AAVrh74, or lipid nanoparticles so one or a few doses distribute expression across multiple tissues instead of repeated local intramuscular injections.","depth":1,"parent_node_id":"7d03dd6d-d40d-4c35-8cb1-e11f8d93ef57","probability_of_confirmation":null,"root_slug":"delivering","root_name":"Delivering","root_cluster":"method","root_canonical_statement":"Vehicles that get therapeutic payloads to their targets — AAV vectors with engineered tropism, lipid nanoparticles (LNPs), exosomes and extracellular vesicles, engineered nanoparticle carriers, non-viral genetic delivery, Mitlet-style organelle-delivery vehicles."},{"node_id":"41f32de7-4273-42cb-88e3-1736df8a017e","node_slug":"deliver-proteins-via-invasive-bacteria","node_name":"Deliver proteins via invasive bacteria","alternate_names":["Deliver proteins with bacterial adhesins"],"scope_statement":"Delivers functional protein cargo into mammalian cells by exploiting engineered or naturally invasive bacteria and their secretion or vacuole-escape machinery to reprogram host-cell behavior.","depth":1,"parent_node_id":"7d03dd6d-d40d-4c35-8cb1-e11f8d93ef57","probability_of_confirmation":null,"root_slug":"delivering","root_name":"Delivering","root_cluster":"method","root_canonical_statement":"Vehicles that get therapeutic payloads to their targets — AAV vectors with engineered tropism, lipid nanoparticles (LNPs), exosomes and extracellular vesicles, engineered nanoparticle carriers, non-viral genetic delivery, Mitlet-style organelle-delivery vehicles."},{"node_id":"ae997125-a2bc-4a1a-96f1-dae9378cfd24","node_slug":"automate-closed-loop-discovery","node_name":"Automate Closed-Loop Discovery","alternate_names":["Automate Hypothesis Discovery Loops","Optimize Reaction Conditions Iteratively","Optimize synthesis conditions computationally"],"scope_statement":"Automates design-build-test-learn cycles with active learning, robotic experimentation, and Bayesian optimization so compounds or biomaterials get iteratively proposed, assayed, and improved faster than by humans shuffling spreadsheets.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"714dacc7-5069-49a3-bade-9cf71a387feb","node_slug":"automate-trial-emulation-pipelines","node_name":"Automate Trial Emulation Pipelines","alternate_names":[],"scope_statement":"Automates target-trial emulation end to end by parsing eligibility and treatment protocols, building OMOP/FHIR concept sets and cohorts, adjusting confounding with propensity scores or inverse-probability weighting, and repeatedly estimating causal effects across many standardized runs instead of pretending an LLM is doing epidemiology by magic.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"87d72c32-d92f-4a86-9f03-2c8ebd596141","node_slug":"discover-age-linked-proteome-shifts","node_name":"Discover age-linked proteome shifts","alternate_names":["Measure age-linked proteome remodeling"],"scope_statement":"Measures age-stratified protein abundance across the C. elegans proteome to identify proteins, pathways, and biological processes that shift with age and thereby nominate aging-relevant mechanisms and targets.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"3f66ab55-cbf6-4450-8f21-5a6d54e3ccb1","node_slug":"discover-aging-dynamics-mechanistically","node_name":"Discover aging dynamics mechanistically","alternate_names":["aging latent-state hazard modeling","Build longitudinal digital twins","cross-species mortality-biomarker dynamical model","digital twin biology","Discover causal aging states","Discover cell-state-specific targets","Discover Homeostasis Failure Maps","Discover Intervention Trajectories In Silico","Discover latent health trajectories","discover stage structure in cellular aging","Discover Targets from Aging Dynamics","infer temporal aging programs","low-dimensional aging dynamics model","map cellular aging progressions","mechanistic aging state-space modeling","mechanistic dynamical systems inference","Model Individual Digital Twins","model sequential aging state transitions","multiscale perturbation-response modeling","reconstruct aging state trajectories","state-space biological modeling","systems dynamics modeling","vitality-style aging dynamics modeling"],"scope_statement":"Infers latent aging state transitions from longitudinal multi-omics, single-cell, or physiological data using mechanistic or constraint-based models such as ODE systems, state-space models, and flux balance analysis, then uses those models to predict interventions worth testing in wet lab rather than pretending correlation is causation.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"7dce78d6-3b47-4411-a031-600aef9856e0","node_slug":"discover-aging-mechanism-gaps","node_name":"Discover Aging Mechanism Gaps","alternate_names":["Discover Mechanisms by Evidence Synthesis","Discover Targets by Literature Curation","Validate disputed mechanism claims","Validate pathways with cross-species perturbations"],"scope_statement":"Maps where evidence for mechanisms such as mTOR, AMPK, senescence, autophagy, and NAD+ biology actually holds up, pits rival causal models against each other, and proposes discriminating experiments using tools like CRISPR screens, Perturb-seq, and single-cell multi-omics instead of just recycling whatever story was fashionable last quarter.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"9332ff7e-3fac-4e3b-bf3b-6209e2aca370","node_slug":"discover-aging-rate-determinants","node_name":"Discover aging-rate determinants","alternate_names":["Discover diet-specific lifespan epistasis","Discover intervention-robust lifespan loci","Map lifespan loci in mice","Measure age-acceleration heterogeneity","Measure social exposure age acceleration"],"scope_statement":"Discovers genetic variants, environmental exposures, and gene-by-environment effects by treating biological age acceleration or delta age from epigenetic, proteomic, imaging, or clinical clocks as the phenotype in association analyses.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"239063d0-3980-400a-bd3f-9c139183a4a4","node_slug":"discover-aging-signatures-from-multi-omics","node_name":"Discover aging signatures from multi-omics","alternate_names":["age-stratified transcriptomic target discovery","aging biomarker gene discovery from RNA-seq","cross-tissue aging gene discovery","Discover age-rising microglial miRNAs","Discover aging-disease signatures","Discover aging mechanisms from transcriptomics","Discover decline-linked biomarkers and targets","Discover dosage-perturbed pathways","Discover IPF aging mechanisms","Discover Shared Aging Mechanisms","Discover with Federated Learning","human aging transcriptome mining","identify aging genes from human transcriptomics","Measure Multi-Omic Aging Signatures"],"scope_statement":"Discovers aging-associated signatures, biomarker panels, and intervention-response predictors by integrating human transcriptomic, proteomic, metabolomic, epigenomic, and clinical datasets with machine-learning models such as multi-view learning, latent factor models, and biological age clocks.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"72f1a721-aeae-4e38-8800-ebd888ff525e","node_slug":"discover-bat-proteomic-regulators","node_name":"Discover BAT proteomic regulators","alternate_names":["Discover proteome-metabolome regulators"],"scope_statement":"Discovers conserved metabolic regulators by quantifying protein abundance in genetically diverse brown adipose tissue and linking proteomic variation to physiological traits with outbred multi-omic mapping.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"42b9a175-ff58-4dab-ad3f-d03edc73ac75","node_slug":"discover-brown-fat-regulators","node_name":"Discover brown fat regulators","alternate_names":["Discover brown fat thermogenesis targets"],"scope_statement":"Profiles the brown adipose tissue proteome by mass spectrometry to identify proteins, post-translational changes, and pathway nodes that regulate thermogenesis, mitochondrial metabolism, and insulin-sensitive energy handling.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"5959b607-4931-4260-a4fe-f1a01ae77446","node_slug":"discover-cancer-resistance-pathways","node_name":"Discover cancer resistance pathways","alternate_names":[],"scope_statement":"Discovers naturally evolved tumor-suppression mechanisms in exceptionally long-lived, cancer-resistant species by comparative genomics, transcriptomics, and functional validation to identify pathways and targets such as TP53 dosage, high-molecular-mass hyaluronan, or enhanced DNA repair that may matter for aging-relevant resilience.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"790bef26-3d5b-40d3-801d-90f08e7dfbed","node_slug":"discover-candidates-by-phenotypic-screening","node_name":"Discover candidates by phenotypic screening","alternate_names":["Discover proximal tubule drug targets","Measure lifespan during screening"],"scope_statement":"Discovers intervention candidates or gene-by-compound interactions by running target-agnostic whole-organism screens in animals such as C. elegans, Drosophila, zebrafish, or killifish and selecting hits from lifespan, stress-resistance, locomotion, fertility, or other in vivo phenotypes instead of pretending the label already told you the target.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"85c58402-b6cc-4226-a31a-8930445453a7","node_slug":"discover-clonal-hematopoiesis-drivers","node_name":"Discover clonal hematopoiesis drivers","alternate_names":[],"scope_statement":"Discovers genes, mutational signatures, and positive-selection patterns in age-expanded blood-cell clones by large-scale somatic mutation analysis of hematopoietic lineages, so you can identify causal drivers and drug targets instead of pretending observation is intervention.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"b6e61185-e922-4bf8-921d-e5a2f7aff877","node_slug":"discover-cysteine-catabolism-regulators","node_name":"Discover Cysteine Catabolism Regulators","alternate_names":[],"scope_statement":"Discovers regulatory proteins that control cysteine breakdown through nodes such as CDO1, CTH, MPST, or CSAD, exposing tractable control points for redox and sulfur-amino-acid metabolism rather than pretending target discovery is already a treatment.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"705f8e16-b687-40e3-8137-b2b2017a1c7f","node_slug":"discover-enhancer-gene-links","node_name":"Discover enhancer-gene links","alternate_names":["Measure enhancer-gene wiring"],"scope_statement":"Discovers which enhancers regulate which genes by learning from CRISPR perturbation screens and other functional genomics data, so you can map cis-regulatory wiring and stop guessing which noncoding variants are causal.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"6abf2a28-4f5c-4339-92be-092bfe4112ec","node_slug":"discover-fungal-bioactive-metabolites","node_name":"Discover fungal bioactive metabolites","alternate_names":["Discover fungal metabolite therapeutics","Discover fungal secondary metabolites"],"scope_statement":"Discovers candidate small molecules by mining fungal secondary metabolites with fermentation, genome mining, LC-MS/MS dereplication, and bioassay-guided isolation, then screens and characterizes the hits instead of pretending the mechanism is known upfront.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"166be97d-a829-4b94-940b-4b96e427f353","node_slug":"discover-genes-by-t2t-assembly","node_name":"Discover genes by T2T assembly","alternate_names":["Assemble reference mammal genomes","Build comparative reference genomes","Build reference-quality genomes","Discover reference genomes and annotations","Discover trait-linked genome architecture","Sequence Conservation Reference Genomes"],"scope_statement":"Builds telomere-to-telomere, chromosome-scale genome assemblies with long-read sequencing and scaffolding so centromeres, subtelomeres, repeats, structural variants, and misannotated loci stop hiding in the gaps.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"d59f853a-7a63-4c7e-a734-41802e8c67e7","node_slug":"discover-genetic-aging-regulators","node_name":"Discover Genetic Aging Regulators","alternate_names":["Discover actionable aging mechanisms","Discover causal aging processes in yeast","Discover cell-death control genes","Discover Gene Function by Inducible Perturbation","Discover genes by yeast overexpression","Discover Hallmark-Guided Targets","Discover regulators with Perturb-seq","high-throughput aging target identification","multi-omic phenotypic screening","parallel senescence hit discovery","perturbation-based senescence target discovery","phenotypic and multi-omic target discovery"],"scope_statement":"Identifies and validates genes, gene networks, or signaling pathways that causally regulate cellular senescence or replicative lifespan using perturbation screens, longitudinal omics, and functional follow-up, so later intervention work has a target worth bothering with.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"e0a75479-2244-4bd3-a36e-7a2ce01560d6","node_slug":"discover-genotype-phenotype-maps","node_name":"Discover genotype-phenotype maps","alternate_names":["Discover candidate causal genes","Discover gene function by morphological profiling","Discover genotype-phenotype associations","Discover IL32 genotype-phenotype links","Discover iron and red-cell regulators","Discover lifespan loci in mice","Discover loci with dense genotyping","Discover spinal curvature determinants","Discover targets by morphological knockout screening","Generate Variant Genomes","Map quantitative trait loci"],"scope_statement":"Discovers genotype-phenotype maps by linking combinations of variants, perturbations, or alleles to measurable traits and disease risk, so you can predict which CRISPR edits, base edits, or knock-ins are likely to produce a target phenotype before you start mutilating cells.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"718d3f4d-4932-4c6f-83c7-c7f03e20ff8c","node_slug":"discover-hypothalamic-stress-transcriptomes","node_name":"Discover hypothalamic stress transcriptomes","alternate_names":["environmental hypothalamus RNA-seq assay","hypothalamic gene expression readout","hypothalamic stress-response transcriptomics","hypothalamic transcriptomic profiling","neuroendocrine transcriptome measurement"],"scope_statement":"Identifies genes, cell states, and pathways in the hypothalamus that shift across housing, husbandry, or environmental stress conditions by comparing bulk or single-cell transcriptomic profiles, with the aim of target discovery rather than treatment.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"d216dfd4-d61d-4b31-ab32-bb269979d722","node_slug":"discover-intervention-candidates","node_name":"Discover Intervention Candidates","alternate_names":["computational drug repurposing","computational target and compound discovery","data-driven therapeutic reprioritization","Discover Drug Targets and Hits","Discover indications by repurposing","Discover Repurposed Drug Candidates","in silico candidate discovery","network-based drug repositioning","Predict Development Success","Rank Rejuvenation Interventions","Rediscover shelved drug candidates"],"scope_statement":"Ranks intervention candidates by fusing drug-target networks, pathway annotations, lifespan assay readouts, toxicology liabilities, and clinical-stage context into one searchable decision surface for what to test next.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"c717bedf-6ec5-4e32-ae36-c1853719cc1f","node_slug":"discover-liver-fat-pathways-by-human-genetics","node_name":"Discover Liver Fat Pathways by Human Genetics","alternate_names":["Discover causal fat depot mechanisms","Discover genetic bone-remodeling drivers","genetically instrumented liver fat analysis","genetic causal inference for liver fat","human genetics of NAFLD mechanisms","liver-fat causal variant stratification","Mendelian randomization of hepatic steatosis"],"scope_statement":"Discovers genes, pathways, and drug targets that regulate hepatic steatosis by using human genetic variation as a natural experiment through GWAS, rare-variant analysis, and Mendelian randomization to separate causal mechanisms from decorative correlation.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"ab725c44-a0e7-459d-a8a4-7082322bce12","node_slug":"discover-longevity-protective-genes","node_name":"Discover longevity-protective genes","alternate_names":["Discover causal longevity genes","discover longevity genes by LoF depletion","exceptional longevity burden genetics","longevity target discovery from population sequencing","natural protection target discovery","protective human knockout analysis"],"scope_statement":"Discovers genes whose intact function is associated with exceptional human lifespan by comparing germline loss-of-function variant burden in centenarians or other long-lived cohorts versus controls using population and statistical genetics.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"cce99c06-6237-4a16-93ca-79289e4609f5","node_slug":"discover-mechanistic-targets-with-ai","node_name":"Discover Mechanistic Targets with AI","alternate_names":["AI-driven biomarker and target inference","AI-driven compound prioritization","AI-guided target discovery","AI target discovery for senescence genes","Autonomous omics target discovery","computational discovery of senescence targets","Computational target and hit discovery","Discover biologic targets computationally","Discover causal drivers from data","Discover Cell State Reprogrammers","Discover Collective-Behavior Patterns","Discover Geroprotectors In Silico","Discover interventions by predictive validation","Discover interventions with formal models","Discover interventions with state models","Discover Multi-Scale Systems Biology","Discover targets and candidate ligands","Discover targets with biomedical LLMs","Discover targets with computational models","Discover Targets with Generative AI","Discover with Tool-Using Agents","Foundation-model drug target discovery","identify senescence-oncology targets","In silico gerotherapeutic discovery","in silico target discovery for cellular senescence","Machine learning drug target prioritization","Machine learning for intervention discovery","Model intervention effects across scales","Model systems to discover interventions","Predict intervention aging effects","Rank genes with LLMs","senescence-cancer target nomination"],"scope_statement":"Discovers intervention targets and candidate therapeutics by fitting AI models with biophysical constraints, causal graphs, dynamical systems, or pathway priors so they predict perturbation effects on senescence, regeneration, and age-linked failure instead of merely memorizing correlations.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"b3f6fcb8-251f-4c88-b51e-532a6ddc339d","node_slug":"discover-papp-a2-binding-architecture","node_name":"Discover PAPP-A2 Binding Architecture","alternate_names":["PAPP-A2 protease cleavage-site mapping","PAPP-A2 structural mechanism discovery","PAPP-A2 structure-function analysis","PAPP-A2 substrate recognition mapping","PAPP-A2 variant mechanism elucidation"],"scope_statement":"Determines the 3D structure of PAPP-A2, its catalytic site, and its substrate-binding interfaces, usually with cryo-EM or X-ray crystallography, so inhibitor or modulator design can proceed on something better than wishful thinking.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"246b053d-40ed-49c5-9c3e-4a42ed07000d","node_slug":"discover-pathways-by-transcriptomics","node_name":"Discover pathways by transcriptomics","alternate_names":["Discover immune-state regulatory circuits","Discover NMJ remodeling targets","Discover transcriptome-ranked gene targets","Integrate Cross-Cohort Transcriptomes"],"scope_statement":"Compares genome-wide RNA expression profiles across perturbations, cell states, or tissues using RNA-seq or single-cell transcriptomics to infer the pathways, transcription factors, and upstream regulators driving a biological process rather than pretending correlation is mechanism.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"a1b73f8e-82ff-44bd-8489-96664b970ec3","node_slug":"discover-progeroid-syndromes-computationally","node_name":"Discover progeroid syndromes computationally","alternate_names":[],"scope_statement":"Discovers candidate progeroid disorders by clustering Human Phenotype Ontology symptom profiles and disease-gene network topology to separate true premature-aging syndromes from everything else that merely looks old at first glance.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"e1aeb6f4-70ed-4c2c-8f15-e4a76173ccb9","node_slug":"discover-protective-mammalian-traits","node_name":"Discover Protective Mammalian Traits","alternate_names":["causal target discovery in hibernators","comparative extremophile mammal genomics","comparative hibernation mechanism mapping","comparative mammalian trait mapping","comparative RNA-seq target mining","comparative transcriptomic target discovery","Compare Exceptional Genomes Across Species","cross-species protective phenotype discovery","deconfound hibernation transcriptomics","differential expression pathway discovery","Discover comparative aging targets","Discover conserved resilience targets","Discover cross-species targets","Discover hibernation entry regulators","discover hibernation protective pathways","evolutionary comparative genomics for target discovery","Identify Natural Defense Mechanisms","identify true hibernation survival mechanisms","natural experiment target discovery","single-cell comparative transcriptomic discovery","state-resolved RNA target discovery","Translate via regenerative mammal comparison"],"scope_statement":"Discovers intervention hypotheses by comparing naturally resilient mammals such as naked mole-rats, bats, elephants, and hibernators to map stress-response circuits, proteostasis programs, DNA repair, cancer resistance, and tissue-maintenance mechanisms that evolution already field-tested better than most grant proposals.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"7e484e55-a644-4a74-8d8e-177c0a5307c7","node_slug":"discover-proteostasis-longevity-correlates","node_name":"Discover proteostasis longevity correlates","alternate_names":[],"scope_statement":"Maps chaperones, unfolded protein response nodes, ubiquitin-proteasome components, and autophagy-lysosome factors whose abundance or activity tracks with longer lifespan across rodent species or strains before anyone starts pretending they know which lever to pull.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"d367cfe4-fd8c-4703-8de6-90076dd23d83","node_slug":"discover-regulators-with-multiplexed-reporters","node_name":"Discover regulators with multiplexed reporters","alternate_names":["Discover regulator-promoter control","Discover targets with barcoded RNP screens"],"scope_statement":"Discovers upstream regulators of a defined transcriptional program by running massively parallel reporter assays under genetic or chemical perturbation, then reading out which cis-regulatory elements, transcription factors, or signaling nodes actually move the program instead of merely waving at it.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"fc5adccd-b491-4e2e-935f-7935023995a1","node_slug":"discover-rejuvenation-via-physics","node_name":"Discover Rejuvenation via Physics","alternate_names":[],"scope_statement":"Uses nonequilibrium thermodynamics, dynamical systems, and information-loss models of cells and tissues to map aging-related state transitions and nominate control points or interventions that might reverse them.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"e2cb6df6-e3a7-43da-bf24-4bd39d76b85d","node_slug":"discover-resilience-derived-drug-targets","node_name":"Discover resilience-derived drug targets","alternate_names":["Discover protective human longevity signals","Discover protective resilience targets","Discover Targets from Protective Genetics","Translate from Human Biology"],"scope_statement":"Discovers drug targets by combining human protective-variant genetics, GWAS/PheWAS colocalization, and causal network models to rank intervention hypotheses tied to resilience phenotypes rather than chasing pet pathways.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"5ce18237-6593-4a47-8b5b-ef78405d0de8","node_slug":"discover-resilience-targets-from-human-genetics","node_name":"Discover resilience targets from human genetics","alternate_names":["Discover human cohort targets"],"scope_statement":"Discovers therapeutic targets by mining naturally protective human variants and loss-of-function alleles in pathways such as TREM2-microglial signaling, APOE lipid handling, and inflammatory cytokine cascades, then follows the genetics into mechanisms that blunt neurodegeneration and chronic inflammatory damage rather than pretending nature invented magic.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"f7efe429-76e8-4460-a471-aae8862bc220","node_slug":"discover-senescent-cell-clearance-effectors","node_name":"Discover Senescent-Cell Clearance Effectors","alternate_names":["Discover shared senescence-clearance mechanisms"],"scope_statement":"Identifies the endogenous immune cell populations and ligand-receptor programs that clear senescent cells by comparing diseased versus matched tissue states with single-cell RNA sequencing, then maps the clearance circuitry to find druggable intervention points.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"13761720-739f-4477-8d7f-4a998e96d190","node_slug":"discover-shared-calcification-pathways","node_name":"Discover shared calcification pathways","alternate_names":["Discover calcification pathways across tissues"],"scope_statement":"Compares molecular dysregulation across calcified soft tissues such as arteries, aortic valves, and kidney or dermal lesions to find recurrent pathways, cell states, and intervention targets instead of pretending each calcification niche is a separate universe.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"1f4daa4f-4c5a-4797-86fe-7bfda881abbe","node_slug":"discover-signals-from-pathology-data","node_name":"Discover Signals from Pathology Data","alternate_names":[],"scope_statement":"Discovers histologic patterns, tissue states, and candidate targets by applying computational pathology methods such as whole-slide image analysis, spatial transcriptomics integration, and cell-level segmentation to biopsy or autopsy tissue.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"70d1b861-fb12-4340-be43-f45451d71752","node_slug":"discover-skin-and-hair-targets","node_name":"Discover skin and hair targets","alternate_names":["Discover targets with skin stem cells"],"scope_statement":"Discovers intervention targets and therapy leads for skin and hair decline by turning epidermal and hair-follicle stem-cell regeneration biology into tractable pathways, genes, and screening hypotheses rather than worshipping a ready-made therapeutic class.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"d0753687-cc8f-4866-9358-e4c41dab7d5d","node_slug":"discover-targets-from-comparative-biology","node_name":"Discover Targets from Comparative Biology","alternate_names":["ancestral variant discovery","ancient DNA comparative genomics","comparative biology hypothesis discovery","comparative biology target discovery","comparative functional genomics","comparative genome assembly and analysis","comparative genomics of cognition","comparative genomics of lifespan","comparative genomics target discovery","comparative geroscience target discovery","comparative lifespan genomics","comparative longevity genomics","comparative neurogenomics target discovery","comparative paleogenomics","comparative reference genomics","comparative resilience target discovery","comparative translational biology","conserved aging mechanism discovery","convergent genomics of intelligence","cross-species cognitive trait genomics","cross-species genomics discovery","cross-species longevity genomics","cross-species longevity pathway discovery","cross-species mechanism mining","cross-species phylogenomics","cross-species target discovery","cross-species variant discovery","Discover comparative mammalian models","Discover conserved lifespan circuits","Discover conserved macrophage states","Discover Convergent Survival Strategies","Discover extinct-lineage sequence variants","Discover Models by Comparative Genomics","Discover resilience traits by comparison","Discover targets by ancestral reconstruction","Discover targets from comparative zoology","Discover trait genes by comparative genomics","evolutionary comparative genomics","evolutionary genomics of longevity","evolutionary genomics target discovery","evolutionary target discovery","evolution-guided target discovery","extinct-extant comparative genomics","high-cognition species genome comparison","Infer trait variants from paleogenomes","multi-species genome comparison","natural resistance mechanism discovery","paleogenomic comparative mapping","paleogenomic trait variant discovery","phylogenetically informed screening","phylogenetic longevity signature mapping","phylogenomic discovery of longevity mechanisms","phylogenomic target discovery","phylogenomic trait discovery","protective mechanism mining across species","Translate conserved aging mechanisms"],"scope_statement":"Discovers protective pathways, genes, and molecular programs by comparing naturally disease-resistant or exceptionally long-lived species or human populations using cross-species genomics, transcriptomics, and functional validation to nominate druggable targets.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"b2043c87-1bc6-4dd5-ae9b-365b5c45dd07","node_slug":"discover-targets-from-human-genetics","node_name":"Discover targets from human genetics","alternate_names":["Discover aging-deviation associations","Discover allele-specific TF binding","Discover arterial calcification genetics","Discover cardiovascular structure genetics","Discover causal drivers of spinal decline","Discover causal noncoding variants","Discover iron-homeostasis regulators","Discover iron-homeostasis variants","Discover iron recycling regulators","Discover vascular calcification genetics","Prioritize causal GWAS variants"],"scope_statement":"Uses germline human genetic variation, including GWAS hits, rare variant burden, Mendelian randomization, and colocalization, to identify causal genes, pathways, and druggable targets worth modulating instead of guessing and hoping for the best.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"83ed0dc0-861b-45f8-8966-5c34465b9c59","node_slug":"discover-targets-from-mammalian-resistance","node_name":"Discover targets from mammalian resistance","alternate_names":[],"scope_statement":"Discovers human therapeutic targets and drug candidates by comparing mammalian disease-resistance phenotypes across species and tracing conserved protective signals through ortholog mapping, comparative transcriptomics, and pathway analysis.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"9612850b-3fe7-4922-a872-95629fb67ecc","node_slug":"discover-targets-with-aging-clocks","node_name":"Discover Targets With Aging Clocks","alternate_names":["Discover aging determinants","Discover aging determinants with clocks","Discover clock-reversing perturbations","Discover determinants from age acceleration","Discover rejuvenation targets with clocks","Discover sex-divergent clock drivers","Rank perturbations with aging clocks"],"scope_statement":"Ranks genes, pathways, compounds, or perturbations by predicted improvement in a specific aging clock such as Horvath, GrimAge, PhenoAge, DunedinPACE, or a transcriptomic age model, instead of doing phenotype-first screening and hoping the biology eventually introduces itself.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"80621d15-bb0a-467b-888a-266b06374d3c","node_slug":"discover-targets-with-constrained-models","node_name":"Discover targets with constrained models","alternate_names":["Build multiscale causal models","causal pathway simulation","computational systems modeling","digital biology modeling","in silico hypothesis testing","mechanistic disease modeling"],"scope_statement":"Discovers aging mechanisms and nominates drug targets or candidate compounds by fitting biologically and physically constrained causal or generative models to real-world human multi-omic, clinical, and longitudinal datasets.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"56ee156d-38ff-425d-853b-003a3f18c519","node_slug":"discover-with-knowledge-graphs","node_name":"Discover with Knowledge Graphs","alternate_names":["Encode Papers as Knowledge Graphs","Map Biological Evidence Networks","Structure papers into claim graphs"],"scope_statement":"Extracts entities and relationships from papers, patents, assay repositories, and biomedical databases into queryable knowledge graphs and retrieval systems so hypotheses about targets, pathways, compounds, and indications can be found without pretending a chatbot invented biology.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"3bfe1bd3-c481-49e3-88fb-d696b21a8865","node_slug":"generate-synthetic-training-data","node_name":"Generate synthetic training data","alternate_names":["Simulate Synthetic Aging Records"],"scope_statement":"Generates synthetic omics, imaging, clinical, or mechanistic simulation data with GANs, VAEs, diffusion models, or agent-based simulators to augment sparse real cohorts and train, stress-test, or calibrate biomarker and discovery models.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"f86eb398-14ca-4737-a9d6-861ed2919f7f","node_slug":"infer-pathways-from-single-cell-phenotypes","node_name":"Infer pathways from single-cell phenotypes","alternate_names":["Discover gamete maturation regulators","Profile Morphology Across Perturbations"],"scope_statement":"Infers gene function and pathway structure by embedding CRISPR-, CRISPRi-, or RNAi-perturbed cells into high-dimensional single-cell phenotype vectors and clustering genes that drive the same morphological or transcriptomic state.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"aed461d1-dece-4372-b5c7-7e2d134783fd","node_slug":"model-expert-tacit-reasoning","node_name":"Model expert tacit reasoning","alternate_names":[],"scope_statement":"Captures tacit expert heuristics, decision rules, and hypothesis-generation moves with methods such as cognitive task analysis, think-aloud protocols, imitation learning, and inverse reinforcement learning to discover experiments and mechanisms that papers leave out.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"c4be7b12-71ab-466d-8ea2-024feee033fb","node_slug":"modulate-protein-interfaces","node_name":"Modulate Protein Interfaces","alternate_names":["Discover covalent peptide hotspots"],"scope_statement":"Modulates protein-protein binding by using structure-guided interface mapping, docking, and design to find or engineer intervention sites such as hot spots, allosteric pockets, or contact residues on complexes like p53-MDM2 or PD-1-PD-L1.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"27f0db4a-e583-487c-b29a-d9630489d653","node_slug":"publish-fair-biological-datasets","node_name":"Publish FAIR biological datasets","alternate_names":["clinical data harmonization","clinical metadata normalization","cross-study data integration","Expose Buried Experimental Results","FAIR clinical dataset curation","Generate model-ready experimental data","Incentivize Standardized Dataset Sharing","research data standardization","Standardize datasets for target discovery"],"scope_statement":"Publishes biological assay and phenotype datasets as FAIR, versioned research objects with machine-readable metadata, provenance, and persistent identifiers so other groups can find them, check them, and reuse them before they vanish into supplementary-file hell.","depth":1,"parent_node_id":"54435a9a-ff83-4683-adc1-1b6e064361a3","probability_of_confirmation":null,"root_slug":"discovering","root_name":"Discovering","root_cluster":"method","root_canonical_statement":"AI and computational platforms for finding new aging targets and intervention candidates — virtual cells, foundation models for biology, structure-based drug design, generative chemistry, single-cell + multi-omic screens, ALEMBIC-style discovery, comparative-genomics target finding."},{"node_id":"de9c8a72-a9e3-4094-be9d-be072cea9f68","node_slug":"calibrate-methylation-clock-platforms","node_name":"Calibrate methylation clock platforms","alternate_names":[],"scope_statement":"Measures cross-platform agreement and calibration between Illumina HumanMethylation450 BeadChip and Infinium MethylationEPIC v2.0 assays so CpG-based chronological-age and biological-age estimates do not drift just because the hardware changed.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"02cd1afc-13b6-4bba-9a97-d9c4db09995f","node_slug":"classify-aging-in-diagnostic-codes","node_name":"Classify Aging in Diagnostic Codes","alternate_names":["Classify Aging as Indication"],"scope_statement":"Classify ageing-associated decline under formal diagnostic taxonomies such as ICD-11 MG2A and XT9T so clinicians, trials, EHRs, and payers can record it as a standardized endpoint instead of pretending it is just background scenery.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"5a4ca5db-843b-403d-ae10-ef8ae0093c0c","node_slug":"classify-premature-aging-phenotypes","node_name":"Classify Premature-Aging Phenotypes","alternate_names":[],"scope_statement":"Classifies whether a patient or syndrome matches a progeroid phenotype by scoring observable clinical features such as growth failure, lipodystrophy, scleroderma-like skin changes, alopecia, and characteristic craniofacial dysmorphology against known premature-aging syndromes rather than pretending to treat anything.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"956286ed-b5e1-401a-8ab7-dd9a9963993b","node_slug":"increase-self-tracking-adherence","node_name":"Increase Self-Tracking Adherence","alternate_names":[],"scope_statement":"Uses behavior design techniques such as reminders, implementation intentions, incentives, streaks, and just-in-time adaptive interventions to keep people logging biomarkers, symptoms, wearables, and exposures often enough to produce analyzable longitudinal data instead of the usual patchy mess.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b5f96a6c-9bab-4201-b83a-ce74bd2f5772","node_slug":"infer-biophysical-state-variables","node_name":"Infer Biophysical State Variables","alternate_names":["Measure latent tissue dynamics","Measure state from streaming care data"],"scope_statement":"Measures latent biophysical parameters such as tissue stiffness, viscosity, pressure fields, wall shear stress, and perfusion by fitting physics-constrained models and machine-learning estimators to imaging data and observed flow or motion patterns.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"792268fc-4fb3-487c-b9ea-d9f979025365","node_slug":"measure-adiposity-phenotypes","node_name":"Measure adiposity phenotypes","alternate_names":["Measure Abdominal Body Composition","Measure adipose morphology from MRI","Measure body composition from corrected MRI","Measure Ectopic Liver Fat","Measure Imaging-Derived Body Composition","Measure metabolic phenotypes with MRI","Measure regional adipose morphology","Measure regional adipose thickness"],"scope_statement":"Measures adiposity state with imaging and molecular phenotyping to separate benign subcutaneous fat storage from ectopic fat burden, including hepatic steatosis and myosteatosis, using markers such as MRI-PDFF, 1H-MRS, CT muscle attenuation, and circulating adipokines or metabolites.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"60b641c1-1542-4f12-bb6a-b99f78ebdffe","node_slug":"measure-age-from-methylation","node_name":"Measure Age from Methylation","alternate_names":["biological age clocking","biological age clock testing","biological age estimation","biological age prediction","build species-specific epigenetic clocks","construct DNA methylation age predictors","CpG interaction methylation clock","develop chronological age methylation models","DNA methylation age acceleration for neurodegeneration","DNA methylation age assessment","DNA methylation age estimation","DNAm GrimAge neurodegeneration prediction","epigenetic age estimation","epigenetic age profiling","epigenetic clock-based neurodegeneration forecasting","epigenetic clock measurement","epigenomic age quantification","estimate age with epigenetic clocks","GrimAge acceleration risk stratification","higher-order methylation clock","infer aging state from methylomes","machine learning DNA methylation age model","measure biological age from CpG methylation","Measure epigenetic age modules","Measure housing effects on aging","methylation clock analysis","methylation clock profiling","molecular aging clock readout","nonlinear DNAm age predictor","nonlinear epigenetic clocking","profile epigenetic age","smoking-linked epigenetic clock prediction","train species-specific methylation clocks","use DNA methylation clocks"],"scope_statement":"Measures biological age by mapping genome-wide CpG DNA methylation patterns into an epigenetic clock that estimates physiological aging state rather than merely counting birthdays.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"aa862f2f-dfbe-4764-ba6e-2b9c6e5bad38","node_slug":"measure-age-specific-mortality-hazard","node_name":"Measure Age-Specific Mortality Hazard","alternate_names":[],"scope_statement":"Measures age-specific mortality hazard across the full lifespan using life tables, survival models, or hazard-rate estimation to test whether mortality rises with age, plateaus, or stays flat enough to support negligible senescence claims.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"19f2d38b-17f1-4c9b-9e30-2976b513b371","node_slug":"measure-aging-from-wearable-time-series","node_name":"Measure aging from wearable time series","alternate_names":["activity-based biological age modeling","Add Sensor Modalities","ambulatory measurement","ambulatory physiologic monitoring","continuous physiological aging monitoring","continuous physiological monitoring","continuous wearable monitoring","decentralized continuous assessment","digital biomarker aging clock","digital phenotyping age estimation","digital phenotyping for biological age","digital phenotyping with wearables","longitudinal digital phenotyping","longitudinal wearable age model","Measure aging in homes","Measure Continuous Human Signals","Measure Daily Function Continuously","Measure health from passive movement","Measure Longitudinal Wearable Biomarkers","Measure performance with multimodal telemetry","Measure risk from biosignals","Model personal state longitudinally","passive health trend detection","passive sensing biological age","passive sensing health-risk estimation","passive wearable sensing","real-world digital phenotyping","remote continuous monitoring","remote physiologic monitoring","sensor-based aging measurement","sensor-derived age acceleration","serial biomarker time-series profiling","wearable aging clock","wearable biomarker age prediction","wearable biomarker tracking","wearable biosignal monitoring","wearable-derived biological age","wearable-derived biological age estimation","within-person trajectory analysis"],"scope_statement":"Measures biological age, stress reactivity, and resilience by modeling dense longitudinal wearable sensor streams such as heart rate, heart rate variability, sleep, temperature, and activity into digital biomarkers or aging clocks rather than altering physiology.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"756d0ca6-ef99-437b-8f45-4f3d4ebfca39","node_slug":"measure-aging-with-cross-species-clocks","node_name":"Measure aging with cross-species clocks","alternate_names":["comparative epigenetic age translation","cross-species epigenetic clocks","multi-species epigenetic clock alignment","species-bridging methylation clocks","translational epigenetic clock mapping"],"scope_statement":"Measures biological age across multiple species by building DNA methylation clocks from conserved CpG markers and orthologous genomic features, so you can compare mice, dogs, humans, and the rest on one scale instead of pretending each species ages in its own private dialect.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"42c923d6-07fc-4fac-897d-64c8878cbb9b","node_slug":"measure-albuminuric-kidney-function","node_name":"Measure Albuminuric Kidney Function","alternate_names":[],"scope_statement":"Measures estimated glomerular filtration rate and urinary albumin leakage, typically with serum creatinine or cystatin C plus urine albumin-to-creatinine ratio, to catch otherwise-missed chronic kidney disease and sort short-term cardio-renal risk in coronary artery disease patients.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"77747072-7075-4ff2-bf76-7c26b25abdc4","node_slug":"measure-alpha-klotho-with-peptide-probes","node_name":"Measure alpha-Klotho with peptide probes","alternate_names":["alpha-Klotho affinity detection","alpha-Klotho affinity peptide probes","alpha-Klotho live-cell imaging","alpha-Klotho peptide-based quantification","alpha-Klotho peptide imaging probes","alpha-Klotho peptide labeling","capture soluble Klotho with affinity probes","detect soluble alpha-Klotho","engineered peptide binders for soluble Klotho detection","enrich and label shed KL protein","Klotho affinity peptide imaging","Klotho-binding peptide assay reagents","Klotho-binding peptide labels","KL pull-down peptides","multivalent peptide alpha-Klotho assay","peptide affinity reagents for α-Klotho","peptide-based alpha-Klotho detection","peptide probes for alpha-Klotho","soluble alpha-Klotho biomarker assay"],"scope_statement":"Measures α-Klotho protein by using peptide affinity probes that bind the extracellular Klotho isoform in assays, biosamples, or imaging workflows, which is measurement plumbing rather than a therapy no matter how excited anyone gets.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"e9f8e068-ab7f-4b8d-a812-9808a9d99b19","node_slug":"measure-apical-sparing-pattern","node_name":"Measure apical sparing pattern","alternate_names":["apical sparing ratio assessment","echo-based amyloidosis classification","longitudinal strain ratio for cardiac amyloidosis","Measure Cardiac Amyloidosis from Echocardiograms","relative apical sparing measurement","relative regional strain pattern analysis"],"scope_statement":"Measures relative apical sparing on speckle-tracking echocardiography to distinguish probable cardiac amyloidosis from hypertensive heart disease or hypertrophic cardiomyopathy when the left ventricle looks thick for more than one reason.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"1bc631e2-6120-4417-9060-94a2461ac224","node_slug":"measure-biodistribution-with-radiotracers","node_name":"Measure Biodistribution with Radiotracers","alternate_names":["Measure brain signaling with PET"],"scope_statement":"Measures in vivo biodistribution, tissue uptake, and target-site localization by administering radiolabeled tracers and detecting their signal with PET, SPECT, autoradiography, or gamma counting.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"63a0ea14-dd4c-4eeb-9f17-e4f2e6651514","node_slug":"measure-biological-age-from-data","node_name":"Measure biological age from data","alternate_names":["aging biomarker clock","aging biomarker measurement","aging clock construction","aging clock development","aging clock modeling","AI-based aging biomarkers","ancestry-specific epigenetic clocks","appearance-based age biomarker","biological age assessment","biological age clocking","biological age estimation","biological age modeling","biological age prediction","biological age scoring of intervention datasets","biomarker-based age prediction","blood biochemistry age predictor","blood biomarker aging clock","blood-chemistry biological age score","blood test age clock","brain age estimation","brain age gap","build biological age clocks","CBC-based biological age model","CBC-based biological age predictor","circulating metabolite mortality predictor","clinical biomarker age clock","clinical biomarker aging clock","clinical chemistry aging clock","composite biological age estimator","composite biomarker age estimator","composite mortality-aware aging clock","computational aging biomarkers","compute aging biomarkers with machine learning","compute disease-linked biological age shift","computer vision aging clock","cross-modal biological age predictor","cross-population biological age validation","deep aging clocks","derive aging state predictors","detect accelerated-aging signatures in fibrosis","Discover transfer-ready age embeddings","embryo polygenic scoring","embryo risk stratification by polygenic score","epigenetic clock modeling","epigenetic clock reanalysis","estimate biological age from multimodal data","facial aging clock","facial-image biological age assessment","frailty index modeling","functional biomarker aging clock","gene-expression clock for skeletal muscle","geroscience biomarker profiling","healthspan biomarker monitoring","healthspan risk clock","hematology and biochemistry age clock","hematology and chemistry aging clock","image-derived biological age prediction","infer aging burden from fibrotic tissue","integrated biological age and survival model","integrated biomarker aging clock","Integrate multimodal aging measurements","Interpret biological-age clock outputs","iterated embryo selection","joint age-survival clock","Measure actionable aging biomarkers","Measure Aging by Cell Morphology","Measure Aging With Methylation MRI","Measure biological age from biomarkers","Measure Biological Age with Deep Learning","Measure Biological State Biomarkers","measure fibrotic aging burden","Measure immune aging clocks","Measure integrated multi-omic states","Measure Mortality Risk From Biomarkers","metabolite-based biological age clock","metabolomic age prediction","mortality-based biological age model","mortality-calibrated physiological clock","MRI brain aging biomarkers","MRI-derived brain age","multi-clock omics benchmarking","multi-cohort mortality-calibrated aging clocks","multigenerational embryo selection","multimodal aging clock","multimodal aging clocks","multi-omic age clocks","multi-omics and sensor age model","multi-round embryo selection","multisystem biological age model","multivariate aging phenotyping","muscle RNA age predictor","muscle transcriptomic age clock","neural network age prediction","neurodegeneration pattern similarity scoring","pathway-aware proteomic clock","periocular age estimation","PGT-P","phenotypic age clock","phenotypic age estimation","phenotypic age model","photo-based age biomarker","photo-based biological age estimation","physiological age clock","physiological age estimation","physiological age estimator","physiological aging clock","physiology-based biological age clock","plasma metabolomic clock","plasma proteomic age predictor","polygenic embryo screening","population-calibrated blood aging clocks","population-specific biomarker aging clocks","preimplantation polygenic testing","proteome-based biological age estimator","proteomic aging clock","proteomic pace-of-aging model","quantify fibrosis-associated age acceleration","recursive polygenic embryo screening","resilience biomarker development","retrospective clock-based intervention ranking","routine blood biomarker age model","sequential embryo ranking","serum metabolite risk score","shared latent aging-state clock","skeletal muscle aging clock","skin and eye-region age phenotyping","train omics and clinical age models","trait-based biological age model","transcriptome-based muscle biological age estimator","transcriptomic age model screening","visual phenotypic aging clock"],"scope_statement":"Measures biological age or age-linked risk by training models on DNA methylation, transcriptomic, proteomic, metabolomic, imaging, wearable, or clinical biomarkers; useful for quantifying state, not for pretending measurement itself fixes anything.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"9c0ba849-8e94-4c72-a0b9-10169c77b715","node_slug":"measure-biology-with-assay-factories","node_name":"Measure biology with assay factories","alternate_names":["Build experimental measurement tools","Discover gene function by optical pooled screens","Measure Cell States from Microscopy","Measure omics with automated sample prep","Screen candidates before animal studies","Screen pooled CRISPR phenoprints"],"scope_statement":"Builds automated, standardized high-throughput assay platforms such as pooled CRISPR screens, high-content imaging, single-cell multi-omics, and robotic cell-culture workflows to generate large labeled datasets fast enough and cheaply enough to train and iteratively improve predictive discovery models.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"80e9a56d-a139-4027-aac5-ec7ebff1b55f","node_slug":"measure-blood-brain-barrier-permeability","node_name":"Measure blood-brain barrier permeability","alternate_names":["Measure BBB Drug Permeability","Measure epithelial barrier integrity","Screen Compounds in BBB Models"],"scope_statement":"Measures human blood-brain barrier integrity and trans-barrier transport in vitro using brain microvascular endothelial cell models, typically with TEER and permeability assays, so you can see what actually crosses the barrier instead of pretending a dish of generic cells is close enough.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"aff383e1-2acd-4887-ad9d-0b18f589f129","node_slug":"measure-brain-mirna-aging-maps","node_name":"Measure Brain miRNA Aging Maps","alternate_names":["Discover brain aging microRNA targets"],"scope_statement":"Measures age- and region-specific microRNA expression across the brain using spatial transcriptomics, small RNA sequencing, or single-cell profiling to build atlases that expose molecular aging signatures as biomarker and target-discovery infrastructure.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"7b8bd6e7-c98f-4093-8321-4e6e236f67c4","node_slug":"measure-cell-type-aging-trajectories","node_name":"Measure cell-type aging trajectories","alternate_names":["Measure myogenic state drift"],"scope_statement":"Measures the direction and magnitude of age-related change for specific cell types from single-cell RNA-seq by fitting quantitative trajectories or pseudotime-like aging coordinates, which is a sharp way to map heterogeneity, not a new law of nature.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"0a071f19-b2d2-4974-84ac-174f5a7a03e7","node_slug":"measure-cerebrovascular-morphology-from-tof-mra","node_name":"Measure Cerebrovascular Morphology from TOF-MRA","alternate_names":["Measure Abdominal Vascular MRI Phenotypes"],"scope_statement":"Measures reproducible cerebrovascular morphology from time-of-flight MR angiography by segmenting intracranial vessels and quantifying features such as diameter, volume, length, and tortuosity across scanners, field strengths, and species.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"d294b6e1-62c2-4d37-908e-64f27a1505fc","node_slug":"measure-circadian-metabolomic-rhythms","node_name":"Measure Circadian Metabolomic Rhythms","alternate_names":[],"scope_statement":"Measures 24-hour plasma, saliva, or urine metabolite oscillations with time-series metabolomics to quantify circadian phase, sleep state, and rhythm disruption; no, measuring the clock is not the same as fixing it.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"16ca84da-8373-446f-8c03-365be764a9aa","node_slug":"measure-circadian-proteomic-biomarkers","node_name":"Measure circadian proteomic biomarkers","alternate_names":[],"scope_statement":"Measures which plasma or serum proteins show reproducible circadian oscillation across repeated sampling, so biomarker panels for aging and disease risk stop pretending that 8 a.m. and 8 p.m. are the same blood draw.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b237243b-9ca7-431f-8ce0-ea76552db481","node_slug":"measure-circulating-klotho","node_name":"Measure circulating Klotho","alternate_names":[],"scope_statement":"Measures soluble circulating alpha-Klotho protein in serum or plasma, usually by ELISA or immunoassay, as a biomarker of physiological decline or response to an intervention rather than as a treatment itself.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"90f0bd4a-fd1f-4840-8b37-6c723441dd73","node_slug":"measure-clonal-hematopoiesis-burden","node_name":"Measure Clonal Hematopoiesis Burden","alternate_names":[],"scope_statement":"Measures age-linked expansion of somatic hematopoietic clones by detecting CHIP-associated mutations such as DNMT3A, TET2, ASXL1, JAK2, TP53, and PPM1D in blood, using clone size and growth dynamics for risk stratification rather than pretending the clones were fixed.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"15cc6bf6-74cb-4ceb-90d6-2daf844f37f7","node_slug":"measure-composite-cardiometabolic-risk","node_name":"Measure composite cardiometabolic risk","alternate_names":["Measure risk by metabolic phenotype"],"scope_statement":"Measures a composite metabolic-risk state by combining markers such as waist circumference, blood pressure, fasting glucose, triglycerides, and HDL cholesterol into an indexed score that estimates vulnerability to cardiometabolic outcomes rather than treating anything.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"67ce5b17-e04a-484e-83d9-65ea202b161f","node_slug":"measure-conserved-methylation-clock-loci","node_name":"Measure conserved methylation clock loci","alternate_names":[],"scope_statement":"Measures DNA methylation at highly conserved CpG-bearing genomic loci across species to validate age-predictive biomarkers for epigenetic clock construction rather than pretending correlation is a treatment.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"6724c1c5-64e1-4110-a945-7f9cec0d7e30","node_slug":"measure-cortical-cross-scale-alignment","node_name":"Measure cortical cross-scale alignment","alternate_names":[],"scope_statement":"Measures how cortical myeloarchitecture, cerebral blood flow, and metabolic specialization align across cortical gradients using multimodal MRI and PET, so tissue-state differences can be quantified in vivo instead of guessed from a single map.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"06f0c15d-6fc2-4c37-b7c6-4c69b0d72f02","node_slug":"measure-cortical-laminar-architecture","node_name":"Measure Cortical Laminar Architecture","alternate_names":[],"scope_statement":"Measures cortical laminar structure in living humans using high-resolution structural MRI, quantitative MRI, and layer-aware analysis to phenotype brain tissue organization for stratification and longitudinal tracking rather than to alter biology.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"a8d8069c-453d-4ae0-9240-e05fe8b39ee3","node_slug":"measure-depot-specific-adipose-lipids","node_name":"Measure depot-specific adipose lipids","alternate_names":[],"scope_statement":"Measures fatty-acid composition across human adipose depots, usually by biopsy plus gas chromatography or mass-spectrometry lipidomics, to turn tissue lipid handling into a quantified metabolic phenotype linked to insulin resistance and cardiometabolic risk.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"abab4596-eae3-4a06-8d65-9c2575ba60d9","node_slug":"measure-disease-hallmark-concordance","node_name":"Measure disease-hallmark concordance","alternate_names":[],"scope_statement":"Measures how closely a disease model reproduces hallmark-level features such as cellular senescence, mitochondrial dysfunction, loss of proteostasis, epigenetic alteration, and stem-cell exhaustion, so researchers can rank models for geroprotector testing instead of pretending every disease model is equally useful.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"d00394d2-f7bb-43bb-85b0-e14cf7bca361","node_slug":"measure-dna-with-nanopores","node_name":"Measure DNA with nanopores","alternate_names":[],"scope_statement":"Measures nucleotide sequence by threading single-stranded DNA or RNA through a biological or solid-state nanopore and decoding base-dependent ionic-current shifts into reads.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"323aa171-1509-4008-908a-aca4e3e16075","node_slug":"measure-genomes-by-parallel-sequencing","node_name":"Measure genomes by parallel sequencing","alternate_names":["Measure genomic sequence variation"],"scope_statement":"Measures DNA sequence directly at scale using massively parallel sequencing, sample barcoding, and multiplexed library prep to make genome readout cheaper and less painfully slow.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"ed046859-1582-46c5-9c97-a027e76acae4","node_slug":"measure-glucose-carbon-flux","node_name":"Measure Glucose Carbon Flux","alternate_names":["Measure Age-Related Glucose Flux"],"scope_statement":"Measures tissue-specific carbon flow from isotopically labeled glucose through glycolysis, the TCA cycle, and adjacent pathways using stable-isotope tracing to quantify pathway activity and substrate fate rather than pretending to modify them.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"f1c1be70-035f-48ae-8fea-ba9391672b5b","node_slug":"measure-gut-microbiome-composition","node_name":"Measure Gut Microbiome Composition","alternate_names":["Measure microbiome compositional shifts"],"scope_statement":"Measures gut microbial community structure with 16S rRNA sequencing, shotgun metagenomics, and taxonomic or functional profiling to track host biological state and response to treatment, not to tinker with the microbes themselves.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"7aab2cd0-ee25-4f99-9fb8-654e630b170c","node_slug":"measure-healthspan-trial-readouts","node_name":"Measure Healthspan Trial Readouts","alternate_names":["aging biomarker qualification","assess biological age endpoints","build composite geroscience outcomes","define clinical aging biomarkers","define geroscience outcome measures","healthspan endpoint validation","lifespan-healthspan endpoint alignment","Measure aging by domain","Measure Aging in Trials","measure aging-related trial outcomes","Measure biomarkers to guide trials","Measure functional biomarker change","Measure function over survival","Measure Intervention Response","Measure Senescent Cell Burden","Operate Digital Functional Endpoints","Quantify aging with explicit endpoints","quantify geroscience endpoints","validate aging intervention endpoints"],"scope_statement":"Defines pre-specified biomarkers, functional endpoints, and assay methods such as DNA methylation clocks, p16INK4a expression, IL-6/hs-CRP panels, grip strength, gait speed, and DEXA body composition to test whether an intervention is actually moving healthspan-relevant biology rather than merely generating vibes.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b2114eb3-8e3c-4033-885c-b3e9f31a2016","node_slug":"measure-host-microbiome-transcript-activity","node_name":"Measure host-microbiome transcript activity","alternate_names":[],"scope_statement":"Measures stool-derived host and microbial RNA with metatranscriptomic sequencing to quantify active pathways, taxa-level function, and biomarker patterns that can drive individualized diet or supplement decisions.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"01bdc169-4715-42d3-91ca-3bc40ef3e993","node_slug":"measure-human-aging-deficits","node_name":"Measure Human Aging Deficits","alternate_names":["comprehensive geriatric assessment","functional aging phenotyping","geriatric functional status assessment","Measure exposome-linked omics aging","Measure Frailty and Function","Measure Multidomain Aging Decline","multidomain aging outcomes measurement","multidomain geriatric assessment"],"scope_statement":"Measures biological age and functional decline in humans with epigenetic clocks, proteomics, metabolomics, gut microbiome profiling, and hard clinical function readouts such as grip strength, gait speed, and VO2 max, so interventions are chosen against observed deficits rather than vibes.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b9e7dd12-3352-4c4c-9898-32620a0addcf","node_slug":"measure-intervention-effects-across-studies","node_name":"Measure intervention effects across studies","alternate_names":[],"scope_statement":"Combines effect sizes from multiple preclinical or clinical studies using meta-analysis and heterogeneity statistics to estimate whether an intervention signal is reproducible rather than one paper getting lucky.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"7a264b12-c329-4309-a1a2-d7b82e2be6e0","node_slug":"measure-lipid-biomarker-panels","node_name":"Measure lipid biomarker panels","alternate_names":[],"scope_statement":"Measures apolipoproteins, lipoprotein particle profiles, triglycerides, and sterols in blood using clinical chemistry, NMR, or mass spectrometry to turn cardiometabolic state into decision-grade risk readouts.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"8babf5f9-ec14-468b-bc6e-26f694e0999b","node_slug":"measure-live-cell-dynamics","node_name":"Measure Live Cell Dynamics","alternate_names":["Measure Biomarkers with Fluorescent Sensors","Measure In Vivo PKA Heterogeneity","Measure Vacuolar pH Dynamics"],"scope_statement":"Measures time-resolved cell-state changes with live-cell imaging, fluorescent biosensors, microfluidics, or impedance-based assays instead of pretending a single endpoint snapshot tells the whole story.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"f19845e2-1485-493f-b0fe-92471b7803b8","node_slug":"measure-longitudinal-biomarker-trajectories","node_name":"Measure Longitudinal Biomarker Trajectories","alternate_names":["deep phenotyping time series","dense longitudinal phenotyping","immune recovery biomarker surveillance","immune response kinetics measurement","longitudinal immune biomarker monitoring","Measure Aging Trajectories","Measure biological state trajectories","Measure circulating disease biomarkers","Measure Disease Biomarkers","Measure fluid disease biomarkers","Measure Health State Longitudinally","Measure longitudinal adherence trajectories","Measure longitudinal innate immune activity","n-of-1 biomarker tracking","personal longitudinal profiling","serial inflammatory marker tracking","serial multi-omic monitoring","treatment-phase cytokine profiling","Validate Longitudinal Aging Biomarkers"],"scope_statement":"Measures rates of change, slopes, variability, and inflection points across repeated biomarkers, clinical labs, wearable signals, or frailty measures to infer biological state from trajectories rather than a single snapshot.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"0a8d8473-2403-4695-8a3c-5670e9526472","node_slug":"measure-metabolites-with-metabolomics","node_name":"Measure metabolites with metabolomics","alternate_names":["Measure circulating glucuronic acid","Measure circulating metabolomic signatures","Measure epigenetic metabolite panels","Measure Epigenetic Metabolite Pools","Measure longevity-linked circulating metabolomes","Measure Metabolic Biomarkers of Frailty","Measure NAD status first","Measure plasma metabolomic risk"],"scope_statement":"Measures endogenous and exogenous metabolites in plasma, serum, urine, or tissue using LC-MS, GC-MS, or NMR metabolomics as a readout of pathway-level biological state rather than an intervention.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"ec38d5e4-9cb3-4191-878c-85ff32cfa31c","node_slug":"measure-mitochondrial-function","node_name":"Measure Mitochondrial Function","alternate_names":["cellular bioenergetics measurement","energetic phenotype measurement","Measure blood-based brain mitochondria","Measure mitochondrial dysfunction panels","Measure Mitochondrial Function Longitudinally","Measure mitochondrial impairment dimensions","Measure Mitochondrial Status from Biofluids","Measure organ-specific mitochondrial pathology","mitochondrial function profiling","mitochondrial phenotyping","mitochondrial respiration assays"],"scope_statement":"Measures mitochondrial respiratory capacity, membrane potential, ATP production, redox state, and mtDNA integrity with assays such as Seahorse extracellular flux, high-resolution respirometry, TMRM/JC-1 imaging, and mtDNA copy-number or heteroplasmy readouts, so intervention effects can be qualified instead of guessed at.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"ec5936ca-5738-4d3c-8dcb-afc448b9c45d","node_slug":"measure-mitochondrial-ultrastructure-in-3d","node_name":"Measure mitochondrial ultrastructure in 3D","alternate_names":[],"scope_statement":"Measures mitochondrial outer membrane, inner membrane, cristae, and crista junction architecture by serial thin-section electron imaging and 3D reconstruction, so organelle topology and the spatial arrangement of complexes such as MICOS and respiratory-chain assemblies are quantified instead of hand-waved from flat pictures.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"2c3bcc44-f978-429c-b987-04c2d24cb90c","node_slug":"measure-mitophagy-with-reporters","node_name":"Measure Mitophagy With Reporters","alternate_names":["Measure Mitophagy Target Engagement"],"scope_statement":"Measures mitophagy directly with reporter systems such as mt-Keima, mito-QC, or tandem fluorescent mitochondrial tags that shift signal when mitochondria enter lysosomes, allowing target-engagement readout in brain tissue before human studies.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"0f08386a-1312-4228-a98e-ad1c4612ad0a","node_slug":"measure-mortality-hazard-trajectories","node_name":"Measure Mortality Hazard Trajectories","alternate_names":["Compare Lifespan Across Relatives","Measure Lifespan During Drug Screening","Measure lifespan in mice","Measure Mouse Lifespan Curves"],"scope_statement":"Measures age-specific mortality hazard and survival curves across the full lifespan to test whether a species follows a Gompertz-like exponential rise, shows late-life hazard deceleration, or barely ages at all.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"0994581e-f420-44e9-927b-165d6d45fd28","node_slug":"measure-mouse-cardiac-mri-phenotypes","node_name":"Measure mouse cardiac MRI phenotypes","alternate_names":["Standardize preclinical cardiac MRI"],"scope_statement":"Measures left-ventricular volumes, mass, ejection fraction, wall thickness, and related functional readouts from cine cardiac MRI in mouse models so heart-failure phenotypes can be compared without the usual hand-drawn-contour chaos.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"de3184f3-3f60-45ba-9cf9-6b3c7881a83b","node_slug":"measure-mtdna-copy-number-directly","node_name":"Measure mtDNA Copy Number Directly","alternate_names":["Measure mtDNA Copy Number"],"scope_statement":"Measures mitochondrial DNA copy number in biological samples by single-molecule nanopore sensing with electrical-signal classification rather than PCR amplification, producing a direct assay of mitochondrial abundance rather than yet another indirect proxy.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"2a5c320d-27d3-4f58-8f85-723edc782b14","node_slug":"measure-multiplex-plasma-omics","node_name":"Measure Multiplex Plasma Omics","alternate_names":[],"scope_statement":"Measures proteins, metabolites, lipids, and cell-free nucleic acids from a single plasma aliquot using standardized pre-analytical handling and multi-omics workflows to cut hemolysis, carryover, and batch noise.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"7cb2543f-3c22-452f-a593-feef4ff4849b","node_slug":"measure-muscle-oxygenation-response","node_name":"Measure muscle oxygenation response","alternate_names":[],"scope_statement":"Measures local skeletal muscle oxygenation and deoxygenation at rest and during load, usually with near-infrared spectroscopy, to test whether an intervention changed perfusion or oxygen extraction rather than pretending to be a mechanism itself.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"f9517fde-8a95-48f2-8165-fc9e22675f20","node_slug":"measure-neurocognition-from-speech","node_name":"Measure Neurocognition From Speech","alternate_names":[],"scope_statement":"Measures neurocognitive function and decline from speech and language features such as pause structure, articulation rate, lexical diversity, semantic coherence, and acoustic biomarkers, using behavioral output as assessment data rather than changing brain biology.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"15aa3fa3-ad01-40e4-9f4f-f1c93bbe6f47","node_slug":"measure-neurodegeneration-with-composite-scores","node_name":"Measure neurodegeneration with composite scores","alternate_names":["ADCOMS","Alzheimer’s Disease Composite Score","clinical outcome composite for decline","cognitive and functional item composite","cognitive-functional composite endpoint","composite cognitive-functional score","integrated cognition-function measure","Measure neurodegeneration biomarkers","Measure progression with composite endpoints","prodromal AD composite endpoint","sensitive progression composite","weighted cognitive-functional composite"],"scope_statement":"Aggregates multimodal neurodegeneration progression signals into a validated composite endpoint score so trials can detect smaller treatment effects and judge whether an intervention actually slows decline rather than merely making charts look busy.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"7b6f1313-f49d-43ab-8ac6-a964a92f2827","node_slug":"measure-ocular-function-and-pathology","node_name":"Measure Ocular Function and Pathology","alternate_names":["Measure ocular toxicity longitudinally"],"scope_statement":"Measures visual acuity, intraocular pressure, retinal structure, visual fields, and anterior or posterior segment pathology with ophthalmic exams and imaging to produce diagnostic readouts and longitudinal baselines for eye health tracking.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"00649ac4-462c-44c2-9406-9d376649b823","node_slug":"measure-organ-iron-by-mri","node_name":"Measure Organ Iron by MRI","alternate_names":["Measure MRI-Derived Spleen Iron","Measure Organ Iron Burden","Measure spleen iron phenotypes"],"scope_statement":"Measures liver, heart, pancreas, spleen, or brain iron burden with quantitative MRI methods such as T2*, R2, or quantitative susceptibility mapping, giving a noninvasive biomarker of systemic iron handling instead of yet another therapy cosplay.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"c21d1049-285a-4874-bdd9-23302c0fd2b9","node_slug":"measure-pathogen-burden-biomarkers","node_name":"Measure pathogen burden biomarkers","alternate_names":["Measure biological agent prevalence","Measure blood-count immune burden","Measure occult mycobacterial DNA","Measure Residual Viral Material"],"scope_statement":"Measures latent and active pathogen burden alongside host immune-activation markers such as CMV or EBV serostatus, microbial DNA/RNA load, C-reactive protein, IL-6, TNF-alpha, and leukocyte immunophenotypes to compare immunophysiological state across cohorts.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"97c52a7f-4cb5-46e1-a9ec-cce1eeb50d15","node_slug":"measure-perfusion-laminar-coupling","node_name":"Measure perfusion-laminar coupling","alternate_names":[],"scope_statement":"Measures how closely regional cerebral blood flow patterns align with cortical laminar and cytoarchitectonic architecture using MRI-derived perfusion and structural maps, treating that coupling as a non-invasive readout of tissue organization, mitochondrial respiratory capacity, and cortex-level metabolic state rather than a therapy (yes, it is a ruler, not a wrench).","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"5840df69-9f34-4d42-999d-fbe74023a8b4","node_slug":"measure-personal-digital-twins","node_name":"Measure Personal Digital Twins","alternate_names":["Build dynamic digital twins","Fuse longitudinal context measures","Measure longitudinal human performance","Model latent health state","Model patient aging surrogates"],"scope_statement":"Builds a computational proxy of one person by fusing longitudinal clinical records, wearable streams, imaging, labs, genomics, and behavior data into an individual-level model for simulation, risk estimation, or treatment matching.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"e40390d3-2a5e-4731-9e4e-4c8abecfac29","node_slug":"measure-population-brain-health-heterogeneity","node_name":"Measure population brain-health heterogeneity","alternate_names":[],"scope_statement":"Measures inter-individual and subgroup variation in cognition, neuroimaging, and blood- or CSF-based neural biomarkers to build calibrated brain-age models, normative reference curves, and functional metrics that do not fall apart the moment you test them outside one convenient cohort.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"819a2286-c384-49ce-ac88-da41c87a93c8","node_slug":"measure-preclinical-tissue-damage","node_name":"Measure Preclinical Tissue Damage","alternate_names":["AAC scoring","abdominal aorta calcification measurement","abdominal aortic calcification assessment","Agatston scoring","assess vascular calcium burden","CAC scoring","Coronary artery calcium scoring","CT calcium burden measurement","Measure Abdominal Aortic Calcification","Measure Aging With Imaging Biomarkers","Measure Anatomical Imaging Biomarkers","Measure Arterial Stiffness Functionally","Measure Atherosclerotic Plaque Regression","Measure Brain Aging with Imaging","Measure Brain Aging with Neuroimaging","measure coronary artery calcium","Measure Disease Burden from Imaging","Measure multimodal health signals","Measure Organ Biomarkers from Abdominal MRI","Measure vascular calcification burden","quantify arterial calcification","quantifying abdominal aortic calcification","vascular calcification burden scoring","vascular calcification imaging","Vascular calcification quantification"],"scope_statement":"Measures subclinical age-related pathology in living humans with noninvasive imaging biomarkers such as coronary artery calcium CT, carotid intima-media thickness ultrasound, brain MRI volumetrics, liver MRI-PDFF, and DXA so decline is quantified before obvious disease shows up.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"384ea4e9-7569-4bd1-980f-1cb76e10d567","node_slug":"measure-progression-with-composite-scales","node_name":"Measure progression with composite scales","alternate_names":["clinical domain composite scoring","clinical endpoint matching","cognitive composite score","composite clinical endpoint","composite clinical endpoint assessment","composite endpoint","composite outcome measure","composite outcome optimization","composite outcome validation","composite progression score","data-driven composite outcome","data-driven endpoint weighting","disease-stage weighted composite endpoint","endpoint refinement","evaluate trial-arm discrimination of composite score","functional composite measure","global composite outcome scoring","global statistical endpoint","hierarchical composite endpoint","integrated efficacy endpoint","item-weighted clinical outcome measure","item-weighted disease progression metric","longitudinal composite severity index","Measure composite and item endpoints","Measure disease progression with composite scales","Measure global agitation burden","multicomponent endpoint","multi-domain clinical composite","multidomain clinical outcome","multidomain outcome measurement","Optimize clinician outcome scoring","optimized composite outcome","optimized longitudinal composite","optimized progression score","optimize endpoint sensitivity","progression-sensitive composite score","qualify multimodal outcome measure","regression-weighted clinical scale","responsiveness-weighted composite endpoint","select stage-appropriate outcome measures","sensitive functional composite","sensitive progression composite","stage-adaptive outcome measure","stage-specific weighted clinical scale","test endpoint sensitivity to change","use fit-for-purpose endpoints","validate composite clinical endpoint","weighted clinical progression score","weighted composite endpoint","weighted symptom progression scale","Weight endpoints by relevance"],"scope_statement":"Builds and validates standardized longitudinal composite outcome measures such as clinical rating scales, multi-domain endpoints, and responder indices to quantify disease progression and detect treatment effects over time without altering the underlying biology.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"e0ad7728-b2b2-4123-aa72-bcedd8a7ee90","node_slug":"measure-proinflammatory-immune-signatures","node_name":"Measure Proinflammatory Immune Signatures","alternate_names":[],"scope_statement":"Measures circulating inflammatory cytokines and immune-related genetic variants to quantify a proinflammatory state and test whether marker panels or genotypes track with a defined health phenotype, rather than pretending correlation is an intervention.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"c9238159-8587-4665-a0b9-037de44f2e01","node_slug":"measure-regulatory-state-from-atac-seq","node_name":"Measure Regulatory State from ATAC-seq","alternate_names":["Measure multiome regulatory state"],"scope_statement":"Measure chromatin accessibility and cis-regulatory state from ATAC-seq reads using physics-informed models that correct for Tn5 insertion bias, fragment-length structure, and local chromatin context rather than pretending raw counts explain themselves.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"3a1dc6ed-ec67-44dc-b6a7-ce62e1d61931","node_slug":"measure-remyelination-dynamics","node_name":"Measure remyelination dynamics","alternate_names":[],"scope_statement":"Quantifies remyelination over time and across age using myelin-sensitive imaging, g-ratio histomorphometry, oligodendrocyte lineage markers, and functional conduction readouts, because guessing that myelin came back is not a measurement.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"cf2f461e-231d-4f6e-ab33-a6411b72ddbb","node_slug":"measure-risk-from-histology","node_name":"Measure Risk from Histology","alternate_names":["clinicopathologic metastasis prediction","digital pathology prognostic biomarker","histopathology-based risk stratification","Measure pathology from medical images","pathology-plus-clinical outcome modeling","predict metastatic risk from pathology images"],"scope_statement":"Measures tissue architecture and cellular morphology from whole-slide histology using multimodal AI to produce a prognostic biomarker or risk score that predicts future clinical events without pretending to modify the disease itself.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"089d8007-5541-425d-b12e-6a3e441ca049","node_slug":"measure-salivary-telomere-length","node_name":"Measure salivary telomere length","alternate_names":[],"scope_statement":"Measures leukocyte-equivalent telomere length from saliva, typically by qPCR of telomeric repeat copy number versus single-copy gene signal, and uses that biomarker to model multimorbidity burden rather than pretending it is a treatment.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"5ae25a61-7bb6-434a-b02f-0854bc96d7de","node_slug":"measure-single-cell-transcriptomic-states","node_name":"Measure single-cell transcriptomic states","alternate_names":["Discover metabolic states from scRNA-seq","Discover pathogenic immune-cell subsets","Discover stage-specific single-cell programs","Measure Cell-Intrinsic Aging Signatures","Measure neurotoxic transcriptomic responses","Measure Single-Cell Aging Trajectories"],"scope_statement":"Measures cell-type-specific transcriptional states with single-cell RNA sequencing and related profiling methods so you can resolve pathway activity, cellular heterogeneity, and perturbation responses instead of pretending bulk tissue averages tell the whole story.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"2cb52927-dec2-49be-983f-a6109cbd6b4c","node_slug":"measure-sleep-spindle-events","node_name":"Measure Sleep Spindle Events","alternate_names":["Measure EEG Sleep Spindles"],"scope_statement":"Measures sleep spindle events in EEG or intracranial neurophysiology data with subject-specific detection thresholds and waveform features to quantify spindle density, timing, and morphology as a functional biomarker of sleep-state brain dynamics.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b84051d5-4990-4269-8032-c0071ebdee62","node_slug":"measure-somatic-mutational-signatures","node_name":"Measure Somatic Mutational Signatures","alternate_names":[],"scope_statement":"Measures recurrent somatic mutational signatures in single-nucleotide variants, indels, and structural variants to infer which DNA-damage and DNA-repair processes are active in cells; useful as a biomarker of genomic damage state, not a treatment.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"8fa3e7fe-ca58-4b5c-aaea-6fdf2f9cba98","node_slug":"measure-spinal-aging-phenotypes","node_name":"Measure spinal aging phenotypes","alternate_names":[],"scope_statement":"Measures age-linked molecular, histologic, and imaging changes in intervertebral discs, vertebral endplates, paraspinal muscle, and spinal alignment to chart how spinal degeneration presents and progresses across the lifespan.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"028ef310-05e1-4a19-a4f6-87bebfa246cf","node_slug":"measure-spinal-curvature-from-dxa","node_name":"Measure Spinal Curvature from DXA","alternate_names":[],"scope_statement":"Measures thoracic kyphosis, lumbar lordosis, or Cobb-angle-derived sagittal curvature from dual-energy X-ray absorptiometry scans to turn routine DXA imaging into a scalable structural aging-phenotype readout.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"99c306a5-11cf-418f-98ba-a2c0fb4d70bb","node_slug":"measure-stem-cell-fitness-ex-vivo","node_name":"Measure Stem Cell Fitness Ex Vivo","alternate_names":[],"scope_statement":"Measures colony formation, expansion kinetics, and viability of a patient's harvested stem cells ex vivo after toxic exposure to quantify stem-cell fitness and treatment readiness rather than to treat anything.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"105450ba-d2bb-406a-96e8-4b51d6b95b2b","node_slug":"measure-stress-recovery-resilience","node_name":"Measure stress recovery resilience","alternate_names":["estimate resilience from longitudinal biomarker variance","infer aging from biological age autocorrelation","Measure Aging With Stress Challenges","measure biological age autocorrelation","measure dynamic organism state indicator fluctuations","measure dynamic organism state resilience","Measure murine aging resilience","measure recovery kinetics of biological age","measure recovery-rate resilience","measure recovery time from physiological state trajectories","measure wearable-derived resilience loss","quantify resilience from biological age dynamics"],"scope_statement":"Measures how quickly and completely an organism returns to baseline after defined perturbations such as heat shock, infection, surgery, fasting, or exercise, and treats that response-and-recovery curve as a biomarker of biological robustness rather than another excuse to sell hormesis.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"17d28b4b-2008-4fc4-9ded-3c8eacb7578b","node_slug":"measure-structured-clinical-phenotypes","node_name":"Measure Structured Clinical Phenotypes","alternate_names":["Harmonize Clinical Records Longitudinally","Measure Agitation With Behavioral Scales","Measure Patients via Structured Intake","Standardize canine aging syndrome phenotyping"],"scope_statement":"Measure phenotypes, symptoms, comorbidities, and outcomes by capturing standardized questionnaires and medical-record variables in interoperable schemas such as OMOP, FHIR, SNOMED CT, ICD-10, and LOINC; it is data plumbing, not treatment.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b1a1de0c-ce24-47b3-a05d-26f520821440","node_slug":"measure-t-cell-repertoire-diversity","node_name":"Measure T-cell repertoire diversity","alternate_names":[],"scope_statement":"Measures T-cell receptor repertoire diversity and clonal expansion, usually by TCR sequencing, to track immune senescence and predict infection vulnerability and survival better than hand-wavy 'immune age' slogans.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"ed73a154-60ee-4fd9-b895-bd45749590e3","node_slug":"measure-tissue-glycation-burden","node_name":"Measure Tissue Glycation Burden","alternate_names":[],"scope_statement":"Measures accumulated advanced glycation end product burden in tissue, typically by skin autofluorescence or direct AGE adduct quantification, as a biomarker of cardiovascular risk rather than any grand plan to remove the damage.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"b545b306-f3cd-43dd-9945-4b48af22bb65","node_slug":"measure-tissue-state-multiplex-spatially","node_name":"Measure Tissue State Multiplex Spatially","alternate_names":["Discover neuromuscular junction state atlases","Measure muscle spatial-state remodeling","Measure Tissue State Profiles"],"scope_statement":"Measures tissue state in situ with multiplex spatial profiling methods such as imaging mass cytometry, CODEX, MIBI-TOF, MERFISH, and spatial transcriptomics to map cell types, niches, and immune architecture across the same section rather than pretending bulk averages are good enough.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"8ec4ce78-05cd-4827-b219-9ca3b1c4367b","node_slug":"measure-transgene-presence-with-fluorescence","node_name":"Measure transgene presence with fluorescence","alternate_names":[],"scope_statement":"Measures whether introduced genetic material is present in living tissue by coupling it to a fluorescent reporter such as GFP, mCherry, or tdTomato so expression can be verified without destroying the sample.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"511c01d7-e2b5-4d07-b88f-91f558d2d3d9","node_slug":"measure-with-open-consent-genomics","node_name":"Measure with open-consent genomics","alternate_names":[],"scope_statement":"Links identifiable whole-genome or exome data to longitudinal medical records under explicit participant consent so datasets can be reanalyzed, recontacted, and results returned without the childish fiction that human genomic data is truly anonymous.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"35657c19-1149-418c-a8e4-6bec427a4c33","node_slug":"monitor-aria-with-serial-mri","node_name":"Monitor ARIA with serial MRI","alternate_names":["Measure toxicity with serial imaging"],"scope_statement":"Uses serial brain MRI to detect treatment-emergent amyloid-related imaging abnormalities, especially ARIA-E and ARIA-H during anti-amyloid antibody therapy, and to decide whether dosing should continue, pause, or stop.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"a03eaa93-4fc8-4751-99bb-a959a23dba1e","node_slug":"stratify-multimodal-interventions-by-biomarkers","node_name":"Stratify multimodal interventions by biomarkers","alternate_names":["Link Biomarkers to Intervention Decisions","Measure pathology before treatment","Stratify Patients by Multi-Omics"],"scope_statement":"Stratifies people by measured deficits across markers such as ApoB, HbA1c, hs-CRP, blood pressure, VO2max, body composition, and sex hormones, then assigns combinations of established interventions instead of pretending one protocol fits everyone.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"93e06e3d-289a-4ca6-a290-59ef027a15a0","node_slug":"trace-flux-into-epigenetic-donors","node_name":"Trace Flux Into Epigenetic Donors","alternate_names":[],"scope_statement":"Traces isotope-labeled carbon through one-carbon and central carbon metabolism to quantify de novo biosynthesis of S-adenosylmethionine (SAM) and acetyl-CoA, so you can see how nutrient handling drives methylation and acetylation capacity rather than merely guessing from pool sizes.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"5139ce60-c547-4fd0-91ba-d0b2a299471b","node_slug":"validate-longitudinal-biomarker-reliability","node_name":"Validate Longitudinal Biomarker Reliability","alternate_names":[],"scope_statement":"Validates biomarkers with repeated-measures, test-retest, and within-subject variance analyses so a marker can track real change in one person over time instead of just wobbling around and pretending to be useful.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"69daf200-bcf9-43db-8489-3fe2de96c4ac","node_slug":"validate-surrogate-trial-endpoints","node_name":"Validate surrogate trial endpoints","alternate_names":["aging biomarker qualification","benchmark geroscience trial readouts","biological age assay validation","clinical-grade aging clocks","develop responsive clinical readouts","establish surrogate aging endpoints","improve efficacy assessment metrics","Measure Epigenetic Clock Responsiveness","operationalize biological age measures","qualify aging biomarkers","qualify surrogate outcome measures","surrogate endpoint development","translational biomarker standardization","Validate Aging Biomarker Readiness","validate biological age clocks","validate digital endpoints","validate novel trial endpoints"],"scope_statement":"Validates biomarker-based surrogate endpoints that predict hard clinical outcomes earlier and more reliably than waiting for disability, dementia, fracture, hospitalization, or death, using longitudinal cohorts, mediation analysis, and trial-level validation against outcomes such as all-cause mortality and major adverse cardiovascular events.","depth":1,"parent_node_id":"abcc14b9-69cb-4dcc-9415-bbb9aeb0eab7","probability_of_confirmation":null,"root_slug":"measuring","root_name":"Measuring","root_cluster":"method","root_canonical_statement":"Measurement infrastructure for biological aging — DNA-methylation clocks (Horvath, GrimAge), organ-specific aging clocks (MitoClock, AC4), proteomic / transcriptomic clocks, intrinsic-capacity metrics, prefrailty signals, MRI-based surrogate endpoints."},{"node_id":"810a79c9-2bba-4667-b429-90bbbc4b8fce","node_slug":"combine-causal-and-restorative-therapies","node_name":"Combine Causal and Restorative Therapies","alternate_names":[],"scope_statement":"Combines a root-cause molecular intervention such as CRISPR correction, AAV gene replacement, senolysis, or partial reprogramming with a second restorative treatment such as cell transplantation, tissue grafting, or pro-regenerative biologics to recover lost tissue mass or function while the upstream damage is being dealt with.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"c9c66041-af7a-41e5-b2c8-5de30a9c87dc","node_slug":"define-healthspan-trial-criteria","node_name":"Define healthspan trial criteria","alternate_names":["Calibrate Biomarker Eligibility Thresholds","Measure biomarker thresholds for enrollment"],"scope_statement":"Defines inclusion and exclusion criteria, prespecified primary and secondary healthspan endpoints, and supportive biomarker panels so an intervention can be tested with something better than wishful thinking.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"c8c480bf-16f5-4a42-8f3d-6fc1b8b8e2b8","node_slug":"detect-trial-data-anomalies","node_name":"Detect Trial Data Anomalies","alternate_names":[],"scope_statement":"Detects fabricated, duplicated, protocol-incompatible, or statistically implausible patient-level and site-level clinical trial records using central statistical monitoring, risk-based quality tolerance limits, metadata forensics, and source-data verification before efficacy or safety analyses mislead everyone.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"abef8aca-cdb2-4925-8151-f94e29118bf5","node_slug":"evaluate-human-response-signatures","node_name":"Evaluate Human Response Signatures","alternate_names":["Discover Mitophagy Response Biomarkers","Modulate pathways with aging signatures"],"scope_statement":"Evaluates how humans respond to interventions by comparing pre/post and responder/non-responder patterns across blood biomarkers, epigenetic clocks, transcriptomics, proteomics, metabolomics, or other multi-omic readouts in clinical cohorts rather than pretending the intervention explains itself.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"b9df8cfd-6557-4b66-ae1e-cc78cb4ee821","node_slug":"measure-anti-aav-immunity","node_name":"Measure Anti-AAV Immunity","alternate_names":[],"scope_statement":"Measures pre-existing anti-AAV neutralizing antibodies or capsid-binding antibodies to exclude participants with likely immune-mediated gene-therapy risk before AAV vector dosing.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"1401512a-abb1-45d8-8588-2260afdb0fc3","node_slug":"measure-biomarkers-the-same-way","node_name":"Measure Biomarkers the Same Way","alternate_names":["Standardize Aging Biomarker Definitions","Standardize mouse lifespan measurement"],"scope_statement":"Measures prespecified aging-relevant biomarkers with the same assays, specimen handling, collection windows, and endpoint definitions across intervention trials so effect sizes, responder subsets, and biomarker-to-clinical outcome links can be compared without the usual methodological sludge.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"7f7aebc3-e5c7-400d-95a9-8ac0b5669fbb","node_slug":"measure-donor-age-transfusion-effects","node_name":"Measure donor-age transfusion effects","alternate_names":[],"scope_statement":"Measures how blood donor age relates to recipient recovery, organ function, and survival in linked transfusion cohorts, using age-stratified exposures to plasma, red cells, or platelets as a human natural experiment rather than pretending this is an intervention.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"5a7f3ff3-0dc6-4469-86e0-bfb7216ddca3","node_slug":"measure-target-engagement-biomarkers","node_name":"Measure Target Engagement Biomarkers","alternate_names":["Measure CNS target engagement","Measure pharmacodynamic biomarkers","Measure tau target engagement"],"scope_statement":"Measures proximal target-engagement readouts such as receptor occupancy, phospho-protein changes, pathway reporter activity, or circulating drug-target complexes to show whether an intervention hit the claimed mechanism, instead of pretending placebo-soaked functional endpoints can answer that.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"39903898-71d8-4b7c-b156-11e0585757ea","node_slug":"operate-a-regulatory-trial-sandbox","node_name":"Operate a regulatory trial sandbox","alternate_names":["Accelerate first-in-human launches","Enable clinical trial cover","Operate Aging Trial Sandboxes","Operate post-Phase I access","Operate Regulatory Trial Pathways","Operate Regulatory Trial Sandboxes","Operate special trial jurisdictions","Pressure Regulators Through State Access","Route Therapies Across Regulators","Sandbox Experimental Therapy Access"],"scope_statement":"Creates a controlled access-and-observation framework that runs experimental interventions through expanded-access, named-patient, hospital-exemption, or other special-access pathways so dosing, monitoring, and iteration can happen outside standard marketing-approval trials.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"fed14df4-444c-4169-8b4a-6b105e827247","node_slug":"operate-cross-border-regulatory-transfer","node_name":"Operate cross-border regulatory transfer","alternate_names":["De-risk via Offshore Pilots"],"scope_statement":"Operates regulatory reliance, mutual-recognition, and harmonized GCP/GMP pathways so trial evidence, approvals, and site operating standards can move across jurisdictions without rerunning the whole circus country by country.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"4e2bb26f-96c1-4585-a2ff-12982c736a6b","node_slug":"operate-frailty-placebo-trials","node_name":"Operate frailty placebo trials","alternate_names":["Control With Sham Arms"],"scope_statement":"Operates randomized, double-blind, placebo-controlled intervention trials in frail older adults using predefined functional endpoints, biomarker panels, and adverse-event monitoring, because anecdotes are not data.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"f0f62cdf-ffdb-4cdd-bc77-99a9978a17d7","node_slug":"operate-multi-indication-trials","node_name":"Operate Multi-Indication Trials","alternate_names":["Test gerotherapeutics in disease"],"scope_statement":"Tests one intervention across distinct age-related indications in parallel or staged clinical programs to see whether a shared mechanism translates across multiple organ-specific manifestations, using basket-style, platform, or master-protocol trial designs rather than inventing a new therapeutic class.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"866bbfc3-9206-4351-9cdc-efe5ab5f2cc5","node_slug":"operate-pragmatic-healthspan-trials","node_name":"Operate Pragmatic Healthspan Trials","alternate_names":[],"scope_statement":"Operates pragmatic randomized trial infrastructure in adults aged 65+ to test simple interventions against hard-nosed functional endpoints such as frailty phenotype, Short Physical Performance Battery score, gait speed, grip strength, and sarcopenia.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"3c64c3fd-a5a9-4c71-88fa-2cd98d7f1a2e","node_slug":"optimize-human-trial-evaluation","node_name":"Optimize Human Trial Evaluation","alternate_names":["adaptive outcome analysis","AI-enabled trial execution","apply double-blind crossover testing","Blind trial assignment","clinical development operations tooling","clinical trial operations optimization","conduct randomized crossover trials","Control expectancy effects in trials","Control Expectation Bias in Trials","Control nocebo comparator bias","cross-trial harmonized efficacy readouts","digital trial operations","endpoint optimization","estimand-based analysis","Evaluate Therapies Rigorously","Harden Clinical Validation","longitudinal treatment-effect modeling","perform within-subject randomized trials","precision stratified trial analysis","run placebo-controlled crossover studies","sensitive endpoint design","statistical assay development","Track intervention adherence remotely","trial endpoint design","trial endpoint optimization","trial recruitment and site optimization","use blinded crossover trial design","Validate Clinical Trial Infrastructure"],"scope_statement":"Optimizes how human intervention studies are run and judged by tightening protocol design, randomization, blinding, adherence tracking, endpoint selection, statistical analysis plans, and outcome readouts rather than changing the intervention itself.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"ecff03df-4962-4dcf-a582-7e51ac1cd2a3","node_slug":"review-human-subject-protocols","node_name":"Review Human-Subject Protocols","alternate_names":["Operate independent therapy review gate","Operate Under Ethics Review"],"scope_statement":"Reviews experimental-therapy protocols through IRB or independent ethics oversight and documented informed consent before any human dosing, to screen risk, decisional capacity, and protocol quality rather than pretending oversight itself changes biology.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"79eda5f8-8984-4f44-b255-eec86d761e92","node_slug":"screen-with-preclinical-imaging-endpoints","node_name":"Screen with preclinical imaging endpoints","alternate_names":[],"scope_statement":"Screens candidate geroprotective compounds by using subclinical imaging readouts such as coronary artery calcium, carotid intima-media thickness, brain MRI volumetrics, retinal OCT, or DEXA-derived body composition as human trial endpoints before overt disease bothers to show up.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"6a469d25-745b-40e9-807e-7f35ec250521","node_slug":"test-interventions-in-n-of-1-trials","node_name":"Test Interventions in N-of-1 Trials","alternate_names":[],"scope_statement":"Tests an intervention by repeatedly randomizing, crossing over, and measuring outcomes within the same person so you can see whether that individual responds, instead of pretending the cohort average answers the question.","depth":1,"parent_node_id":"000f01f1-a42c-487d-873c-fa8d14e36105","probability_of_confirmation":null,"root_slug":"operating-trials","root_name":"Operating Trials","root_cluster":"method","root_canonical_statement":"Clinical-trial infrastructure capabilities — time-scale endpoint design, biomarker inclusion-criteria methodology, robust statistical methods for aging-trial readouts, trial-integrity analytics, regulatory-strategy support."},{"node_id":"5a535e58-3412-4d31-ad80-c2a3a0676ef7","node_slug":"engineer-therapeutic-delivery-formulations","node_name":"Engineer Therapeutic Delivery Formulations","alternate_names":["cold-chain resilient drug delivery","controlled drug administration","Deliver by interfacial digestion control","Deliver Cisplatin Locally","Deliver drugs through oral mucosa","Deliver drugs via biodegradable implant","Deliver lipids via alginate microbeads","Deliver Lipophiles Through Digestion","Deliver Lipophiles to Distal Gut","Deliver nonviral genetic payloads","Deliver via administration redesign","Deliver via Melanin Coatings","Deliver via Prodrug Design","lymphatic-targeted mucoadhesive delivery","mucoadhesive nanocarrier transport","mucoadhesive nanoparticle delivery","mucosal nanoparticle delivery","mucus-penetrating and retaining nanoparticle delivery","post-storage dose reliability","precision payload delivery","Protect payload with excipients","route-specific dosing","shelf-stable therapeutic delivery","site-specific delivery","stability-preserving drug delivery","storage-stable formulation and delivery","targeted drug delivery"],"scope_statement":"Improves how a therapeutic payload is administered and reaches its target by engineering formulations and delivery systems such as lipid nanoparticles, depot injectables, enteric coatings, microneedle patches, or receptor-targeted conjugates.","depth":1,"parent_node_id":"df0911ed-256c-461f-99f9-7bffaeabd30c","probability_of_confirmation":null,"root_slug":"translating","root_name":"Translating","root_cluster":"method","root_canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."},{"node_id":"fbdc8bf3-ed70-4580-95ee-d60d99936cf9","node_slug":"induce-canine-metabolic-dysfunction","node_name":"Induce Canine Metabolic Dysfunction","alternate_names":[],"scope_statement":"Induces an age-like metabolic phenotype in dogs by high-fat dietary overload, producing insulin resistance, dyslipidemia, and compensatory pancreatic beta-cell stress as an in vivo model for mechanism studies and intervention testing.","depth":1,"parent_node_id":"df0911ed-256c-461f-99f9-7bffaeabd30c","probability_of_confirmation":null,"root_slug":"translating","root_name":"Translating","root_cluster":"method","root_canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."},{"node_id":"434c4c93-470e-4414-966e-054b0de272b0","node_slug":"translate-approved-drugs-into-trials","node_name":"Translate Approved Drugs Into Trials","alternate_names":[],"scope_statement":"Moves approved compounds such as metformin, rapalogs, or SGLT2 inhibitors into human proof-of-concept by using drug repurposing, 505(b)(2) regulatory routes, pragmatic trials, and real-world evidence instead of waiting for de novo discovery to finish its nap.","depth":1,"parent_node_id":"df0911ed-256c-461f-99f9-7bffaeabd30c","probability_of_confirmation":null,"root_slug":"translating","root_name":"Translating","root_cluster":"method","root_canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."},{"node_id":"8e96952e-4090-4acd-8f0c-ee28a2f559b6","node_slug":"translate-interventions-into-humans","node_name":"Translate interventions into humans","alternate_names":["Conduct proof-of-concept geroscience trials","convert animal lifespan findings into therapies","cross-species gerotherapeutic translation","Evaluate geroprotectors in clinical trials","model-organism-to-mammal intervention translation","preclinical longevity translation","Run human geroscience trials","Test anti-aging interventions in humans","Translate longevity interventions to human studies","translate preclinical longevity hits"],"scope_statement":"Tests whether an intervention that worked in mice, rats, dogs, or nonhuman primates keeps a measurable pharmacodynamic, biomarker, safety, or efficacy signal in actual people using first-in-human studies, bridge biomarkers, PK/PD modeling, and translatable endpoints.","depth":1,"parent_node_id":"df0911ed-256c-461f-99f9-7bffaeabd30c","probability_of_confirmation":null,"root_slug":"translating","root_name":"Translating","root_cluster":"method","root_canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."},{"node_id":"6f28257c-e509-4f72-8702-7205cab74632","node_slug":"translate-via-companion-animal-models","node_name":"Translate via Companion-Animal Models","alternate_names":["bridge with companion-dog data","canine translational de-risking","companion animal translational studies","comparative translational medicine","Measure canine aging biomarkers","naturally occurring disease models in pets","pet dog translational bridge","run companion-dog bridge studies","translate via canine real-world evidence","use client-owned dogs as a translational model","Validate in Companion Disease Models","veterinary clinical translation"],"scope_statement":"Uses naturally occurring disease in companion animals, especially pet dogs, as an intermediate translational model to test intervention effects, dosing, biomarkers, and clinical endpoints before betting on humans.","depth":1,"parent_node_id":"df0911ed-256c-461f-99f9-7bffaeabd30c","probability_of_confirmation":null,"root_slug":"translating","root_name":"Translating","root_cluster":"method","root_canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."},{"node_id":"09a790a4-1ef5-495c-9346-07ac0acc4387","node_slug":"validate-biomarkers-across-species","node_name":"Validate biomarkers across species","alternate_names":[],"scope_statement":"Tests whether biomarker panels, epigenetic clocks, frailty indices, and intervention responses agree across humans and parallel animal models such as mice, dogs, and nonhuman primates before anyone pretends they are clinic-ready.","depth":1,"parent_node_id":"df0911ed-256c-461f-99f9-7bffaeabd30c","probability_of_confirmation":null,"root_slug":"translating","root_name":"Translating","root_cluster":"method","root_canonical_statement":"Cross-species and lab-to-clinic translation infrastructure — canine geriatric-syndrome models, extreme-longevity species research (naked mole rat, bowhead whale, hibernating mammals), comparative-genomics-driven human-mechanism discovery, radiation-resistance biology, conserved-pathway validation."}]},"counts":{"roots":13,"nodes":356},"generated_at":"2026-09-27T04:38:23.781Z","access_level":"public"}